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 RATIONAL DESIGN OF CALCIUM BIOSENSORS 
by 
APRIL L. ELLIS 
Under the Direction of Jenny J. Yang 
ABSTRACT 
 
 Understanding the temporal and spatial changes in calcium concentration has 
been a difficult endeavor for many years due to the relatively small changes in calcium 
concentration during messenging events, the rapid changes upon physiological 
messenging, and the unavailability of fast, efficient, and sensitive sensors to detect 
calcium changes.  In addition, the key factors in calcium binding have yet to be 
determined due to the metal-metal interactions, cooperativity, and conformational 
change involved in calcium binding to natural calcium-binding proteins.  To overcome 
these obstacles and to engineer calcium sensors for in vivo studies of calcium signaling 
events, calcium binding sites have been engineered into Green Fluorescent Protein.  
The engineered binding sites demonstrate terbium binding affinity from 2-30 µM and 
calcium binding affinity from 50-100 µM.  Site 177 demonstrates green fluorescence 
when expressed in mammalian cells and produces a response to calcium concentration 
changes when expressed in the cytosol.  Addition of the cycle 3 mutations (M153T, 
V163A, F99S) to Site 177 allowed for increased brightness in the emission of the 
chromophore but still exhibited calcium response.  The second generation Site 1 
 demonstrates fluorescence response to calcium concentration changes when 
expressed both in the cytosol and in the endoplasmic reticulum.  Addition of M153T and 
V163A to Site 1 allowed for expression of fluorescent protein at 37 °C in HeLa cells and 
at 30 °C in bacteria.  Site 1-M153T/V163A exhibits chromophore fluorescence response 
to calcium with a Kd of 100 µM and competition with Rhodamine-5N produced a calcium 
Kd of 107 µM.  This designed sensor, Site 1-M153T/V163A is the first demonstration of 
a designed calcium binding GFP with calcium response measured both in vivo and in 
vitro. 
 
INDEX WORDS: calcium, green fluorescent protein, protein design, metal binding, 
calcium sensor 
 RATIONAL DESIGN OF CALCIUM BIOSENSORS 
 
by 
 
APRIL L. ELLIS 
 
 
A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy 
in the College of Arts and Sciences 
Georgia State University 
 
 
 
 
 
 
 
 
 
 
2006
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
April Lee Ellis 
2006 
 RATIONAL DESIGN OF CALCIUM BIOSENSORS 
 
by 
 
APRIL L. ELLIS 
 
 
 
 
 
 
Major Professor: Jenny J. Yang 
Committee:  W. David Wilson 
Giovanni Gadda 
Vincent Rehder 
Charles Louis 
 
Electronic Version Approved: 
 
Office of Graduate Studies 
College of Arts and Sciences 
Georgia State University 
May 2006 
 
 
 iv
Dedication 
This body of work has been a difficult endeavor for six years, but there have 
been many people who have cheered me along and lent me their support.  First, I must 
dedicate this work to my mother, Linda Ellis, and my father, James A. Ellis, Jr., for 
without them I would never have made it through.  They are the best people in the world 
and have always told me I could do anything I set my mind to do.  They have never 
pushed and have been proud of me for every accomplishment.  Mom, thanks for being 
my best friend in the world.  Dad, thanks for not treating me like a girl and teaching me 
to drive a Bobcat.  My friends have also helped me to get through by allowing me to 
vent my frustrations with this project, to lend a hand or advice for experiments and data 
analysis, and to just generally be “there”.  Dr. Anna Wilkins Maniccia (grad school was 
the best because of you banana), John Maniccia (how do you put up with us?), Dr. 
Doyle J. Barrow, Jr. (“I’ve got the ways and means to New Orleans”….thanks for 
introducing me to experiences outside of science), Hsiau-Wei Lee (friends for so long, 
don’t forget me), and Katheryne Donald (the friend of my youth, may things be different 
in the future) have been the best a girl could ask for in support and help.  My family has 
been wonderful and have each expressed their pride in my accomplishments.  Thanks 
ya’ll.  I must also thank my grandparents for their solid foundation of our family and for 
making sure I remember my roots even with all of my education.  Lastly, my heart and 
my sweet pea, you have kept me at peace and with a tranquil state while reminding of 
the fun and spice of life, thank you. 
 v
Acknowledgements 
Many people have assisted in the studies summarized in this work both directly 
and indirectly.  First, my adviser Dr. Jenny J. Yang has pushed and prodded to make 
me into the researcher that I am today.  She always backed us and took care of us.  Dr. 
Yang’s research group has my thanks for all of their help, especially Angela Holder and 
Yun Huang (Nancy).  Their help with this project is immeasurable. Thank you to our 
summer student Dorinda Nelson for her help in expression of the GFP variants. 
Our collaborators, Dr. Charles Louis and Dr. Monica Lurtz of UC Riverside, Dr. 
Vincent Rehder and Kristy Welshhans of GSU, and Dr. Aldebaran Hofer of Harvard 
University have provided studies of our sensors and experimental planning and 
discussion, which is all much appreciated.  Dr. Myron Williams of Clark Atlanta 
University, Dr. Teryl Frey of GSU, and the late Dr. Alec Hodel of Emory University 
helped us to initiate this project and their assistance is much appreciated. 
Technical support provided by Birgit Neuhaus (confocal facility) and Don Aiken 
(Zeiss International) is greatly appreciated. 
My dissertation committee, Dr. Charles Louis, Dr. David Wilson, Dr. Giovanni 
Gadda, and Dr. Vincent Rehder are immensely thanked for their assistance in the 
completion of my degree requirements. 
To all of the professors at GSU during my undergraduate and graduate career, 
thank you!  You all made me appreciate and love science.  Thanks to Dr. Jerry Smith for 
suggesting that I complete a PhD. 
 vi
The American Heart Association and the Brain and Behavior program are much 
thanked for funding of my predoctoral fellowships.  The NIH and NSF are thanked for 
funding.
 vii
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS v
LIST OF TABLES xii
LIST OF FIGURES xiv
CHAPTER 
 
1    INTRODUCTION 1
     1.1 Calcium Signaling and Homeostasis 1
     1.2 Drugs and Agonists Involved in Calcium Signaling 3
     1.3 Current Methods to Monitor Calcium Concentration 7
     1.4 Criteria for an Ideal Sensor 17
     1.5 Green Fluorescent Protein 19
     1.6 Calcium-binding Proteins and Calcium-binding Sites 27
     1.7 Our Design Approach and Previous Work in the Yang Lab 33
     1.8 Our Approach to Engineer Calcium Sensors 34
     1.9 The Objective of this Dissertation 37
     1.10 The Significance of this Dissertation 38
2   MATERIALS AND METHODS 40
2.1 Near Infrared Calcium-binding Dye 15C5-774 40
2.2 Site-directed Mutagenesis 43
2.3 Competent Cell Preparation 44
 viii
2.4 Incorporating EGFP Gene in Different Vectors 48
2.5 Expression and Purification of Histidine tagged GFP 48
2.6 Hitrap Q Purification 53
2.7 Protein Refolding with Urea 53
2.8 Circular Dichroism of Variant Proteins 54
2.9 Thermal Denaturation of Designed Proteins by Circular 
Dichroism 
 
54
2.10 GFP Fluorescence Spectroscopy 55
2.11 Measuring Metal Effects on Histidine Tagged Proteins 55
2.12 Metal Binding Analysis 56
2.13 Terbium Binding Affinities for the Variant Proteins 60
2.14 Protein-dye Calcium Competition 61
2.15 Protein-Terbium Metal Competition 62
2.16 pKa Measurements of EGFP and EGFP Variants 63
2.17 Quantum Yield Measurements of EGFP, L194N, and L15N 65
2.18 Chromophore Reduction 66
2.19 Mammalian Cell Culture 66
2.20 Cryogenic Stock Preparation 68
2.21 Plate Preparation and Transfection of Sensor DNA 69
2.22 Fluorescence Imaging of Variant Proteins by Inverted 
Epifluorescence 
 
69
2.23 Calcium Response by Inverted Epifluorescence Microscopy 70
 ix
2.24 Calcium Response by Confocal Microscopy 72
2.25 Transfection of 177c3 for Suspension Growth in HeLa Cells 73
2.26 Fluorescence of 177c3 after Expression in Suspension HeLa 
Cells 
 
74
3    STUDY OF A CALCIUM-BINDING NEAR INFRARED DYE 75
3.1 Rationale for Development of Near Infrared Calcium Sensitive 
Dye 
 
75
3.2 Design of 15C5-774 76
3.3 Solution properties of 15C5-774 78
3.4 Metal binding affinities and selectivity of 15C5-774 78
3.5 pH dependence 83
3.6 Comparison of 15C5-774 and commercially available dyes 85
3.7 Conclusions 86
4   DESIGN OF CALCIUM-BINDING SENSORS: the first generation 88
4.1 Rationale for Engineering Calcium Biosensors by Design 88
4.2 Design of Potential Calcium Binding Sites 89
4.3 Engineering a Calcium-binding Protein 105
4.4 Expression and Purification of EGFP and Calcium-binding 
Variants 
 
108
4.5 Investigation of Histidine Tag Interference by Interactions with 
Metal Ions 
 
123
4.6 Metal-binding of Designed Proteins 130
4.7 Optical Properties of EGFP and the Designed Proteins 157
 x
4.8 Conformation Analysis of Secondary Structure by CD 168
4.9 Endeavoring to Understand Fluorescence Loss of the 
Designed Proteins 
 
174
4.10 Disulfide Bonds and Chromophore Reduction 188
5    THE EVOLUTION OF SENSOR 177 196
5.1 Mammalian Screening of Designed Proteins 196
5.2 Expression of Designed Proteins in Mammalian Cells 199
5.3 Engineering a Brighter Sensor: incorporation of the cycle 3 
mutations 
 
212
5.4 Calcium response of 177 and 177c3 in the cytosol 224
5.5 Calcium Response of Sensors 177 and 177c3 when 
Expressed in the ER 
 
239
5.6 Calcium response of 177c3 in vitro 247
5.7 Major Findings 254
6    SECOND GENERATION OF DESIGNED SENSORS 255
6.1 Lessons Learned: design of a second generation of sensors 255
6.2 Protein Engineering of Calcium Sensors 260
6.3 Mammalian Expression of the Second Generation 262
6.4 Site 1 Calcium Response in Vivo 268
6.5 Site 1 in Vitro Profile and Calcium Response 276
6.6 Creation of Site 1 cycle 3 282
6.7 Major Findings 
 
295
 xi
7    CONCLUSIONS AND MAJOR FINDINGS 299
7.1 Major Findings of the Designed Calcium-binding Proteins 299
7.2 Expression of Designed Proteins in Mammalian Cells 301
7.3 Major Findings from In Vivo Imaging of Calcium Response 302
7.4 Major Findings of the Second Generation of Designed Proteins 304
7.5 Major Findings of the in Vivo Calcium Measurements of Site 1 305
REFERENCES 306
 
 xii
LIST OF TABLES 
1.1  Agonists to induce calcium change in the cell 6
1.2  Summary of GFP mutations 23-26
2.1 Primers for the first generation of designed proteins 45
2.2 Primers for the second generation of designed proteins 46
2.3 FPLC programs for the His tag purification 52
2.4 Example spreadsheet for input in Specfit/32 57
2.5 A list of the buffers utilized for pH dependence measurements 64
3.1 Binding affinities of 15C5-774 and the ionic radii of the metals 
studied 
 
82
4.1 Solvent accessibility of GFP (1b9c) calculated by GetArea 92
4.2 The design sites engineered into Green Fluorescent Protein 101
4.3 Summary of the conditions tested to provide EGFP variant 
fluorescence 
 
113
4.4 A list of the metals studied for interference with histidine tagged 
proteins with the ionic radius and coordination numbers 
 
129
4.5 The binding affinities, ligands, and charge of the amino acids in 
the binding pocket of the designed proteins 
 
137
4.6 A summary of the surrounding positive and negative charges for 
each studied binding pocket 
 
155
4.7 A table of the partial sites studied with the final fluorescent 
mutations shown in green 
 
175
4.8 The pKa values of EGFP, L15N, and L194N as measured by 
absorbance and fluorescence in various buffers to maintain the 
pH at each desired value 
 
180
 xiii
4.9 A summary of the quantum yield and extinction coefficient 
measurements for EGFP, L15N, and 194N 
 
189
5.1 A summary of the four mammalian cell lines utilized in the 
characterization of the designed GFP calcium-binding proteins 
 
198
5.2 Primers to insert the ER signal tags into EGFP variants 240
6.1 The second generation designed proteins are detailed with the 
calcium-binding pocket ligands, the charges introduced by 
mutation to the binding ligands, and the similar first generation 
sites 
 
256
6.2 The order of the mutagenesis performed for the second 
generation 
261
 
 xiv
LIST OF FIGURES 
1.1  Calcium’s role in the cell 2
1.2  Process to induce calcium change in the cell 4
1.3  BAPTA structure 8
1.4  TF-BAPTA spectra with calcium 8
1.5  Fura-2 structure 10
1.6  Rhodamine-5N structure 10
1.7  Structure of apo and calcium-loaded aequorin 14
1.8  Illustrations of Persechini’s constructs 15
1.9  Structure and spectra of Green Fluorescent Protein 20
1.10 Chromophore formation of GFP 22
1.11 The two possibilities of fluorescence change caused by calcium 
binding to a designed fluorescent protein 
 
28
1.12 Pentagonal bipyramidal geometry of calcium binding 30
1.13 Continuous calcium binding sequence of the EF hand and 
examples of natural calcium-binding proteins 
 
31
1.14 Proteinase K with the calcium binding sites highlighted 32
1.15 Designed protein 7E15-CD2 35
2.1 A screen capture of Specfit/32 is shown to illustrate the program’s 
use in calculating binding affinities 
 
59
3.1 Synthesis of 15C5-774 77
3.2 Absorbance spectra of 19.52 µM 15C5-774 with increasing 
concentrations of CaCl2  
79
3.3 Fractional change of the absorbance at 774 nm as a function of 
Ca2+ concentration 
81
 xv
 
3.4. A comparison of the Ca2+ free and Ca2+ loaded spectra of 15C5-
774 at pH 6, pH 7.4, and pH 8.7 
 
84
4.1 The ideal pentagonal bipyramidal geometry of a calcium binding 
site with the oxygen-calcium-oxygen angles (ϕ1), (ϕ2), and (ϕ3) 
illustrated 
 
91
4.2 Illustrations of the models highlighting the locations of the 
designed proteins  
 
102
4.3 DNA and protein sequence of the host EGFP  106
4.4 The vector map of pet28a  107
4.5 SDS-PAGE gel and room light and fluorescent images of the cell 
pellet after expression of EGFP  
 
109
4.6 SDS-PAGE gel and cell growth curve of the expression of 120 
and 177  
 
110
4.7 A graph of the Fluostar microplate assay results for the 
expression of designed protein 194a and four of its variants, 
K85D, S86D, L194N/K85D, and L194N/S86D 
 
112
4.8 Purification scheme for EGFP utilizing the Hitrap nickel chelating 
column 
 
116
4.9 SDS-PAGE gel and room light and fluorescent images of the 
purification of EGFP  
 
117
4.10 SDS-PAGE gel of purification fractions after FPLC of EGFP 
illustrating dimer formation of the protein 
 
118
4.11 SDS-PAGE gels of site 120 purification 120
4.12 Emission spectra (excitation at 482 nm) of 10 µM GFP without 
and with 1 mM calcium 
 
125
4.13  Fluorescence spectra and metal binding fit of the nickel titration 
of histidine tagged GFP-S65T  
 
126
 xvi
4.14 Overall fluorescence emission decrease at 510 nm when excited 
at 482 nm of GFP-S65T caused by interference of the histidine 
tag with metals 
 
127
4.15  Structure of EGFP with the tyrosines and tryptophan highlighted 132
4.16 Fluorescence spectra with excitation at 280 nm and binding 
curve of terbium bound to a designed variant, 177  
 
133
4.17 Fluorescence spectra with excitation at 280 nm and binding 
curve of terbium bound to a designed variant, 120  
 
134
4.18 Fluorescence spectra with excitation at 280 nm and binding 
curve of terbium bound to a designed variant, 194a  
 
135
4.19 Fluorescence spectra with excitation at 280 nm and binding 
curve of terbium bound to a designed variant, 194b  
 
138
4.20 Fluorescence spectra of the binding competition of 177 with 
terbium for other metals  
 
140
4.21  The decrease in terbium FRET enhancement observed when 
other metals compete for binding to site 120  
 
141
4.22  The spectra of the titration of Rhodamine-5N with calcium  143
4.23 Fluorescence spectra and Specfit/32 fit of Rhod-5N in 
competition with Site 177 for calcium binding  
 
145
4.24 Fluorescence spectra and Specfit/32 fit of Rhod-5N in 
competition with Site 194a for calcium binding  
 
147
4.25 Specfit/32 global fit of the competition of 45 µM L194N/S86D and 
20 µM Rhod-5N for calcium binding  
 
149
4.26 Fit of the competition of 45 µM L914N/S86D and 20 µM Rhod-5N 
for calcium with a competition equation 
 
150
4.27 Chromophore emission change of L194N/S86D upon addition of 
calcium  
 
151
 xvii
4.28 Illustrations of the three studied binding sites  154
4.29 Absorbance spectra and neutral and anionic states of the 
chromophore of EGFP 
 
158
4.30 Absorbance spectra of EGFP at pH 4 and pH 7.4  160
4.31 Absorbance spectra of EGFP and the designed protein 177 161
4.32 Emission spectra of GFP with the water scattering peak evident 
as it changes emission wavelength along with a change in the 
excitation wavelength 
 
163
4.33 Aromatic fluorescence emission with excitation at 280 nm of 
L194N/S86D  
 
164
4.34 Emission of EGFP L194N/S86D with varying excitations to 
illustrate the energy transfer from the aromatics to the 
chromophore 
 
165
4.35  Energy transfer of EGFP observed between the aromatics and 
the chromophore 
 
166
4.36 Circular dichroism of EGFP  169
4.37 Circular dichroism of 120, 177, and 194a  170
4.38 CD spectra of designed protein 194a with calcium, lanthanum, 
and terbium  
 
171
4.39 CD spectra of designed protein 120 at various pH values  173
4.40 Pymol picture of EGFP site 120 to illustrate the position of V120  177
4.41 An illustration of the 194 family of designed proteins  178
4.42 Absorbance spectra of EGFP at various pH  181
4.43 pKa plots of the absorbance at 398 nm and 488 nm of EGFP at 
various pH  
 
183
4.44 EGFP pH dependence by fluorescence with excitation at 398 nm 
and 482 nm 
184
 xviii
 
4.45 pKa plots of the fluorescence at 510 nm and 450 nm with 
excitation at 398 nm EGFP  
 
185
4.46 pKa plot of the fluorescence at 510 nm with excitation at  482 nm 
EGFP at various pH  
 
186
4.47 Absorbance and fluorescence spectra of EGFP at various 
concentrations to calculate the quantum yield  
 
190
4.48 Absorbance and fluorescence spectra of L15N at various 
concentrations to calculate the quantum yield  
 
191
4.49 Extinction coefficient calculation for EGFP at 488 nm  192
4.50 Extinction coefficient calculation for L15N at 280 nm  193
4.51 L194N/S86D in 10% β-mercaptoethanol with and without calcium  195
5.1 Vector map and details of the pcDNA3.1+ vector from Invitrogen 200
5.2 Images of site 120 in HeLa cells  201
5.3 Images of 194a in HeLa cells  201
5.4 Images of Site 120b in CHO cells  203
5.5 Images of Site 229 in HeLa cells  203
5.6 Images of L15N/R122D in CHO cells  204
5.7 Images of L194N/S86D in HeLa cells  205
5.8 Images of Site 177 expressed in HeLa cells  205
5.9 Site 177 with different  amounts of DNA transfected into HeLa 
cells  
 
208
5.10 Images of EGFP transfected into Vero cells at different 
DNA:liposome ratios  
 
209
 xix
5.11 Images of Site 177 expressed in Vero cells at different DNA 
concentrations  
 
210
5.12 Images of Site 177 expressed in CHO cells  211
5.13 EGFP with Site 177 ligands and the cycle 3 mutations  214
5.14 Images of 120c3 and 194a-c3 in HeLa cells  216
5.15 Images of site 177 in HeLa cells  218
5.16 Images of Site 177 in CHO cells  219
5.17 Expression of 177 and 177c3 in HeLa cells at 30 °C 220
5.18 Images of 177c3 expressed in HeLa cells at 30 °C  and 37 °C  222
5.19 Imaging on the inverted Nikon microscope of EGFP expressed in 
HeLa cells with induction of calcium concentration change 
 
226
5.20 Calcium response of Sensor 177 expressed in the cytosol of 
HeLa cells  
 
227
5.21 Averaged and normalized data of Sensor 177’s in vivo calcium 
response 
 
228
5.22 Statistical evaluation of the calcium response imaging of 
cytosolically expressed 177 in HeLa cells  
 
229
5.23 Imaging of cytosolically expressed 177 in HeLa cells with 
addition of 50 µM ATP  
 
231
5.24 Imaging of cytosolically expressed 177 in HeLa cells with 
addition of thapsigargin and calmidazolium 
 
232
5.25 Imaging of cytosolically expressed EGFP in HeLa cells on the 
Zeiss Axiovert 200 microscope  
 
233
5.26 In vivo calcium response of 177 as imaged by the Zeiss Axiovert 
200  
 
234
 xx
5.27 In vivo calcium response of 177c3  237
5.28 In vivo calcium response of 177c3 in HeLa cells imaged on the 
Zeiss Axiovert 200 
 
238
5.29 Confocal images of Sensor 177-ER cotransfected with DsRed2-
ER in HeLa cells  
 
242
5.30 Colocalization of 177c3-ER and DsRed2-eR in HeLa cells  243
5.31 Calcium response of 177-ER with the addition of ATP 245
5.32 Response of 177c3-ER as imaged by confocal microscopy  246
5.33 Excitation  and emission spectra of 177c3 in cell supernatant  249
5.34 Emission spectra of 177c3 lysate with increasing calcium 
concentration 
 
250
5.35 Excitation and emission spectra of EGFP with and without 
calcium 
 
253
6.1 Models of the second generation of designed calcium-binding 
proteins  
 
258
6.2 Images of the first round of mutations for Site 1, L194E/S86D, 
expressed in HeLa cells 
 
264
6.3 Images of Site 1 expressed in HeLa cells with all three mutations 265
6.4 Site 2 partial mutations of R122E/V120S expressed in HeLa cells 265
6.5 Site 5 with mutations L7D/V12N expressed in HeLa cells 267
6.6 Site 1 calcium response in HeLa cells  270
6.7 Calcium response of Site 1 expressed in HeLa cells obtained on 
the Nikon inverted epifluorescence  microscope 
271
6.8 ER targeted Site 1 cotransfected with DsRed2-ER and calcium 
response of Site 1-ER by confocal microscopy 
 
273
6.9 Control experiments of EGFP-ER expressed in HeLa cells  274
 xxi
6.10 Fluorescence imaging for calcium response of Site1-ER 
expressed in HeLa cells  
 
275
6.11 SDS-PAGE gels of the purification of Site 1-His/pcDNA  278
6.12 SDS-PAGE gel of the partitioning by molecular weight of Site 1 
expressed in HeLa cells 
 
279
6.13 Excitation and emission spectra for Site 1 cell lysate  281
6.14 Excitation and emission spectra for Site 1 cell lysate with 
increasing calcium concentration 
 
283
6.15 Images of Site 1 expressed in HeLa cells at 30 °C  and 37 °C for 
48 hr 
 
285
6.16 Images of Site 1-M153T/V163A expressed in HeLa cells at 30 °C 
and 37 °C for 48 hr 
 
286
6.17 Images of Site 1 expressed in HeLa cells at 30 °C and 37 °C  for 
72 hr  
 
287
6.18 Images of Site 1-M153T/V163A expressed in HeLa cells at 30 °C 
and 37 °C for 72 hr 
 
288
6.19 Fluostar microarray results of the expression of Site 1-
M153T/V163A in bacteria 
 
290
6.20 SDS-PAGE gel of the expression of Site 1-M153T/V163A in E. 
coli  
 
291
6.21 Excitation and emission with excitation at 398 nm  spectra of Site 
1-M153T/V163A with calcium after expression in E. coli 
 
293
6.22 Calcium induced chromophore emission change for Site 1-
M153T/V163A expressed in E. coli with excitation at 482 nm  
 
294
6.23 Rhodamine-5N competition with Site 1-M153T/V163A for 
calcium binding  
 
296
6.24 The Specfit results of the competition between Site 1-
M153T/V163A and Rhodamine-5N 
297
 
  
Chapter 1 Introduction 
1.1 Calcium Signaling and Homeostasis 
As a secondary messenger, calcium regulates many biological processes in 
various intracellular compartments (Fig 1.1) (1, 2).  First isolated by Sir Humphrey Davy 
in 1808, calcium was named for the latin calx, meaning lime.  Further studies in the last 
two centuries have revealed that calcium is involved in muscle contraction (including 
heartbeat), is the major component of bones and teeth, and is involved in vision and in 
neuronal signaling (3-7).  Normally, during rest conditions, the intracellular calcium 
concentration is ~0.1 to 1.0 µM (8).  When the cell is excited, its intracellular calcium 
concentration can rise up to ~10 µM by release from internal calcium stores in the 
endoplasmic reticulum (ER) or by entering the cell from the extracellular matrix through 
the action of calcium pumps (9).  The cellular compartments are also involved in 
calcium signaling.  In the ER, calcium is stored in its free form and in complex with 
proteins, such as calsequestrin, and is thought to range in concentration from 100 µM to 
1 mM (1).  Calcium is released from the ER in response to IP3 (inositol 1,4,5-
triphosphate) binding to IP3 receptors, which is an element of numerous signal 
cascades, such as in response to histamine.  In the mitochondria, calcium has been 
observed to play a role in metabolism.  When mitochondrial calcium is decreased, the 
rate of metabolism is decreased and, therefore, the rate of ATP production is decreased 
(10).  In addition, mitochondrial uptake of calcium regulates the calcium wave induced 
by ER release of calcium by decreasing the amount of calcium in the cytosol available  
1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.1 Calcium’s role in the cell modified after Malviya and Rogue (11). 
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for sensitizing the IP3 receptors.  The sensitization of the IP3 receptors allows for 
calcium induced calcium release from the ER, promoting a calcium wave across the cell 
and turning on other signals.  When the mitochondria uptakes calcium, it slows this 
wave and, in turn, controls other signaling events (12).   
Both overloading and depleting the calcium concentration inside cells is directly 
related to different disease states in human health, such as Marfan’s Syndrome and 
Osteoporosis (13, 14).  Mishandling of calcium, such as inappropriate protein binding or 
release can turn on or off many signals that could lead to disease states or death, such 
as malignant hyperthermia (15-19).  Calcium’s prevalence throughout the biological 
system is well-known and some of its actions have been well-studied, but the temporal 
and spatial changes of calcium in response to various processes is not well understood.  
As shown in figure 1.1, many proteins are calcium ion dependent for their function, 
including calmodulin, a signaling protein whose functions in the regulation of more than 
100 biological processes are controlled by calcium binding, which allows calmodulin to 
bind to target molecules (20-25).  The troponin family of proteins confer calcium 
sensitivity to muscle cells, allowing for contraction and relaxation as the calcium 
concentration changes (26).  Monitoring the effects of calcium on the abundant cellular 
processes has, thus far, been a difficult endeavor due to numerous factors, such as lack 
of sensitive and fast sensors. 
1.2 Drugs and Agonists Involved in Calcium Signaling 
 There are abundant agonists that bind to receptors on the cell surface or on the 
ER membrane that induce calcium response.  Figure 1.2 illustrates a few of those  
3
  
 
 
 
 
 
 
Fig 1.2 Examples of the various means to modify calcium concentration in the cell are 
illustrated. 
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pathways.  As shown in table 1.1, the most noted response is the binding of an agonist, 
such as ATP or histamine, to G-protein coupled receptors.  This binding induces IP3 
release by breakdown of phosphotidylinositol-4,5-bisphosphate into IP3 and 
diacylglycerol (DAG) by phospholipase C.  The released IP3 then binds to IP3 receptors 
on the ER membrane, stimulating calcium release from the ER and, in turn, increasing 
cytosolic calcium.  Calcium can then bind to calcium binding proteins, such as 
calmodulin, to signal other processes to occur.  Bradykinin, a small peptide, also 
stimulates this pathway by binding to G-protein coupled receptors.  DAG produced 
during this process increases the affinity of protein kinase C for calcium, thereby 
stimulating its action.   
 Another process utilized by neuroscientists is the binding of carbachol, an 
acetylcholine analog that does not hydrolyze, to muscarinic receptors expressed by 
neural cells and smooth muscle cells.  Carbachol binding induces calcium oscillations in 
the cytosol, again invoking other signal pathways (27). 
 Calcium is, quite often, its own agonist.  Calcium Induced Calcium Release 
(CICR) causes Ryanodine Receptors to release calcium, which triggers other events.  
Ryanodine Receptors are located on the ER membrane in certain cell types and can 
completely empty the ER of calcium (8, 9). 
 Sphingosine-1-phosphate, when present in the extracellular matrix, can trigger 
calcium release from the ER when the ceramide production pathway is induced.  
Sphingolipids are involved in many processes and are known to regulate cell growth  
5
  
Table 1.1 A table of the most common agonists to induce intracellular calcium change. 
Drug/Agonist Use Cell Type 
Ionomycin 
H+/Ca2+ Exchanger 
Forms channels shuttling Ca2+ into the cell 
At low concentrations, cytosolic calcium increase 
At high concentrations, said to act on ER as well 
HeLa 
HEK293 
Cos7 
Carbachol 
Binds to muscarinic receptors (acetylcholine receptors) 
and causes Ca2+ oscillations in the cytosol 
HEK293 
Neurons 
ATP Ca2+ release from ER due to IP3 activation Any 
Histamine Ca2+ release from ER by acting as an IP3 agonist Any 
Cyproheptadine 
Histamine inhibitor used to reverse or stop Ca2+ release 
by histamine action 
Any 
Soponin/digitonin 
Detergents that create pores in the cell membrane 
allowing calcium entry or other drugs 
Any epithelial 
Bradykinin 
Ca2+ release from the ER by stimulating production of 
phospholipase C, which makes IP3 and triggers the IP3 
pathway 
Fibroblasts 
Vascular 
endothelial 
IP3 or InsP3 
Inositol 1,4,5-
triphosphate 
With addition of a detergent, IP3 entering the cell binds 
to the IP3 receptor on the ER causing a Ca2+ release 
from the ER 
Any epithelial 
Thapsigargin 
Block Ca2+ reuptake pumps in ER allowing slow Ca2+ 
leak 
Any 
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and death.  Calcium’s involvement in this process is not yet well understood, but 
investigations are currently underway (28, 29). 
 In Calcium Signalling, Hofer details the use of TPEN (tetrakis-(2-pyridylmethyl) 
ethylenediamine) to decrease ER calcium to a large extent (30).  TPEN has been used 
as a heavy metal scavenger, but has also been found to be permeable to the cell 
membrane.  After entering cells, TPEN binds calcium and becomes trapped so it does 
not leak out of the cells.  In addition, since TPEN is membrane permeable, there is no 
need to permeabilize the cells with detergent. 
1.3 Current Methods to Monitor Calcium Concentration 
 1.3.1 Small molecules to monitor calcium 
 Currently, many approaches are taken to study calcium including calcium-binding 
dyes and protein-based sensors.  Commercially available dyes are obtainable in a wide 
variety of colors, spectroscopic properties, and binding affinities.  Many of the dyes are 
cell permeable esters and are loaded into mammalian cells through simple incubation.  
Molecular Probes offers numerous calcium binding indicators with spectra ranging from 
the ultraviolet to the red (31).  The binding affinities range from 60 nM to hundreds of 
micromolar.  Largely, the dyes are BAPTA-based indicators with different functional 
groups to change the binding affinities and the colors.  BAPTA        
(1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) is a strong calcium chelator 
(Kd = 60 nM) based on EGTA that functions by binding calcium with the four acetic acid 
moieties in the structure (Figs 1.3 and 1.4).  The absorbance of BAPTA is calcium 
dependent with a decrease evident at 250 nm as calcium is increased (31-33). 
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Fig 1.3 The structure of BAPTA, a calcium chelator whose absorbance changes upon 
calcium binding (Molecular Probes, Inc.). 
 
 
 
 
Fig 1.4 The spectra of TF-BAPTA in 10 mM Tris with increasing calcium shown to 
illustrate the absorbance change of BAPTA dyes upon binding calcium.  The binding 
affinity for this particular dye was measured to be 13 µM in our laboratory. 
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Fura-2, a popular calcium indicator shown in figure 1.5, is BAPTA based with a 
more conjugated system to allow for fluorescence at 510 nm when excited at 340 or 380 
nm.  The excitation spectrum of Fura-2 is calcium dependent with an increase observed 
at 340 nm upon increasing calcium concomitant with a decrease at 380 nm.  During the 
measurements of Fura-2, the emission of the dye is measured with excitation at two 
wavelengths, and the emission increase with 340 nm excitation should correlate with an 
emission decrease with excitation at 380 nm.  The ratiometric property of this indicator 
is highly valued in the study of calcium as they allow for better calibration of an 
experiment and for more reliable calcium measurements.     
 Another type of small molecule dye is Rhodamine-5N shown in Fig 1.6, which is 
also BAPTA based, but exhibits virtually no fluorescence in the calcium free state and 
increases in fluorescence as calcium is increased.  The fluorescence of this molecule is 
red with maximum emission observed at 578 nm.  The Rhodamine based dyes have 
been utilized in cell studies by direct injection of the dye or by incubating the cells with 
the AM ester derivative of the molecule, which can freely pass across the cell 
membrane, and imaging induced calcium changes in the cytosol (34, 35).  The AM ester 
derivatives are not active until they pass into the cell and the cell machinery cleaves the 
ester portion.  Once that portion is cleaved, the dye theoretically can not cross the cell 
membrane to leak back out of the cell.  Most of the available dyes are also constructed 
as AM esters.  Rhodamine-5N will be further discussed in Chapter 4 as a means to 
obtain calcium binding affinity of calcium binding proteins through competition. 
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Fig 1.5 The structure of Fura-2, a BAPTA based calcium indicator (Molecular Probes, 
Inc.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.6 The structure of Rhodamine-5N from Molecular Probes.  The spectral properties 
are illustrated in Chapter 4. 
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 Derivatives of these dyes, such as Mag-Fura-2, have been utilized to study 
calcium in cell subcompartments.  Hofer reports the use of Mag-Fura-2 as an ER 
calcium indicator, citing that Mag-Fura-2 will enter the ER of certain cell  types (BHK 
fibroblasts, for example) and that removal of the dye from the cytosol allows one to 
measure the ER calcium change in response to a variety of agonists (30).  The weaker 
binding affinity of Mag-Fura-2, as compared to Fura-2, allows for measurement in the 
ER. 
Although many dyes with different desirable properties are available, small 
molecule indicators also contain their own set of disadvantages.  Dyes may be loaded 
into cell subcompartments by varying temperature or extracellular medium or buffer to 
induce the cells to shuffle the dye to different compartments, but dyes can not be 
targeted to specific cell compartments nor is it quick or easy to verify which 
compartment is loaded.  The small molecules often enter more than one compartment 
with no straightforward way to separate and identify the compartments.  Also, dyes will 
localize in intracellular organelles to an unpredictable extent, causing difficulty in 
accurately determining the dye concentration and monitoring calcium concentration.  
The synthesis of ratiometric dyes have helped reduce this problem, but many 
applications need particular properties not available with the ratiometric dyes.  In 
addition, Fura-2 is ratiometric but must be excited by UV light, which may damage the 
tissue under study.  At increased temperatures, small molecule dyes tend to leak out of 
the cells causing a disruption in experimental procedures.  Some of the small molecule 
indicators have been observed to be sequestered into vesicles due to their 
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hydrophobicity.  Many of these dyes have such strong calcium affinities that they have 
been observed to cause a buffering effect in cells so that the calcium signaling is not 
correctly observed and calcium is not correctly handled.  Hofer reports that the buffering 
effect of BAPTA-AM can mimic the uptake of calcium by the mitochondria, which 
modulates the rate of ER store refilling (36).  Wang et. al. observed deleterious effects 
on the intercellular calcium waves induced by mechanical stimulation when the cells 
were loaded with the high affinity BAPTA (37).  Many of these dyes are perturbed by 
cellular components, such as pH, ATP, and salt.  Environmental factors, i.e. 
temperature, may also have an effect on the dyes’ ability to report cellular calcium 
changes.  Lastly, small molecule indicators do not provide the necessary sensitivity for 
thick tissues, intact organisms, or non mammalian cells and are subject to interference 
by autofluorescence.  To overcome this problem, we have explored the synthesis and 
design of a calcium binding dye based on a near infrared absorbing moiety and the 
metal binding properties of a 15-crown-5 moiety (Chapter 3). 
 1.3.2 Protein based calcium sensors 
 An alternative to small molecule dyes are calcium-sensitive proteins.  Proteins 
can be directly expressed by the cells to be studied and can be targeted to specific 
subcompartments with the addition of signal peptides, small amino acid chains that 
direct an expressed protein to various cell compartments (i.e. the calreticulin sequence 
that directs to the ER).  Proteins do not leak out of cells due to their larger size.  Protein 
sensors can also be used in a wide variety of cell types, including mammalian and 
bacteria.  A desirable protein sensor will not be perturbed by cellular components and 
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will not be vesicularized.  Currently, there are four classes of protein based calcium 
sensors developed in the past several years.  The first is aequorin (Fig 1.7), a natural 
calcium-dependent protein from jellyfish, which is known as the companion protein to 
green fluorescent protein (38).  The protein contains 4 high affinity EF hand calcium 
binding motifs and a fluorescent cofactor, coelenterazine, which fluoresces upon 
calcium binding.  Aequorin has been utilized to great extent in the study of intracellular 
calcium dynamics and homeostasis due to its inherent calcium sensitivity and the ability 
to target the protein to particular intracellular compartments with signal peptides (39-42).  
In addition, aeuqorin’s coupling of calcium binding and light emission falls in the perfect 
range for intracellular calcium study with low micromolar concentrations of calcium 
necessary to cause light emission (43, 44).  However, aequorin requires the constant 
addition of coelenterazine, which is consumed after each reaction (45), further 
complicating the imaging measurements.  A second approach was directed by 
Persechini and coworkers by engineering a calmodulin binding peptide from smooth 
muscle light chain kinase between two differently colored fluorescent proteins, blue and 
red mutants of green fluorescent protein (46-48), as shown in figure 1.8.  This approach 
measures calcium by reduction in FRET between the two fluorescent molecules caused 
when the peptide binds calmodulin and separates the two fluorophores.  The initial 
constructs indicated inefficient FRET due to the far separation of the excitations and 
emissions of the blue and red fluorophores.  Further work revealed that the use of blue 
and yellow constructs increased the FRET efficiency.  In addition, to further increase the 
efficiency and to allow for “direct” monitoring of calcium, the C-terminal of one of the  
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Fig 1.7 The structures of 
aequorin from jellyfish in 
the apo and calcium 
loaded forms.  The 
fluorescent cofactor, 
coelenterazine, is 
shown in blue in the top 
illustration.  Calcium is 
shown in orange in the 
bottom illustration.  The 
structure of aequorin 
undergoes a 
conformational change 
upon calcium binding.  
The structures were 
visualized by Pymol (49) 
using the pdb 1EJ3 (top) 
and 1SL8 (bottom). 
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Fig 1.8 Illustrations of Persechini’s constructs, which allows for monitoring of calcium 
through calmodulin (blue) binding to the calmodulin binding peptide (shown in orange) 
through the use of energy transfer.  When the peptide is not bound to calmodulin, 
energy transfer occurs between the green and red mutants of GFP.  The distance is 
increased between the two fluorophores upon calmodulin binding so that no energy 
transfer is observed, only green fluorescence.  The GFP proteins are visualized using 
Pymol (49). 
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fluorescent proteins was amended to include calmodulin so that binding of the small 
peptide to the C-term calmodulin would separate the fluorophores and decrease FRET.  
Persechini’s constructs better indicate calcium changes, but the constructs suffer from 
interference from endogenous proteins, i.e. calmodulin and calcium binding peptides, so 
that the true spatial and temporal changes in calcium can not be accurately measured.  
In addition, the constructs with only the binding peptide rely on the availability of 
calmodulin in the cell and truly measures the calmodulin change, not the calcium 
change.  Tsien, Miyawaki and coworkers furthered this approach by engineering 
constructs with calmodulin between two fluorescent proteins so that calcium binding to 
calmodulin would separate the two fluorophores and decrease FRET (50).  They 
created numerous constructs by varying the color of the fluorescent pairs, varying the 
calmodulin mutant used, adding the binding peptide to the construct so both calmodulin 
and the peptide were contained in one molecule, and circularly permutating the 
fluorescent molecules for more desirable properties (50-54).  These sensors more 
directly monitored calcium changes than Persechini’s contructs, but they all utilize 
calmodulin as their target molecule, causing interference from endogenous proteins.  
With FRET, the ability to monitor multiple wavelengths provides ratiometric 
measurements so that data can be normalized.  However, energy transfer is distance 
and orientation dependent, is not as efficient as direct fluorescence change, and 
requires more convoluted microscopy set ups than single fluorophores.  One of the 
newer approaches, developed by Heim and Griesbeck, utilizes Troponin C (TnC) as the 
calcium binding moiety, which would encounter less interference in cell types that do not 
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produce TnC than the calmodulin based sensors.  This construct was able to monitor 
the calcium oscillations produced by carbachol addition and indicated an 80% increase 
in fluorescence upon ionomycin and calcium addition.  To date, this is the best 
published calcium sensor, but the construct can not be used in skeletal or cardiac 
muscle cells that produce TnC, limiting the use of the sensor (27).  Cardiac mishandling 
of calcium has been reported to be a large problem in cardiac disease, and the study of 
cardiac calcium could lead to prevention or cessation of heart disease (55-58).  This 
limits the use of the TnC sensor, and an ideal sensor should be of use in all mammalian 
cell types.  Protein-based calcium sensors have many advantages, but the currently 
available protein-based sensors are not as sensitive to small calcium changes as small 
molecule dyes.  The sensors based on natural calcium-binding proteins, as most of 
them are, contain numerous calcium binding sites causing difficulty in data 
deconvolution, and they can not be tuned to different affinities because they employ 
natural calcium binding sites.  To overcome these difficulties, we have designed a 
calcium-binding protein with an intrinsic ability to report calcium changes. 
1.4 Criteria for an Ideal Sensor 
 The ideal calcium sensor to monitor real time calcium alterations requires many 
features that have not been found in a single sensor up to this point.  First, the sensor 
must exhibit a large change in optical signal, preferably fluorescence with minimized 
background interference, such as autofluorescence.  A near infrared signal would be 
ideal because all background interference would be eliminated.  A signal increase in 
intensity upon calcium binding would be the most useful.  A wavelength change would 
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only be acceptable if the calcium free and calcium bound wavelengths were far 
separated as most imaging is performed on microscopes with filters that allow a certain 
band of wavelengths through without distinguishing small wavelength shifts.  Ideally, a 
sensor should contain the means to measure both a calcium sensitive signal and a 
calcium insensitive signal so that the data could be normalized and the concentration of 
the sensor could be easily calculated.  This would eliminate any interference in calcium 
measurements due to cell shape change or swelling.  Second, the binding of the sensor 
should be selective for calcium as magnesium and other ions are in much greater 
abundance in the cell.  The binding site should be tunable to obtain a large range of 
binding affinities so the correct affinity could be utilized for each subcompartment to be 
studied as well as the cytosol.  Third, fast off rates to allow the signal to truly reflect 
calcium changes are necessary.  The off rates of the currently available sensors are too 
slow to monitor the fast calcium dynamics that occur in the cell.  Schuhmeier and 
coworkers measured the koff of EGTA in cells to be 2.73 s-1 (59).  Linse and Forsen 
report the off rate for calcium of regulatory proteins, i.e. calmodulin, to be 10 – 103 s-1 
while the off rates of non-regulatory proteins, such as calbindin D9k, to be 1 to 3 s-1, in 
the range of EGTA (60).  Linse and Forsen also report the off rates of calbindin mutants 
measured by 45Ca NMR to be <10 s-1 for the first site (61).  The off rates of current 
protein based calcium sensors are generally much slower (~1 s-) with the exception of a 
recent report of 256 s-1, described by Palmer and Tsien, for a sensor with “improved 
reaction kinetics” (62).  The sensor should have fast off rates so that quick calcium 
signals can be monitored.  Fourth, the sensor should not induce a buffer effect by 
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disrupting calcium signaling intra- or intercellularly.  Fifth, the sensor should not exhibit 
pH sensitivity in the cellular pH flux range (6.0 to 8.5) or the pH sensitivity should be 
small enough to account for in the measurements.  Sixth, an ideal sensor should have 
the ability to be targeted or delivered to any desired location.  Protein sensors can be 
targeted with the addition of signal peptides to the ER, mitochondria, nucleus, and cell 
membrane.  A protein based sensor must be engineered with a stable host protein, 
preferably with its own ability to report calcium binding.  To monitor calcium variations in 
the ER, mitochondria, and extracellular environment requires a sensor with a binding 
affinity in the proper range for the range of calcium concentration in each of those 
locations.  The ER, as a calcium store, contains ~0.5 mM calcium at rest.  The 
mitochondria contains less calcium at rest, but the calcium concentration increases 
when calcium waves are induced in the cell.  The extracellular matrix contains 1.8 mM 
calcium at rest with large local changes as signals are propagated.  Each of these 
locations requires sensors with different affinities, which have not been available to date 
due to the reliance on natural calcium binding proteins as the binding moiety of the 
sensors.   
1.5 Green Fluorescent Protein 
Green fluorescent protein has been chosen for the initial design process (Fig 1.9) 
due to the abundant literature information and previous mutational work.  Green 
fluorescent protein from Aequorea victoria, or jellyfish, is a bioluminescent protein that is 
a companion to aequorin, a calcium binding protein discussed in section 1.3.2.  The 
blue emission from aequorin is used by GFP to create a green glow in the cell, hence  
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Figure 1.9 β-barrel structure of green fluorescent protein visualized with Pymol (1b9c) 
with the chromophore shown in green.  The excitation and emission spectra of EGFP 
are shown on the bottom. 
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the reason jellyfish glow (63).  The structure of GFP is an 11 stranded β-barrel with an 
α-helix running through the middle of the barrel and several loops and short helices 
capping the barrel on each end.  The chromophore in GFP, consisting of residues 65-67 
(Ser, Tyr, and Gly), is attached to the α-helix and almost completely buried in the center 
of the barrel (64).  The proposed formation of the chromophore is illustrated in Fig 1.10.  
Wavelength shifts of the absorbance of the chromophore occur with a change in 
protonation.  The anionic form has an excitation maximum at 475 nm whereas the 
protonated or neutral forms exhibit a maximum at 395 nm.  The emission of the wild 
type protein has a λmax at 504 nm (65).  Generally, both forms exist in solution in a 6:1 
neutral:anionic ratio (63).  Wild type green fluorescent protein is ~28 kDa and contains 
238 residues (63).  
 Many mutations have been investigated as a means of changing the 
wavelengths of the chromophore, the folding properties, and the temperature sensitivity, 
as detailed in table 1.2.  Tsien divided GFP mutations into several classes according to 
the changes in the chromophore.  With all of the mutations, GFP’s intrinsic ability to fold 
properly has been established.  In aerobic conditions, the chromophore forms despite 
the mutations.  So called “folding mutants” have been made to help GFP to fold and 
form the chromophore in higher temperatures (37 °C vs. 25 °C) and with quicker 
maturation rates, such as the cycle3 derivative.  In addition, many mutations have been 
performed on this protein to shift the chromophore’s optical activity (63, 66, 67), to form 
metal binding sites (68, 69), and to attach metal sensitive proteins for design of  
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Fig 1.10 Chromophore formation of GFP modified after that proposed by Tsien in his 
1998 review (63) is shown.  This is the generally accepted formation reaction although 
the true formation has not yet been elucidated. 
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Table 1.2 A summary of the mutations made to GFP with various affects.  The 
information was gleaned from Tsien’s review (63) unless otherwise noted. 
Name Mutation (s) λ exc ε 
(M-1 cm-1) 
λem Effects Ref 
 T203I 400  512   
H9 T203I/S202F 398  511   
H9-40 T203I/S72A/Y145F 399 29,000 511 
chromophore 
considered neutral 
phenol; bright as 
cycle 3 
 
5B, 9B T203H/S65T 512 19,400 524   
 T203H/S65G/S72A 508 48,500 518 
phenolate anion with 
stacked π-electron 
systerm (yellow) 
 
 T203F/S65G/S72A 512 65,500 522 
phenolate anion with 
stacked π-electron 
systerm (yellow) 
 
6C T203Y/S65T 513 14,500 525   
10B T203Y/F64L/S65G/S72A 513 30,800 525   
10C T203Y/S65G/V68L/S72A 513 
36,500 
(83,400) 527 
phenolate anion with 
stacked π-electron 
system (yellow) 
 
10C 
Q69K  
T203Y/S65G/V68L/
Q69K/S72A 516 62,000 529 
phenolate anion with 
stacked π-electron 
systerm (yellow) 
(70) 
 
T203Y/S65G/V68L/
S72A/S147H/ 
Q204H 
   Cu2+ binding mutant (68) 
 T203Y/S65G/V68L/S72A/E95H/Q184H    Cu
2+ binding mutant (68) 
11 T203W/S65G/S72A 502 33,000 512   
Topaz T203Y/S65G/S72A/K79R 514 94,500 527 
phenolate anion with 
stacked π-electron 
system (yellow) 
 
 S65 to  R, N, D, F, W    
weak or no 
fluorescence  
 S65A 471  503, 504   
EGFP 
mut2 
 
S65A/V68L/S72A 481  507 19-fold fluorescence intensity increase  
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Name Mutation (s) λ exc ε 
(M-1 cm-1) 
λem Effects Ref 
 S65T 489, 488 
39,200 or 
52,900 
509-
511 
2 different trials by 
same investigator; 
6-fold greater peak 
amplitude of E. coli 
expressed protein 
relative to WT; 18-
fold brighter than 
WT by FACS; 4-fold 
faster oxidation; no 
photo-isomerization; 
very slow photo-
bleaching when 
excited at 280 nm  
 
 S65C 479 47,400 507   
EGFP 
mut1 S65T/F64L 488  507 
35-fold fluorescence 
intensity increase  
 F64L/S65T/V163A 488 42,000 511 
chromophore 
considered 
phenolate anion 
 
ECFP 
F64L/S65T/Y66W/
N146I/M153T/ 
V163A/N164H 
   Calmodulin--M13 Ca2+ binding mutant (70) 
EYFP S65G/S72A/T203Y    
yellow mutant, used 
by Tsien as CaM 
fusion for Ca2+ 
binding 
(70) 
RSGFP4 F64M/S65G/Q69L 490  505 24-fold brighter than WT by FACS  
EGFP 
mut3 S65G/S72A 501  511 
21-fold fluorescence 
intensity increase 
relative to WT  
 
smRS-
GFP 
S65T/F99S/M153T/
V163A 489  511 
solubility changes, 
S65T mutant 
background 
 
P4-1 S65T/K238E/ M153A 
504 
(396)  514   
Emerald S65T/S72A/N149K/M153T/I167T 487 57,500 509 
chromophore 
considered 
phenolate anion; 
bright as cycle 3 
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Name Mutation (s) λ exc ε 
(M-1 cm-1) 
λem Effects Ref 
P11 I167T 471 
(396)
 502 
(507)
  
 E222G 481  506   
cycle 3 F99S/M153T/ 
V163A 
395 
(475)
30,000 
(6500-
8500) 
508 
(540)
45-fold brighter 
whole cell 
fluorescence relative 
to WT GFP when 
excited by UV light; 
4-fold less bright 
whole E. coli cell 
fluorescence relative 
to EGFPmut1 when 
excited at 488 nm 
 
P4 or 
BFP 
Y66H 382 21,000 448 blue fluorescent  
P4-3 Y66H/Y145F 381 22,300 445 blue fluorescent; 
imidazole in 
chromophore  
 
smBFP Y66H/F99S/M153T/ 
V163A 
382  448 blue fluorescent; 
solubility changes; 
Y66H mutant 
background 
 
W Y66W 458  480 blue fluorescent  
W2 Y66W/I123V/ 
Y145H/H148R 
/M153T/V163A/ 
N212K 
432 
(453)
 480 blue fluorescent  
W7 Y66W/N146I/ 
M153T/V163A/ 
N212K 
433 
(453)
 475 
(501)
blue fluorescent  
W1B Y66W/F64L/S65T/N1
46I/M153T/V163A 
434 
(452)
32,500 476 
(505)
  
W1C Y66W/S65A/S72A/N
146I/M153T/V163A 
435 21,200 495   
 Y66F 360  442 blue fluorescent; 
less bright than WT; 
shortest wavelength 
excitation and 
emission peaks  
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Name Mutation (s) λ exc ε 
(M-1 cm-1) 
λem Effects Ref 
EBFP F64L/S65T/Y66H/ Y145F 380  440 
blue fluorescent; 
brighter signal;   
 F64L/S65T     improves expression  
 F64L/T203Y    improves ε   
 V68L/ S65A    improves expression  
 V68L/ T203Y    improves ε   
 S72A/ S65G     improves expression  
 S72A/ S65A    improves ε   
 S72A/ T203Y    improves expression  
 F99S    improves ε and brightness  
 Y145F/ Y66H    improves ε and brightness  
 N146I/ Y66W    improves ε and brightness  
 M153T/ Y66W    improves expression  
       
       
 M153T    improves ε and brightness  
 V163A/ Y66W    
improves expression 
and thermo-
tolerance 
 
 V163A/ Y66H     improves brightness  
 V163A    improves thermo-tolerance  
 
I167T/ 
V163A/S175G/ 
S65T 
   improves ε and brightness  
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biosensors (70-72).  Although much of this work has been successful, the end results 
generally contain very large proteins that are difficult to work with and may not be 
usable for intracellular study due to the disadvantages stated in section 1.4.  Also, the 
utilization of Fluorescence Resonance Energy Transfer in detecting calcium does not 
provide the necessary sensitivity in cellular work.  The design of a calcium binding site 
within the frame of GFP that would cause an emission increase upon binding of calcium 
would make a smaller protein that is easier to study with faster kinetics and eliminates 
the conformational changes that accompany the currently available protein sensors.   
Fig 1.11 illustrates two hypothetical responses that could be observed upon calcium 
binding to a designed calcium-binding fluorescent protein.  A fluorescence increase 
would be most preferred for microscope imaging of live cells since microscopes employ 
filters with 20 to 30 nm band passes.  A wavelength shift would be preferred for in vitro 
studies so that small concentration changes would not impair the study. 
1.6 Calcium-binding Proteins and Calcium-binding Sites 
 Oxygen is the preferred ligand for calcium binding, commonly from the amino 
acid sidechains of Glu, Asp, Gln, and Asn, the mainchain carbonyl and water, but also 
from Ser and Thr in some proteins.  Calcium binding to small molecules can occur with 
4 to 12 ligands with water as an available ligand.  In proteins, generally calcium binding 
occurs with 5 to 8 ligands with water binding in one or two positions.  Although the 
pentagonal bipyramidal geometry is the most often observed, some proteins also bind in 
an octahedral geometry.  EF hands, with a helix-loop-helix calcium binding motif, bind 
calcium in a pentagonal bipyramidal geometry with one ligand, aspartate or glutamate,  
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Fig 1.11 The two possibilities of fluorescence change caused by calcium binding to a 
designed fluorescent protein are illustrated.  An increase in fluorescence is desired for 
experimental ease in the use of microscopes to monitor live cells.  A wavelength shift 
would be desired for in vitro measurements, but the shift would necessarily be large to 
monitor with the use of microscopes that employ filters. 
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used as a bidentate with both oxygens binding to calcium (1.12).  EF hands contain the 
binding ligands in a short sequence and are known as continuous sites (Fig 1.13).  
Discontinuous binding sites do not contain the ligands in a short sequence, but, rather, 
from various parts of the protein with the site forming by the fold of the protein.  Trypsin 
from S. griseus and proteinase K are examples of calcium binding proteins with 
discontinuous binding sites (Fig 1.14) (73, 74).   
One of the most well studied calcium binding proteins is calmodulin, a ubiquitous 
protein that contains four calcium binding sites, two each in two domains.  The calcium-
binding sites are known as EF-hands with the helix-loop-helix structure first 
characterized by Dr. Robert Kretsinger (75-78).  Upon binding calcium, calmodulin 
undergoes a drastic conformational change, exposing the hydrophobic helix that can 
then bind to target molecules, such as myosin light chain kinase.  The four sites have 
been studied in a variety of methods, such as through cleavage of the two domains, 
individual peptides, and study of the intact protein.  
Most natural calcium binding proteins contain more than one calcium binding site 
and undergo conformational changes upon binding.  The binding sites are subject to 
cooperativity, metal-metal interactions, and environmental factors (60).  The study of the 
key determinants for calcium binding has been an on-going endeavor for decades.  
There are several factors that have been shown to be important in calcium binding.  The 
EF hands in the proteins have an intrinsic calcium binding ability based on the type, 
charge, and arrangement of the calcium ligands.  Since the binding process is highly 
cooperative, the calcium affinity observed for the intact protein also contains  
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Fig 1.12 Pentagonal bipyramidal binding geometry of EF hand proteins with Glu as the 
bidentate.  The actual residues shown are from loop III of calmodulin.  The red spheres 
indicate oxygen.  The dark blue spheres are carbon, and the light blue sphere is 
nitrogen.  The dashed line indicates bonds to calcium. 
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Fig 1.13  (a) Illustration of the continuous calcium binding sequence of the EF hand with 
the binding ligand positions given by the X, Y, Z coordinates most commonly used.  The 
coordinates are X = 1, Y = 3, Z = 5, -Y = 7, -X = 9, and -Z = 12, which are binding 
residues for calcium.  Differences in these amino acids identity changes the binding 
affinity of the loop and accounts for the different affinities of different proteins with the 
same motif.  Position 12 (-Z) is usually a glutamate.  (b) Pymol illustrations of 
calmodulin (79) and parvalbumin (80) demonstrating EF hand calcium binding sites and 
cadherin (81), a non-EF-hand CaBP. 
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Fig 1.14 Proteinase K with the two calcium (red) ions and binding sites (ligands in blue 
and green) highlighted (2PRK pdb) and visualized with Pymol (49).  These two 
discontinuous sites also contain water as calcium ligands. 
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contributions from the metal-metal interactions and the cooperativity of the protein.  The 
charge balance created by the oxygens from Glu and Asp is likely the reason for those 
two types of residues occurring most often in calcium binding.  In addition, these two 
residues hydrogen bond to other amino acids—sidechain or mainchain amide and often 
the sidechains of the other binding ligands—providing increased stability of the protein 
upon calcium binding.  The number of charged ligands in the calcium coordination 
sphere also plays a role in calcium binding affinity.  The environment of the calcium 
binding site also affects the affinity.  Linse and Forsen have shown that a more 
electronegative environment causes a stronger binding affinity for a given calcium site 
and that surrounding electrostatic environment affects the cooperativity of calcium 
binding in multi-site systems (82, 83).  With all of the understanding gleaned in the last 
30 years, quantitative estimation of the key factors for calcium binding is yet to be 
established.  Therefore, to systematically reveal the key determinants for calcium 
binding requires a new strategy and model system. 
1.7 Our Design Approach and Previous Work in the Yang Lab 
 To understand site specific calcium binding affinity of each EF loop of calmodulin 
and to estimate the cooperativity of couple EF hand motifs, Yang and coworkers have 
developed a grafting approach by engineering individual EF hand motifs into a host 
protein (84, 85).  We have also developed a design approach to understand the key 
factors for calcium binding by creating calcium binding sites in a host protein that does 
not intrinsically bind calcium.  An initial survey of the literature was performed to 
ascertain the most common calcium binding properties observed for natural calcium 
33
  
binding proteins with the assets desired for our design, such as a strong binding affinity 
and selectivity over other metals.  The approach initially employs computer programs 
that search the backbone of a protein, with the desired angles and distances input from 
the user, to locate possible calcium binding sites.  These identified sites contain the 
necessary geometry for calcium binding once the suggested mutations are made.  The 
output of the computer programs are analyzed for the best possible sites based on 
several criteria.  Once a site or several sites are chosen, mutagenesis is carried out to 
engineer the designed protein.  Expression, purification, and biophysical studies are 
performed on the protein to understand the calcium binding affinity, geometry, etc. 
Previously in our laboratory, numerous calcium binding proteins have been 
engineered based on domain 1 of the rat cell adhesion molecule CD2 (cluster of 
differentiation) (86-89).  Fig 1.15 demonstrates one of these designed proteins, 7E15-
CD2, characterized by Dr. Anna Wilkins Maniccia.  The designed calcium binding 
proteins maintain the original structural properties and cell adhesion functions (86-88).  
These proteins have been shown to bind calcium with a range of affinities based on 
their unique positions in the protein, protein environment, and ligand type and charge.  
The effect of ligand type and coordination sphere charge on calcium binding as well as 
the effect of the electronegative environment on calcium binding affinity has been 
illustrated by work in our laboratory. 
1.8 Our Approach to Engineer Calcium Sensors 
Proteins with the intrinsic ability to report on changes in the cellular environment 
could provide a diagnostic tool to monitor calcium and report calcium changes.   
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Fig 1.15 Designed protein 7E15-CD2, which exhibits a nanomolar Tb(III) binding affinity 
and a low micromolar Ca(II) binding affinity, is illustrated. 
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Fluorescent proteins, such as Green Fluorescent Protein (GFP) from Aequorea victoria, 
or jellyfish, and Discosoma Red (DsRed) from coral contain an intrinsic fluorescence 
with their own chromophores formed during folding and have a β-can structure that is 
different from CD2, which is an Ig-fold.  We hypothesize that fluorescent proteins with 
different calcium binding affinity and strong selectivity can be successfully designed 
using our design approach.  In addition, we hypothesize that a calcium binding site 
engineered into the chromophore sensitive locations could provide a change in the 
fluorescence of the chromophore upon binding (Fig 1.11) thereby allowing for 
observation of calcium inside living cells.  Our approach is to design a calcium-binding 
site in a fluorescent protein so that a change in fluorescence will be observed upon 
calcium binding. 
The design process to engineer a calcium-binding site into a non-calcium-binding 
protein incorporates current knowledge about natural calcium-binding proteins, including 
continuous (EF-hand type) and discontinuous calcium-binding sites as discussed in 
section 1.7.  Computer programs were initially utilized to identify possible binding sites.  
The output sites were evaluated and possible sites were chosen based on our 
established criteria.  Several sites were examined for metal binding properties, 
structure, expression in mammalian cells, and calcium response in mammalian cells.  
The most promising sites were chosen for further study. 
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1.9 The Objective of this Dissertation 
 In this dissertation, several studies on the design of calcium sensors using a 
small molecule dye and designed calcium binding proteins will be discussed.   
Chapter 2 discusses the materials and methods utilized in the progress of this 
dissertation.  The molecular biology to obtain the mutated DNA is detailed.  Expression 
and purification of the designed proteins, along with differences between fluorescent 
and non-fluorescent designed proteins, are described.  Structural and metal binding 
analysis protocols are given in detail.  Mammalian cell expression and calcium response 
measurements are also illustrated. 
 Chapter 3 discusses the near infrared calcium binding dye synthesized by Dr. 
Christian Mason and studied by this researcher.  The metal binding analysis of the dye 
is detailed. 
 Chapter 4 discusses the design process of the variants, including the criteria for 
evaluating the sites.  The mutagenesis, expression, and purification are described and 
discussed.  The biophysical analysis and metal binding studies of the designed proteins 
are also described and discussed. 
 Chapter 5 communicates the mammalian screening of the designed proteins and 
details the discovery of the Site 177’s fluorescence in HeLa cells.  The calcium 
response and optimization studies of Site 177 are discussed.  The production of a 
brighter sensor containing the 177 binding site is detailed. 
 Chapter 6 describes the second generation of designed sensors chosen after the 
lessons observed from the first generation.  The new criteria utilized in selecting the 
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new sites are discussed.  The molecular biology, screening, and calcium response in 
the cytosol and in the ER are detailed. 
 Chapter 7 is a summary of all of the work detailed in this dissertation since the 
work is varied in its designation.  The chapter endeavors to bring together the 
knowledge gleaned from this work. 
1.10 The Significance of this Dissertation 
 The significance of this work is several fold.  First, the process of designing 
calcium binding sites in GFP will provide further knowledge on the key factors of 
calcium binding and will demonstrate that our design process can be utilized in a 
multitude of proteins.  The ability to understand the intricate properties of calcium 
binding and calcium dependent processes would provide insights into the molecular 
basis of diseases related to improper binding of calcium.  Second, applying our design 
approach to the creation of a calcium sensor eliminates many of the drawbacks for the 
currently available sensors.  The designed sensors will not be FRET based and will 
report calcium binding by a change in the intrinsic fluorescence of the host protein.  With 
a single site designed into the protein, there will be no interference from endogenous 
proteins.  In addition, the single site will allow for easier and quicker data analysis as it 
will directly report calcium changes in each part of the cell and not rely on binding to 
target molecules.  Also, the designed sensors can be targeted to different locations in 
the cell, such as the ER, where the study of calcium handling is essential.  Third, our 
study will contribute to the knowledge of the chromophore formation of fluorescent 
proteins, such as GFP and DsRed, by demonstrating the amino acids necessary for 
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proper formation.  In addition, the comparison of optical properties of EGFP variants 
expressed in bacterial systems versus protein expressed in mammalian systems will 
generate knowledge on the protein folding pathway and the environment necessary for 
proper chromophore formation.  Fourth, this work will further our ability to design 
calcium binding proteins to control their function. 
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Chapter 2 Materials and Methods 
 
2.1 Near Infrared Calcium-binding Dye 15C5-774 
2.1.1 Synthesis 
The synthesis was performed by Dr. Christian Mason at Georgia State 
University.  All reagents were obtained from Aldrich. A solution of IR-786 Iodide (550 
mg, 0.9 mmol) and 4-aminobenzo-15-crown-5 (270 mg, 0.95 mmol) in anhydrous N,N-
dimethylformamide (10 ml) was heated to 140 °C for 2 h under nitrogen atmosphere. 
After cooling, the solution was stirred and treated dropwise with aqueous 
tetrafluoroboric acid (24%, 2 ml), which caused crystallization of the complex 3 (15C5-
774)·2HBF4.  The crystalline precipitate was filtered and washed with water. 
Crystallization from an acetone/methanol mixture by addition of tetrafluoroboric acid 
followed by filtration, washing with water and then ethyl ether, and drying at 70 °C/1.0 
mmHg gave an analytically pure product: yield 500 mg (63%); mp>200 °C (decomp.); 
1H NMR (dimethyl sulfoxide-d6/tetramethylsilane, 400 MHz, 30 °C) δ 1.68 (s, H), 1.88 (t, 
J=6 Hz, 2H), 2.73 (t, J=6 Hz, 2H), 2.88 (t, J=6 Hz, 2H), 3.37 (s, 6H), 3.65 (m, 6H), 3.85 
(m, 4H), 3.90 (m, 4H), 4.20 (m, 4H), 4.28 (m, 4H), 5.69 (d, J=12 Hz, 2H), 7.01 (t, J=7 
Hz, 2H), 7.07 (d, J=7 Hz, 2H), 7.27 (t, J=7 Hz, 2H), 7.40 (t, J=7 Hz, 2H), 7.42 (d, J=8 
Hz, 2H), 7.78 (d, J=12 Hz, 2H), 8.25 (s, 1H); 13C NMR (dimethyl sulfoxide-d6, 100 MHz, 
30 °C) δ 20.9, 25.6, 27.3, 28.1, 28.9, 29.6, 31.4, 46.8, 68.2, 68.3, 68.7, 69.4, 70.6, 94.0, 
99.9, 101.8, 107.2, 108.2, 111.3, 116.0, 121.0, 121.5, 121.7, 122.3, 125.1, 126.0, 127.9, 
128.5, 130.5, 134.4, 134.5, 138.2, 139.5, 140.9, 142.7, 142.8, 143.7, 148.7, 148.9, 
153.7, 165.5, 172.6; Vis-NIR (methanol:Tris [20:80 v/v] pH 7.4) λmax=774 nm ( =42 600 
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M−1 cm−1), which varies with pH changes. Analysis, calculated for 
3(C46H56BF4N3O5)·2HBF4: C, 63.05; H, 6.52; N, 4.79. Found: C, 63.31; H, 6.28; N, 4.64.  
2.1.2 Absorbance analysis 
All absorbance measurements were taken on a Shimadzu UV-1601 
spectrophotometer interfaced to a PC operating under Windows 98.  The data analysis 
was performed using Microsoft Excel 2000 and KaleidaGraph 3.0.  All chemicals used 
were ACS grade reagents.  All metals tested were in the chloride salt form.  The 
titrations were performed with stock solutions of 15C5-774 containing varying 
concentrations of metal in 20% MeOH and buffered with 10 mM Tris. The Tris buffer 
was chelexed with Bio-Rad Laboratories Chelex 100 Resin and adjusted to pH 7.4 with 
HCl.  The pH was measured with a Beckman 360 pH meter by removing 1 ml 
increments and measuring with a small electrode.  A stock solution of 15C5-774 in 
100% MeOH was made by dissolving 1.2 mg of dye in 5 ml of MeOH for a concentration 
of ~275 µM.  
2.1.3. Metal titrations 
First, stock solutions of metal in Tris buffer were made through serial dilutions 
from 1 M to 1 mM.  Then 1 ml dye/metal stock solutions containing a constant 19.52 µM 
dye concentration (using 275 µM stock dye in MeOH) and various metal concentrations 
(using stock metal in Tris) were made with the Tris/MeOH buffer.  A zero point was 
made with dye, Tris, and MeOH (no metal) at the same concentration as the 1 ml 
stocks, and its absorbance was recorded.  A certain volume was removed from the 
cuvette and placed in the waste container.  The same volume of one of the dye/metal 
41
  
stock solutions was placed into the cuvette.  After mixing well, the absorbance of the 
dye at that metal concentration was recorded.  These steps were repeated until 
saturation was reached.  Depending on the metal being tested, saturation was reached 
at about 400 µM–60 mM.  
2.1.4 Data analysis 
The metal concentration at each point was calculated using Eq 2.1: 
T
SACLC
V
MVMV
metal
)*()*(
][
+
=  
where VLC is the volume left in the cuvette after removal of the exchange volume, MC is 
the molarity of the volume in the cuvette, VA is the volume added to the cuvette, MS is 
the molarity of the stock solution of the volume added, and VT is the total volume in the 
cuvette after the volumes are exchanged (normally 1 ml).  
The Kd values were calculated by creating a scatter plot of the fractional change 
versus the metal concentration.  Fractional change is given in the Eq 2.2: 
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where Ap is the absorbance of that data point, A0 is the absorbance of the zero point, 
and Amax is the absorbance at the most saturated point.  The fractional change was then 
fit with a curve using the Eq 2.3, which assumes a 1:1 metal:chelate complex: 
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where [D]T is the total dye concentration, [M]T is the total metal concentration, and Kd is 
the dissociation constant of the reaction.  When this equation is input into KaleidaGraph, 
the Kd is graphically estimated and can be adjusted as necessary to achieve the best 
result.  
2.1.5 pH dependence 
For the pH dependence studies, the pH of Tris for the lower pH work was 
adjusted to 6 with HCl.  For the higher pH study, new Tris buffer was prepared, treated 
with Chelex-100 resin to remove background calcium, and left at pH 8.7.  The stock 
metal solutions for calcium and magnesium were made with this Tris buffer in 1 ml 
volumes using serial dilutions.  The sample solutions were made with these metal 
solutions.  An additional zero point (without metal) was made to test the initial pH.  The 
pH of the titrated solution was tested after the titrations were complete.  
2.2 Site-directed Mutagenesis 
 Site-directed mutagenesis of the designed proteins was carried out utilizing 
polymerase chain reaction.  All primers were designed in-house and purchased from 
Sigma-Genosys or Operon.  The primers were reconstituted in EB buffer (10 mM Tris, 
pH 8.5) and phosphorylated according to the manufacturer’s protocol for T4 PNK 
(phosphonucleotide kinase) (Promega).  PCR was carried out with a MJ Research 
(without heated lid) or Techne (with heated lid) thermocycler.  Reactions carried out in 
the MJ Research thermocycler were topped with a drop of mineral oil to prevent 
evaporation.  The polymerase employed was either cloned pfu or turbo pfu (Invitrogen), 
and the PCR was completed following the manufacturer’s protocols.  The primers are 
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listed in table 2.1 for the first generation and table 2.2 for the second generation of 
designed sensors.  Following PCR, the DNA was separated on a 0.8% agarose gel and 
extracted from the gel using a Qiagen gel extraction kit.  The linear DNA was then 
ligated with T4 DNA ligase (Promega) following the manufacturer’s instructions for 22 
hrs at 4 °C with the addition of approximately 3 mM ATP to provide energy for the 
reaction.  The circular DNA was transformed into E. coli (either DH5α or Top10) 
competent cells and plated on Luria-Bertani plates with the appropriate antibiotic for the 
host vector, usually ampicillin.  Several colonies from the plate were grown overnight at 
37 °C with agitation in 10 mL LB-antibiotic, and the DNA was purified with either a 
Qiagen Miniprep kit or an Eppendorf Fast Plasmid Mini kit.  The DNA was then 
sequenced at the core facility at GSU. 
2.3 Competent Cell Preparation 
 E. coli cells are made chemically competent with calcium chloride.  A fresh LB no 
antibiotic plate is quadrant streaked with glycerol stocks of E. coli cells and allowed to 
grow overnight at 37 °C.  A single colony is inoculated into 10 mL of LB (no antibiotic) 
and grown overnight at 37 °C.  The overnight growth is transferred into fresh LB (no 
antibiotic) in a 100x dilution into 200 or 400 mL of media and allowed to grow to an 
optical density of 0.5.  Samples are taken near the flame.  The cells are then centrifuged 
at 3K for 5 min after balancing near the flame in a previously autoclaved 500 mL 
Oakridge centrifuge bottle.  The supernatant is discarded and the pellet is resuspended 
in 100 mM CaCl2 by gently swirling (previously autoclaved).  If the cells are grown in  
44
  
Table 2.1 The primers utilized to engineer the first generation of designed proteins. 
Designed 
Protein 
Mutation(s) Primer Name Primer Sequence 
120 V120N, 
R122D, 
K113D 
EGFP120FOR 
EGFP120BACK 
GACACCCTGAACAACGACATCGAGCTG 
GCCCTCGAAGTCCACCTCGGCG 
120b V120N, 
R122D,  
EGFP120FOR 
120_122BACK 
GACACCCTGAACAACGACATCGAGCTG 
GCCCTCGAACTTCACCTCGG 
 L15N 15FORW 
15BACK 
GTGCCCATCAATGTCGAGCTGGTC 
CACCCCGGTGAACAGCTCCTC 
177 I171D, 
S175D, 
V176A, 
Q177N 
EGFP177FOR 
EGFP177BACK 
ACGGCGACGCGAACCTCGCCGACC 
CCTCGTCGTTGTGGCGGATCTTG 
194a L194N,  194FORW 
194BACK 
GGCCCCGTGAATCTGCCCGAC 
GTCGCCGATGGGGGTGTTCT 
 K79D, 
K85D 
79_85FORW 
79_85BACK 
GACTTCTTCGATTCCGCCATGCCC 
GTGCTGATCCATGTGGTCGGGGT 
194b L194N,  194FORW 
194BACK 
GGCCCCGTGAATCTGCCCGAC 
GTCGCCGATGGGGGTGTTCT 
 K79D, 
S86D 
79_86FORW 
79_85BACK 
GACTTCTTCAAGGACGCCATGCC 
GTGCTGATCCATGTGGTCGGGGT 
229 M78N, 
H81D 
78_81FORW 
78_81BACK 
GACCACAATAAGCAGGACGACTTCTTC 
GGGGTAGCGGCTGAAGCACTG 
 H199D 199FORW 
199BACK 
CCCGACAACGACTACCTGAGCAC 
CAGCAGCACGGGGCCGTCG 
 I229D 229FORW 
229BACK 
GCCGCCGGGGACACTCTCGG 
GGTCACGAACTCCAGCAGG 
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Table 2.2 The primers utilized to engineer the second generation of designed proteins. 
Designed 
Protein 
Mutation(s) Primer Name Primer Sequence 
Site 1 L194E 
 
L194E_FORW 
L194E_BACK 
GGCCCCGTGGAGCTGCCCGAC 
GTCGCCGATGGGGGTGTTCTG 
 S2D S2D_FORW 
S2D_BACK 
CTAGAATGGTGGACAAGGGCGAGG 
AGGGCCCGGATCCGAGCTCG 
Site 2 L15D,  L15D_FORW 
L15D_BACK  
GTGCCCATCGACGTCGAGCTGGAC 
CACCCCGGTGAACAGCTCCTC 
 R122E, 
V120S 
R122E_V120S_FORW
R122E_V120S_BACK 
GACACCCTGTCGAACGAGATCGAGCTG
GCCCTCGAACTTCACCTCGGC 
Site 3 F83D F83D_FORW 
F83D_BACK  
CAGCACGACGACTTCAAGTCCGC 
CTTCATGTGGTCGGGGTCGCG 
 I152E, 
A154D, 
I161D 
152_154_161_FORW 
152_154_161_BACK 
CAGAAGAACGGCGACAAGGCGAAC 
CTTGTCGTCCGTGTCATAGACGTTG 
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Designed 
Protein 
Mutation(s) Primer Name Primer Sequence 
Site 4 T59D T59D_FORW 
T59D_BACK  
CCCTGGCCCGACCTCGTGACC 
CACGGGCAGCTTGCCGGTGG 
 I136S, 
L141N 
136_141_FORW 
136_141_BACK 
CACAAGAACGAGTACAACTACAACAGC
CCCCAGGGAGTTGCCGTCCTCC 
 Q177E Q177E_FORW 
Q177E_BACK 
GGCAGCGTGGAGCTCGCCGAC 
GTCCTCGATGTTGTGGCGGATC 
 F100E F100E_FORW 
F100E_BACK 
CACCATCTCCGAGAAGGACGACGG 
CGCTCCTGGACGTAGCCTTGG 
Site 5 L7D, V12N L7D_V12N_FORW  
L7D_V12N_BACK 
GGGTGAACCCCATCCTGGTCGAG 
CGGTGAAGTCCTCCTCGCCCTTGC 
 F114D, 
L119E 
F114D_L119E_FORW
F114D_L119E_BACK 
GACACCGAGGTGAACCGCATCGAG 
GCCCTCGTCCTTCACCTCGGCG 
 M88S M88S_FORW 
M88S_BACK  
CAAGTCCGCCTCGCCCGAAGGC 
AAGAAGTCGTGCTGCTTCATGTG  
Site 6 M88T M88T_FORW 
M88S_BACK  
CAAGTCCGCCACGCCCGAAGG 
AAGAAGTCGTGCTGCTTCATGTG 
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400 mL of media, 24 mL of CaCl2 should be used.  The cells are then incubated on ice 
for atleast 30 min.  The cells are centrifuged at 5.5K for 7 min and the supernatant is 
discarded.  The pellet is resuspended in cold 100 mM CaCl2 (5 mL for 400 mL of 
growth) and 15% glycerol (previously autoclaved) by gentle swirling.  The cells are then 
aliquotted into autoclaved 1.7 mL centrifuge tubes and stored at -80°C for later use. 
2.4 Incorporating EGFP Gene in Different Vectors 
 For expression of the proteins in E. coli, the DNA was subcloned into the pet28a 
vector, which contains a kanamycin resistance gene and a multiple restriction site.  The 
DNA and the vector were digested for 3-4 hrs at 37 °C with BamHI and EcoRI enzymes 
following the manufacturer’s suggestions.  After digestion, the DNA was separated on a 
0.8% agarose gel and purified with a Qiagen gel extraction kit.  The desired gene was 
then ligated to the vector with T4 DNA ligase as detailed above.  The DNA was 
transformed into DH5α competent cells and allowed to grow in LB medium at 37 °C 
overnight.  Individual colonies were grown in 10 mL LB-ampicillin (100 µg/mL) overnight, 
and the DNA was purified with the Qiagen Miniprep kit.  All subclones were verified by 
automated sequencing at the core facility at GSU.  For expression in mammalian cells, 
the DNA was subcloned into pcDNA3.1+ in the same manner as the pet28a subclone. 
2.5 Expression and Purification of Histidine tagged GFP 
2.5.1 Expression of GFP and the variants 
The DNA was transformed into BL21(DE3) and plated on LB-kanamycin (30 
µg/mL kanamycin) plates.  Single colonies were inoculated in 10 mL LB-kan overnight 
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at 37 °C with agitation.  The overnight inoculum was transferred into 1 L of fresh LB-kan 
and allowed to grow to an OD600 of 0.6.  The growth was then induced with 0.2 mM 
IPTG and allowed to grow for 3-4 hr.  The cells were harvested by centrifugation at 7K 
for 20 min.  The cell pellets were stored at –20 °C and retained for purification. 
After expression, the fluorescence of GFP and the variants was measured with a 
Fluostar Microplate Reader.  This instrument allows insertion of a microplate containing 
samples and provides a readout of the fluorescence intensity.  Samples (1 mL) of the 
expression were taken at 1 hr intervals up to 3 hr.  For overnight growths, samples were 
also taken the following morning.  The bacteria were pelleted at 14 K rpm, and the 
media was removed.  The pellet was resuspended in 200-400 µL of 10 mM Tris, pH 7.4.  
the cells were then added to the Corning 96 well plate with 10 mM Tris, pH 7.4 as the 
background.  The fluorescence was then monitored by the Fluostar. To begin with the 
Fluostar instrument, double click the “Fluo32” shortcut on the desktop.  Click Run.  Go 
to Test Setup on the menu and click Layout.  Click Create Layout.  Click New, choose 
96 well plate, enter a name.  Select cells for samples.  Choose standard, blank, and 
samples to be tested from the drop down menu on the left, then click in the grid on the 
right at the appropriate place.  For example, if the standard is in the top left well, select 
standard from the drop down menu and then click in the top left cell—the program will 
highlight that cell and label it accordingly.  Click OK when finished.  Go to Test Setup 
on the menu and click Tests.  Click New, well mode, select microplate brand—we use 
Corning, 96.  Click Layout, enter the excitation and emission filters of your choice, the 
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other factors do not need to be changed.  Click OK twice.  To insert the plate into the 
instrument, click plate out on the menu buttons at the top of the screen.  The plate 
holder will eject, place the plate into the holder.  Click plate in on the menu buttons.  
Click Measure on the menu buttons (looks like a stop light).  Choose the profile you 
made from the tests list.  Click Plate ID, type a filename.  Click Gain.  Select the entire 
grid or select the highest fluorescence sample, click well adjustment—the machine will 
measure for the gain and make the adjustments.  Click OK.  Click Start.  When the 
measurement is finished, usually about 1 min, go to Results on the menu and choose 
Excel.  The software will export your results to Excel.  In Excel, double click on the 
filename you entered.  Click Update.  Choose the Evaluation spreadsheet at the 
bottom.  Delete the last table that is filled with #DIV.  The results will be displayed as 
raw data and as corrected with the blank, copy the spreadsheet into a new workbook to 
save.  The spreadsheet can also be printed at this point. 
2.5.2 Purification of GFP and the variants 
For purification, a 5 mL nickel chelating column connected to a FPLC was 
utilized.  The FPLC was first prepared by washing the Ni2+ column with water for 15-20 
min to remove any storage solvent.  The column was then loaded with Ni2+ by washing 
with 0.1 M Ni2+ for 5-10 min.  The column was then washed again with water to remove 
any unbound nickel, and the column was equilibrated with Buffer A (50 mM PO4, 250 
mM NaCl, pH 7.4) for 10-15 min.  The cell pellet was resuspended in 10 mL of lysis 
buffer (20 mM Tris, 100 mM NaCl, 0.1% Triton X-100, pH 8.0) and sonicated to break 
the cell membrane.  The sonication was separated by centrifugation at 17K for 30 min, 
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and the supernatant was collected.  The supernatant was filtered and injected into the 
previously prepared FPLC.  Generally, 3 or 4 mL of the supernatant was injected for 
each wash cycle.  The protein was allowed to bind to the column and washed with 
Buffer A until the absorbance returned to baseline.  Injections and wash cycles were 
repeated until all protein was loaded onto the column.  The protein was eluted with a 
gradient of imidazole in phosphate buffer (Buffer A plus 0.5 M imidazole) with a gradient 
method.  GFP usually eluted at ~250 mM imidazole, and fractions in this range were 
collected in 4 or 8 mL portions.  The purity of the fractions were verified by SDS-PAGE, 
and the pellet after sonication was checked for remaining protein by SDS-PAGE.  The 
programs for the FPLC are listed in table 2.3. 
Fractions containing imidazole were combined and dialyzed into 10 mM Tris, 1 
mM DTT, 1% glycerol.  The protein’s concentration was measured by UV/vis 
absorbance at 280 nm using Beer’s Law (A = εcl) and an extinction coefficient 
calculated for EGFP (5690 * #Trp + 1280 * #Tyr) of 21,890 M-1 cm-1.  All protein was 
stored with 1% glycerol at 4 °C on ice or in 20% glycerol at -20 °C. 
In the case of several of the designed variants, the insoluble protein after 
sonication was solubilized with 8 M urea.  The solution was diluted 10x into buffer and 
centrifuged to remove cellular debris.  The supernatant was injected into an FPLC 
joined to a size exclusion column to remove undesirable proteins (10 mM Tris, pH 7.3), 
and the fractions were analyzed by SDS-PAGE for purity and presence of the desired 
protein. 
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Table 2.3 FPLC programs for his-tagged protein purification.  B is buffer B. 
Program 6  Program 7  
Break 
Point 
 Conditions Break 
Point 
 Conditions 
0.0 0% B 0.0 0% B 
 Flow Rate = 5 mL/min  Flow Rate = 5 mL/min 
 Fraction Size = 0 mL  Fraction Size = 8 mL 
 Buffer Valve Position = Pos1  Buffer Valve Position = 
Pos1 
 Inject Valve Position = Load  Inject Valve Position = Load 
 Set Peak Collect = no  Set Peak Collect = no 
 Autozero = no  Autozero = no 
 Event Mark = no  Event Mark = no 
10.0 Autozero = yes 1.0 10% B 
11.0 Inject Valve Position = Inject 3.0 10% B 
 Autozero = yes 40.0 100% B 
13.0 Inject Valve Position = Load  Fraction Size = 0 mL 
73.0 End Method 42.0 100% B 
  45.0 0% B 
   End Method 
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2.6 Hitrap Q Purification 
To further purify the protein, a Hitrap Q anion exchange column was employed 
Before use, the column was equilibrated with 5 column volumes (25 mL) of start buffer 
(20 mM Tris, pH 8.0), 5 column volumes of elution buffer (20 mM Tris, 1 M NaCL, pH 
8.0), and then 5 column volumes of start buffer.  The initial injection sample was diluted 
with start buffer.  Protein was continually injected into the column and the column was 
washed with start buffer to remove contaminating proteins until all protein was bound to 
the column or the column was completely colored with protein.  The protein was then 
eluted with a gradient of elution buffer.  EGFP usually eluted at ~400 mM NaCl.  The 
column was then washed with 100% elution buffer to remove any remaining 
contaminants.  The column was washed with start buffer and ddH2O before storage.  
The further purified protein was concentrated down in 20% glycerol with the Amicon 
pressure concentrator and dialyzed against 10 mM Tris, 1 mM DTT to exchange buffer 
and remove salt.  The protein was then stored in 20% glycerol at -20 °C in aliquots of 1 
mL.  The protein’s concentration was measured by UV/vis absorbance (after dialyzing 
and adding 20% glycerol) at 280 nm using Beer’s Law (A = εcl) and an extinction 
coefficient of 21,890 M-1 cm-1. 
2.7 Protein Refolding with Urea 
The cell pellet was thawed and 8 M urea was added in small increments (one mL 
or less) to the cell pellet until the pellet dissolved.  Once the pellet was dissolved, the 
mixture was 10x diluted into the appropriate buffer (Tris usually) with dropwise additions 
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of the mixture into the buffer while stirring.  Once all of the urea/cell pellet was added to 
the buffer, the mixture was centrifuged for 15-20 mins at 17 K to separate the 
solubilized protein from the cell parts and insoluble proteins.  The supernatant and pellet 
were collected and analyzed on SDS-PAGE.  The supernatant was dialyzed in a 3 KDa 
dialysis membrane in a large volume of buffer overnight at 4 °C to remove the urea.  
2.8 Circular Dichroism of Variant Proteins 
 Far UV circular dichroism (CD) of wild type and variant proteins was performed 
on a Jasco 810 spectropolarimeter  equipped with a Peltier temperature control unit and 
connected to a PC.  All measurements were performed with a cell pathlength of 1 mm, 
either 50 or 100 nm/min scan speed, and four accumulations.  The protein 
concentration was 10 or 15 µM, and the buffer for metal binding studies was 10 mM 
Tris, 1 mM DTT, 1% glycerol, pH 7.4.  The buffer for pH dependence without calcium 
was 20 mM phosphate, 1 mM DTT, 1% glycerol.  The buffers for pH dependence with 
calcium were acetate or citrate, MES, PIPES, and Tris and all contained 1 mM DTT and 
1% glycerol. 
2.9 Thermal Denaturation of Designed Proteins by Circular Dichroism 
 The thermal stability of the designed proteins was measured by Far-UV CD from 
260 nm to 200 nm in the temperature range of 10-100 °C with 5 °C increments.  The 
samples were made with 10 µM of protein and with either 1 mM EGTA or 1 mM calcium 
in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4.  The 1 mm pathlength rectangular cell 
was used, which holds 300 µL of sample, and was closed with parafilm during the 
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operation.  The signal was monitored at 216 nm with 600 sec (10 min) between each 
temperature to equilibrate at that temperature.  The scan speed was 50 nm/min.  A scan 
of the entire spectrum was recorded at each temperature. 
2.10 GFP Fluorescence Spectroscopy 
Fluorescence studies were performed on a Photon Technologies, Inc. Lifetime 
Fluorimeter.  All terbium fluorescence experiments utilized an excitation of 280 nm, 
excitation slit widths of 8 nm, and emission slit widths of 12 nm.  The emission was 
scanned from 500 nm to 600 nm with the monitored peak at 545 nm.  A glass plate 
filtered the second order scattering at 560 nm. 
GFP fluorescence was monitored from 500 nm to 600 nm with the excitation at 
488 nm, 482 nm, or 398 nm, depending on the variant protein.  Trp fluorescence of the 
GFP variants was monitored with excitation at 280 nm and emission between 300 and 
400 nm.  The slit widths were adjusted as necessary for the proper intensity range. 
2.11 Measuring Metal Effects on Histidine Tagged Proteins 
The fluorescence of the protein (1 µM) was monitored with and without metal on 
a PTI Lifetime fluorimeter.  The excitation was 482 nm, and the emission from 490 to 
570 nm was recorded.  Titrations were performed by keeping the protein concentration 
constant and increasing the metal concentration until the signal no longer changed.  
The metal binding affinities were calculated assuming a 1:1 protein:metal ratio using 
equation 2.3 shown in section 2.4.1. 
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2.12 Metal Binding Analysis 
 To analyze the data by Specfit/32, the data must first be prepared in a text 
spreadsheet in the proper setup for Specfit/32 to read.  The spreadsheets were 
prepared in Microsoft Excel and saved as *.txt files for import into Specfit/32.  For 
terbium binding to a single site protein, the components included in the spreadsheet are 
total metal concentration and total protein concentration at each titration point.  For 
competition between a protein and another chelator for metal, the components are the 
total metal concentration, the total protein concentration, and the total chelate 
concentration (such as a dye).  An example of a multicomponent titration spreadsheet is 
shown in table 2.4.  Nm stands for number of measurements (13 in this case and must 
be included in the left column next to each component concentration), Nw for number of 
wavelengths (for example 500 nm to 600 nm is Nw = 100), and Nc for number of 
components.  The model 1 is for ligand binding.  The three rows below that information 
are the metal concentration, protein concentration, and the dye concentration.  The 
[H+]= row is the hydronium ion concentration, which is the inverse log of the pH.  The 
titration spectra are then copied below the [H+]= row with the wavelengths in the 
leftmost column and each spectra beneath the appropriate titration point.  A note of 
caution should be made here that any errors in the spreadsheet (typographical or 
otherwise) will result in errors in the binding affinity calculation.  Be very careful to 
examine the spreadsheet before proceeding to Specfit/32. 
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Table 2.4 An example of the spreadsheet imported into Specfit/32 to obtain the protein 
Kd from the dye competition assay.  The rows continue to the end of the wavelengths 
measured, and the columns continue to the right for the number of data points (i.e. 
metal concentrations).  Nm stands for number of measurements, Nw for number of 
wavelengths, and Nc for number of components.  The model 1 is for ligand binding.  
The three rows below that information are the metal concentration, protein 
concentration, and the dye concentration.  The [H+]= row is the hydronium ion 
concentration, which is the inverse log of the pH. 
NAME        
X/Z  
Mode Nm Nw Nc Model X-axis Y-axis Z-axis 
1 13 91 3 1 0 2 0 
13 0.00E+0 4.88E-06 1.45E-05 2.86E-05 4.67E-05 7.27E-05 1.05E-04 
13 3.96E-05 3.96E-05 3.96E-05 3.96E-05 3.96E-05 3.96E-05 3.96E-05 
13 2.59E-05 2.59E-05 2.59E-05 2.59E-05 2.59E-05 2.59E-05 2.59E-05 
[H+]= 6.31E-08 6.31E-08 6.31E-08 6.31E-08 6.31E-08 6.31E-08 6.31E-08 
560 3312.9 7045.1 13345 24315 32706 49273 5.90E+04
561 3601.4 7808.1 15213 26894 36771 5.41E+04 6.49E+04
562 4196.7 8655.8 17036 29890 41427 6.04E+04 7.33E+04
563 4389.1 9351.1 18195 32547 4.48E+04 6.69E+04 8.00E+04
564 5090.9 10507 20147 36730 5.00E+04 7.40E+04 8.83E+04
565 5347.6 11320 21904 3.90E+04 5.40E+04 7.96E+04 9.63E+04
566 5833 12537 23750 4.25E+04 5.79E+04 8.68E+04 1.04E+05
567 6134 13242 25638 4.61E+04 6.32E+04 9.35E+04 1.11E+05
568 6543.3 14153 27334 4.89E+04 6.74E+04 9.88E+04 1.20E+05
569 7085.3 14775 2.89E+04 5.10E+04 7.13E+04 1.03E+05 1.26E+05
570 7474.8 15586 3.00E+04 5.41E+04 7.45E+04 1.09E+05 1.33E+05
571 7527 16344 3.16E+04 5.66E+04 7.84E+04 1.16E+05 1.40E+05
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To calculate the binding affinity of the titrated species, open Spefit/32 and click 
the menu choice “Import”.  Choose “Multiscan Data Files”.  A window will open to import 
the files.  Select the appropriate file and click “Import Files” or simply double click on the 
desired file.  Click “Exit”.  A graph of the data should appear.  Select “Model” on the top 
menu and choose “M/L/H+ Complex”.  A new window will open to allow the user to input 
the appropriate information for the titration.  An example of the window is shown in 
figure 2.1.  The Species column includes all components present in the titration, free 
and bound, such as the free metal, free protein, and the metal:protein complex.  For the 
inputs, 0 is no component, and 1 and higher is the number of components in that 
particular species.  For example, a terbium:protein titration would include 100 for the 
metal free, 010 for the protein free, and 110 for the metal:protein complex.  A dye 
competition assay with protein would include 1000 for metal free, 0100 for dye free, 
0010 for protein free, 1100 for metal:dye complex, and 1010 for metal:protein complex.  
To add the necessary number of species by clicking “Add” on the bottom.  To change 
the 0,1 for each species, click in the box for that species, click in the “M” or “L” box as 
appropriate and click the up and down arrows to change the number.  The “Colored” 
column applies to the components that contribute to the measured spectra.  The boxes 
should be check for protein:terbium complexes, dye, or dye:metal complexes since 
these species contribute to the spectra.  Leave “Known Spectra” blank.  The “Fixed” 
column refers to the binding affinities in the Log(β) column.  Single components or 
species are 0 in the Log(β) and are fixed.  The box should be unchecked for the binding 
affinity being calculated.  For competition assays, the known binding affinities should be  
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Fig 2.1 A screen capture of Specfit/32 is shown to illustrate the program’s use in 
calculating binding affinities.  The complexation systems model is utilized to calculate 
metal:ligand interactions, whether the ligand is protein or another molecule.  The user 
inputs the appropriate components in the Species column.  The case of terbium binding 
to a single binding site on a protein is illustrated in the blown up image of the 
Complexation Systems window.  The panel of buttons on the left are for fitting the data 
(Fit) and viewing the fit after the fitting routine (Extract). 
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included with the fixed box checked.  The affinity must be provided as the log Ka.  To 
convert from Kd, use the equation 2.4:  )
1log()log(
dK
=β  
Click “Save”.  The window will disappear.  Click the “Fit” button on the left side.  The 
number in the Log(β) box for the complex species in the binding affinity.  However, the 
Log(β) actually equals log Ka.  To convert to Kd, use the following equation 2.5: 
βlog10
1
log
1
==
a
d ofKinverse
K  
The results can be printed by clicking the “Print” button.  Click “Exit”.  Click the “Extract” 
button on the left to view the data fit.  The fit can be saved as an ascii file for graphing in 
another program by choosing “File” and “Save As”, select the folder and type the 
filename.  The file will be saved with a *.csv extension. 
2.13 Terbium Binding Affinities for the Variant Proteins 
An experiment was performed with Site 120 and Site 177 with constant terbium 
concentration (12 µM) and increasing protein concentration.  The buffer was 10 mM 
Tris, 1 mM DTT, 1% glycerol, pH 7.4, and the protein concentration was increased in 
increments of 2 up to 10 µM.  Terbium fluorescence was monitored with a spectra 
recorded at each protein concentration. 
For terbium FRET titrations of 120, 177, and 194a, the beginning protein 
concentration was 3 µM, and the buffer was 20 mM PIPES, 10 mM KCl, 1 mM DTT, 1% 
glycerol, pH 6.8.  A 1.0 mM or 5.0 mM stock terbium containing the same concentration 
of protein was directly added into the protein samples during titration.  Blank samples 
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were measured with buffer and increasing terbium at the same concentrations as the 
protein samples.  The raw data was baseline corrected, and the integrated area was 
calculated for the peak of interest.  The integrated area was utilized to calculate the 
dissociation constants.  Also, the data was fit with Specfit/32, a global fitting program 
developed by Dr. Robert Binstead. 
For site 194b, the above conditions were initially employed, but protein 
precipitation was observed.  Other buffer conditions were attempted to retain solubility: 
10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4 and 50 mM Tris, 1 mM DTT, 1% glycerol, 
pH 7.0.  Also, lower protein concentrations of 1 and 1.5 µM were tested.  Also, a 
Hamilton automatic titrator was installed on the PTI fluorimeter during this time so it was 
utilized during the titrations.  The cuvette volume was 2.5 mL of protein with stock 
terbium at 400 µM or 1 mM (no protein) added in during the titration. 
2.14 Protein-dye Calcium Competition 
 The samples for the protein-dye calcium competition were made by first making a 
stock solution of protein (30 or 40 µM) and Rhodamine-5N (~20 µM) in 10 mM Tris, 1 
mM DTT, 1% glycerol, pH 7.4.  An aliquot of 1 mL was taken from the stock and 10 µL 
of 100 mM CaCl2 was added.  The solutions were allowed to equilibrate at 4 °C for 30 
mins.  To the fluorescence cells was added 1 mL of the protein-dye stock, and 10 µL of 
buffer was added to dilute the samples by the same amount as the calcium solution.  
The fluorescence was then performed with a pathlength of 1 cm, excitation slit widths of 
1 nm, and emission slit widths of 4 nm.  The excitation was 552 nm, and the emission 
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was scanned from 560 to 650 nm.  Volumes of the calcium-dye-protein stock were 
added and allowed to equilibrate for 10 mins.  The spectrum was then taken for each 
calcium concentration.  After the titration, the dye concentration was verified by visible 
absorbance at 552 nm with an extinction coefficient of 63,000 M-1cm-1 for calcium 
loaded Rhodamine-5N.  The data was fit with the program Specfit/32. 
2.15 Protein-Terbium Metal Competition 
 Sites 120 and 177 were investigated for metal binding by loading the protein (3 
µM) with 50 µM of terbium and then adding 10 mM calcium, 10 mM magnesium, or 100 
µM lanthanum.  Site 177 was also monitored with additions of 100 µM, calcium 1 mM 
calcium, and 10 mM potassium.  The samples were made in 10 mM Tris, 1 mM DTT, 
1% glycerol, pH 7.4.  The fluorescence was measured with excitation at 280 nm at slit 
widths of 8 and 12 nm for the excitation and emission, respectively, when measured on 
the PTI fluorimeter noted previously.  Site 120 was measured on a newly obtained PTI 
fluorimeter (noted as PTI2) with slit widths of 6 nm for all. 
 The wild type EGFP was tested for calcium induced changes in the chromophore 
fluorescence by measuring the fluorescence in the presence and absence of 1 mM 
calcium.  The protein concentration was 3 µM, and the buffer was 10 mM Tris, 1 mM 
DTT, 1% glycerol, pH 7.4.  The excitation was 482 nm with excitation and emission slit 
widths of 2 nm. 
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2.16 pKa Measurements of EGFP and EGFP Variants 
 To measure the chromophore pKa of EGFP and the variant proteins, separate 
samples were made at each pH to be measured and the absorbance and fluorescence 
of the samples were examined.  Various buffers were utilized to maintain the pH at each 
desired value, which are listed in table 2.5.  DTT (1 mM) and 1% glycerol were added to 
each buffer prior to use.  The stock buffers were made by Dr. Jin Zou in this laboratory 
for everyone’s use with aliquots taken by each lab member.  The protein concentration 
was ~10 µM for each mutant.  The samples were allowed to equilibrate at 4 °C 
overnight.  A baseline was run for each pH with the appropriate buffer before the 
sample at that pH was measured.  The absorbance was measured from 600 nm to 200 
nm so all protein peaks would be included.  The cuvettes were cleaned between pH 
samples with 1% Liqui-nox to remove any protein.  The pH was measured for each 
sample after the spectra were acquired. 
For fluorescence, the samples for absorbance were diluted 10x (in duplicate) with 
the appropriate buffer for a final concentration of ~1 µM.  One set of samples was 
maintained without calcium while 1 mM calcium was added to the other set.  The 
samples were allowed to equilibrate overnight at 4 °C.  The fluorescence was measured 
with the excitation at 482 nm, the excitation slit width at 1.5 nm, and the emission slit  
width at 2 nm.  The emission was scanned from 490 to 570 nm.  The sample at pH 9 
was measured first so the slit widths could be set for optimal intensity, and the samples 
were measured with decreasing pH.  The cuvettes were cleaned with 1% Liqui-nox  
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Table 2.5 A list of the buffers utilized for the pH dependence 
measurements. 
Buffer pH 
0.5 M Acetate (CH3COOH) 4.0 
10 mM Acetate 4.5 
10 mM MES (2-Morpholinoethanesulfonic acid) 5.0, 5.2, 5.7, 6.0 
10 mM PIPES (1,4-Piperazinediethanesulfonic acid) 6.5, 7.0 
10 mM Tris [Tris (hydroxymethyl) aminomethane] 7.4, 8.0, 8.5, 9.0 
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between samples.  Separate cuvettes were used for the samples with and without 
calcium.  The pH of each sample was measured after the spectra were obtained. 
2.17 Quantum Yield Measurements of EGFP, L194N, and L15N 
 All protein was freshly purified before use.  The protein samples were made in 
low concentrations (0, 0.4, 0.8, 1.2, 1.6, 2 µM) as to avoid inner filter effects, and were 
made in duplicate in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4.  Quartz fluorescence 
cells were utilized for both absorbance and fluorescence measurements.  The UV/vis 
spectrometer was baselined with the buffer from 600 to 300 nm for EGFP and from 600 
to 240 nm for the mutants.  The fluorescence was measured with slit widths of 2 nm for 
the excitation and 1.5 nm for the emission with an excitation wavelength of 488 nm.  
The sample was then removed from the fluorimeter and the absorbance was 
immediately measured.  This was repeated for all concentrations.  The cells were 
washed with ddH2O between samples. 
 The integrated area for the fluorescence spectra was calculated for each 
concentration and was then plot vs. the absorbance at 488 nm.  The equation: 
⎟⎟⎠
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with QX as the quantum yield of the sample, QST as the quantum yield of the standard, 
the slope of the linear fit for the fluorescence integrated area vs. absorbance for the 
sample and the standard, and η as the solvent viscosity was utilized.  Initially, the 
literature value for EGFP was treated as the standard and the EGFP samples were 
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cross-referenced with each other.  The average value obtained in-house for EGFP was 
used in the calculations for the mutants. 
 The extinction coefficients for EGFP at 488 nm and for the mutants at 280 and 
488 nm were calculated with the same data from the quantum yield measurements.  
The absorbance at the desired wavelength was plotted vs. the sample concentration 
(M) and a linear fit was obtained.  The slope of the fit is equivalent to the extinction 
coefficient times the pathlength, which was 1 cm in this case. 
2.18 Chromophore Reduction 
 The protein L194N/S86D was tested for chromophore reduction by adding β-
mercaptoethanol or dithiothreitol (DTT) and monitoring the fluorescence changes.  The 
protein (1 µM) was incubated with 5%, 10%, 20%, 30%, and 50% β-mercaptoethanol for 
30 mins at 4 °C with and without 1 and 10 mM calcium in 10 mM Tris, 1% glycerol, pH 
7.4.  DTT was also tested at 10 mM with and without 1 mM calcium.  The fluorescence 
emission was monitored with excitation at 398 nm and at 488 nm with slit widths of 1 nm 
for all. 
2.19 Mammalian Cell Culture 
HeLa cells were obtained from Dr. Monica Lurtz in Dr. Charles Louis’s laboratory.  
HEK293 cells were obtained from Dr. Zhi-ren Lui’s laboratory.  CHO cells were obtained 
from Dr. Ludmilla Pereglyna’s laboratory.  Vero cells were obtained from Dr. Teryl 
Frey’s laboratory.  All of these cells are adherent, and stocks are grown on 100 mm cell 
culture dishes.  When confluence is reached (~95%), the cells are passaged and 
66
  
allowed to continue to grow.  The cells are passaged by removal of medium, wash with 
HBSS-- buffer, and addition of 1 mL of 1x trypsin.  After the cells detach, the trypsin and 
cells are diluted with 9 mL of HBSS--.  The cells are triturated ~10 times to fully suspend 
the cells.  One to two mL is plated back, and the rest of the cells are discarded.  Nine 
mL of fresh media is added to the plate and triturated ~5 times.  The cells are placed 
back into the 37 °C incubator and allowed to grow with 5% CO2 until they reach 
confluence again.  The media for the HeLa cells is Dubelco’s Modified Eagle’s Medium 
(DMEM, Sigma) with 1 g/L glucose and L-glutamine, sodium bicarbonate, 10% fetal calf 
serum (FCS), and 1% Penicillin-streptomycin (Pen-strep or PS).  The media for the 
HEK293 cells is the same as for the HeLa cells except the glucose is 4.5 g/L.  The 
media for the CHO cells is Ham’s F-12 with sodium bicarbonate, 10% FCS, and1% 
Pen-strep.  The media for the Vero cells is the same DMEM as for the HeLa cells.  In 
general, the cells were passaged every 2-3 days. 
 To prepare the media for the HeLa cells, dissolve one bottle of DMEM (Sigma) 
with 1 g/L glucose and Glutamax in 800 mL of ddH2O.  Add 3.7 g of NaH(CO3) (44 mM) 
and dissolve.  Adjust the pH to 7.2 to 7.3 with 6 M HCl.  Add the media to a graduated 
cylinder and bring to 1 L.  Filter the media in the laminar flow hood with a Sterivex 0.22 
µm filter into autoclaved glass bottles.  Store at 4 °C.  Before using the media for cell 
culture, add 50 mL Fetal Calf Serum (FCS) and 5 mL Penicillin-Streptomycin (Pen-
Strep) to 500 mL of media. 
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 To prepare the HBSS-- buffer, dissolve one bottle of Hank’s Balanced Salt 
Solution without divalent cations in 800 mL of ddH2O.  Add 0.0238 g of HEPES (10 
mM), 0.42 g of NaHCO3 (5 mM), and 0.38 g (1 mM) EGTA.  Dissolve all reagents and 
adjust the pH to 7.2 to 7.3 with 5 M NaOH.  Add the solution to a graduated cylinder and 
bring to 1 L with ddH2O.  Filter the buffer with 0.22 µm Sterivex into autoclaved glass 
bottles and store at 4 °C. 
 To prepare HBSS++ buffer, dissolve one bottle of Hank’s Balanced Salt Solution 
with divalent cations in 800 mL of ddH2O.  Add 0.0238 g of HEPES (10 mM), 0.42 g of 
NaHCO3 (5 mM), and 0.38 g (1 mM) EGTA.  Dissolve all reagents and adjust the pH to 
7.2 to 7.3 with 5 M NaOH.  Add the solution to a graduated cylinder and bring to 1 L with 
ddH2O.  Filter the buffer with 0.22 µm Sterivex into autoclaved glass bottles and store at 
4 °C. 
2.20 Cryogenic Stock Preparation 
 Cryogenic stocks of the four cells lines were made by first trypsinizing the cells 
as usual to remove them from the plate.  The cells were diluted to 10 mL with HBSS-- 
buffer and fully resuspended.  The cells were collected in a 15 mL sterile centrifuge 
tube, and a 10 µL sample was taken to count the cells.  The cells were centrifuged at 
700 rpm for 5 min.  The cells were counted on a hemacytometer under a microscope 
with a 10x objective.  Once pelleted, the supernatant was removed from the cells and 
discarded.  The cells were resuspended in enough cell-freezing medium (regular 
medium with 5% DMSO) for 2-5 x106 cells/mL.  Aliquots of 1 mL were made in 
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cryogenic vials.  The vials were placed in an alcohol freezing box (1°C/min) and placed 
at –80 °C overnight.  The vials were then transferred to a cryobox and let at –80 °C or 
were placed in a liquid nitrogen cryo tank for long-term storage.  The liquid nitrogen is 
replenished approximately every 6 weeks since it evaporates over time. 
2.21 Plate Preparation and Transfection of Sensor DNA 
 For transfections, the plates were prepared one or two days ahead of time.  For 
confocal or inverted microscope imaging, 35 mm plates with glass coverslips were 
utilized and plated with ~0.5 x 106 cells.  For the transfection, the liposome 
(Lipofectamine2000, Invitrogen) was mixed with Opti-MEMI media and allowed to 
equilibrate for 5 mins at room temperature.  The DNA (2 µg per plate) was mixed with 
Opti-MEMI.  The DNA and liposome solutions were then mixed together (DNA:liposome 
1:3) and allowed to equilibrate for 20 mins in the dark at room temperature.  During this 
time, the plates were washed 2 times with 1-2 mL Opti-MEMI to remove serum.  The 
DNA-liposome mixture was then added to the plates along with additional Opti-MEMI.  
The cells were incubated for 4-5 hr at 37 °C and 5% CO2.  The media was changed to 
fresh media and left at 30 °C for 48-72 hrs. 
2.22 Fluorescence Imaging of Variant Proteins by Inverted Epifluorescence 
 A Zeiss Axiovert 200 inverted fluorescence microscope was employed to screen 
the mutants for fluorescence.  For screening, plastic dishes were utilized and the 40x 
dry objective or the 20x dry objective was used for imaging.  The cells were inspected 
with transmitted light and all three available filter sets, DAPI, FITC, and Texas Red.  The 
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camera’s exposure time was adjusted based on the brightness of the fluorophore.  
Images were taken with the Zeiss Axiovision software, saved in the *.zvi format, and 
exported into *.jpg. 
2.23 Calcium Response by Inverted Epifluorescence Microscopy 
An inverted epifluorescence microscope (Zeiss Axiovert 200) was utilized for 
calcium response measurements in vivo.  The microscope is equipped with a Xenon Arc 
Lamp, filters for DAPI, FITC, and Texas Red, and transmitted light.  An Axiocam 5 CCD 
camera is connected to the microscope at a right angle to the stage.  The microscope is 
connected to a computer with Zeiss Axiovision 4.0 software for data collection and 
analysis.  The microscope is also equipped with 10x, 20x, and 40x dry objectives that 
contain correction collars for use with plastic.  A Fluar Ph3 40x oil objective or a 100x 
Neofluar oil objective was utilized for calcium response measurements.  Fields 
containing healthy, confluent, fluorescent cells were located by use of the binoculars.  
The software was then set to show live images through the camera, the shutter was 
turned to send 80% of the light to the camera, and the binoculars were turned off (to 
remove magnified room light).  Images were obtained at appropriate exposure times for 
the sensor being imaged.  The images were saved in both the Zeiss *.zvi format and in 
*.jpg for ease of use in other programs.  For calcium imaging, a time series in black and 
white (smaller file sizes) was performed with 30 s intervals between images and 17-20 
images were obtained.  The fluorescence light was shuttered off between images so 
that the cells were only exposed to light during the image acquisition to decrease 
photobleaching.  Three images were taken before any additions to establish a baseline.  
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Ionomycin (2 µM, premixed in 100-200 µL of HBSS++) was added to the dish, and two 
images were taken.  Calcium was then added in 10 mM or 20 mM increments (premixed 
in 100-200 µL of buffer) to a total concentration of 60 mM, and images were taken after 
each addition.  The data analysis was performed with the Axiovision software on the 
microscope computer or with the free version available from the Zeiss website in our 
laboratory.  Regions of interest were drawn around each cell, and the intensity table 
was exported into Microsoft Excel for graphing.  In Excel, the data was plotted with the 
intensity on the y axis and the time on the x axis.  Comparable experiments were 
normalized, averaged, and error bars were plotted. 
 All calcium response experiments with the Nikon inverted epifluorescence 
microscope were performed by Dr. Monica Lurtz in Dr. Charles Louis’s laboratory 
(University of California, Riverside).  The coverslips containing the transfected cells 
were placed into a holder with 2 mL of HBSS++ and onto the microscope stage.  
Transmitted and fluorescent light with a 40x or 100x oil immersion objective were 
utilized to locate a field with healthy, fluorescent cells, preferably with some confluency 
to maintain the cells’ health during the experiment.  Exposure times were adjusted for 
each fluorophore to obtain the maximum range of intensities for each image.  In 
general, control experiments with EGFP utilized two neutral density filters and 40 ms 
exposure.  Images for the calcium response experiments with the designed sensors 
underwent 40 ms exposure without the neutral density filters.  The standard FITC filter 
with excitation at 490 nm and emission centered at 520 nm was utlized.  Experiments 
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were performed with additions of 2 µM ionomycin and three additions of 20 mM calcium 
by removing 0.5 mL to 1 mL of the bathing medium from the dish, mixing the reagent to 
be added with the bathing medium, and applying the mix to the dish.  Stable baselines 
were obtained before and after the ionomycin addition to ensure no artifacts were 
detected.  After calcium addition, the calcium was removed by washing with a semi-
perfusion system back (a pump removed bathing medium while a pipet was utilized to 
add buffer to the dish) to 1.8 mM calcium (normal for HBSS++) and the fluorescence 
decrease was recorded.  After the calcium was reduced to buffer conditions, the calcium 
was again increased to monitor the fluorescence change.  These experiments were 
performed multiple times (more than 8 plates) to ensure statistically relevant changes. 
 Other experiments were performed with addition of calmidozolium to block the 
calcium pumps and thapsigargin to empty the ER calcium stores.  The ionomycin and 
calcium additions were then repeated under these conditions. 
2.24 Calcium Response by Confocal Microscopy 
 To measure the fluorescence change in vivo when agonists were introduced for 
variant 177 when expressed in HeLa and HEK293 cells, a Zeiss inverted confocal 
microscope was employed (Core Facility, GSU).  The microscope is equipped with UV, 
Argon, and He/Ne lasers.  The Argon laser at high power (nearly maxed) was utilized to 
excite in the 488 nm region with the proper band pass filters to measure fluorescence at 
approximately 510 nm (FITC bandpass 505-530 nm) with a 100x oil immersion 
objective.  The coverslip was placed into a holder with 2 mL of HBSS++ and onto the 
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microscope stage.  Transmitted and fluorescent light was utilized to locate fields that 
contained transfected, fluorescent, healthy cells.  The laser power and Z-planes were 
adjusted to obtain the best image.  Single images were taken of the field before the 
timecourse was performed.  The timecourse was executed with 30 s intervals between 
scans to allow enough time for additions.  Ionomycin (1-2 µM) was added after the first 
2-4 scans and allowed to stabilize for 3-4 scans.  Calcium in 10-20 mM concentrations 
was added 1-3 times and images were continually taken.  The outside calcium was 
washed away by exchanging the buffer with HBSS++.  All experiments were performed 
several times to ensure reproducibility. 
 Once the images were obtained, the LSM510 software was utilized to quantitate 
the fluorescence change after addition of calcium by drawing regions of interest 
outlining the cells.  The intensity at each time point was obtained and graphed vs. time.  
Microsoft Excel was utilized to graph and analyze the data. 
2.25 Transfection of 177c3 for Suspension Growth in HeLa Cells 
 To transfect the HeLa cells to grow in suspension, 6 100 mm plates were grown 
to confluency.  They were then transfected with the DNA to encode the 177c3 variant 
protein.  The DNA (12 µg per plate) was mixed with Opti-MEMI, and the Liposome 
(Lipofectamine 2000, Invitrogen) was mixed with Opti-MEMI in a 1:3 ratio with the DNA 
(36 µL per plate).  The DNA-Opti and Lipofectamine-Opti was then mixed together and 
allowed to incubate at room temperature in the dark for 20 mins.  The plates were 
washed with Opti-MEMI two times to remove all traces of serum.  The DNA-
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Lipofectamine was then added to the plates along with 9 mL of fresh Opti-MEMI.  The 
plates were incubated for 4 hrs at 37 °C with 5% CO2.  The transfection media was then 
removed, and the cells were harvested by trypsin treatment and centrifugation for 5 
mins at 1000 rpm.  The cells were resuspended in the MantaRay sterile, disposable 
bottle in 400 mL of fresh DMEM with 10% FCS and 1% PS.  The cells were allowed to 
grow for 6 days at 30 °C in a non-CO2 incubator with the MantaRay bottle placed on a 
stir plate.  Fresh media was added each day to a total of 1 L. 
2.26 Fluorescence of 177c3 after Expression in Suspension HeLa Cells 
 After 6 days, the 177c3 transfected HeLa cells were harvested by trypsin 
treatment and centrifugation.  The cells were washed once with HBSS++ and 
recentrifuged.  The cells were then resuspended in 5 mL of 10 mM Tris, pH 7.4 by 
trituration.  The cells were sonicated with 20 sec intervals six times.  The solution was 
centrifuged at 17 K for 20 mins to separate the cell membrane from the supernatant.  
The supernatant was then examined by fluorescence spectroscopy. 
 One mL of the supernatant was placed into a 1 cm pathlength quartz 
fluorescence cuvette.  The excitation was scanned from 300 to 500 nm with excitation 
slit widths of 4 nm and emission slit widths of 4 nm with the emission set to 510 nm.  
The emission was then scanned from 500 to 600 nm with the excitation at 450 nm, 469 
nm, and 483 nm.  Emission scans were performed with the excitation at 483 nm with 
several additions of 100 µM calcium until precipitation was observed. 
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Chapter 3 Study of a Near Infrared Calcium-binding Dye 
3.1 Rationale for Development of Near Infrared Calcium Sensitive Dye 
The measurement of intracellular calcium and other metal concentrations has 
benefited greatly by the development of dyes whose binding affinities correlate to the 
cellular environments (90-93).  Currently, most of the commercially available dyes are 
either absorbance or fluorescence based indicators with optical activities in the 
ultraviolet or visible regions of the spectrum (32).  For example, the commercially used 
dyes Fura-2 and Indo-1 are excited between 300 and 600 nm (92), and Calcium 
Crimson has the longest excitation wavelength of 593 nm (32).  One of the challenges 
to be solved is the existence of background interference from cell parts and 
contaminants in the ultraviolet and visible regions.  The accurate measurement of 
intracellular calcium concentration, especially with penetration to multiple layers of cell 
tissue and high sensitivity, remains to be developed as an analytical method (43).  The 
use of a metal binding dye with chromophore activity in the near infrared region has the 
advantage of greatly reduced background interference since most biomolecules do not 
have absorbance in this wavelength region (94).  Akkaya et al.  has reported several 
squaraine-based metal-binding near infrared dyes, including chemosensors with EDTA 
and BAPTA chelating moieties, which could sense calcium concentration (94, 95).  With 
these dyes, the addition of calcium results in a decrease of the NIR signal.  However, 
the detailed metal binding properties have not been reported.  In this chapter, the 
synthesis and detailed analysis of a novel metal binding dye 15C5-774 that binds 
metals with micromolar affinity is described.  This abbreviation denotes a metal binding 
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benzo-15-crown-5 moiety (15C5) linked at the meso position to a heptamethine cyanine 
as shown in figure 3.1.  The crown ether-substituted cyanine absorbs at 774 nm in 
methanol and Tris buffer (20:80 v/v).   
3.2 Design of 15C5-774 
The compound, 15C5-774, was synthesized by Dr. Christian Mason formerly of 
Georgia State University.  15C5-774 is a NIR chromophore-modified crown ether.  The 
properties of crown ethers as metal binding compounds have been reported extensively 
(96-109).  The size of the crown ether ring may be varied to provide a proper cavity for 
metal binding based on the size of the metal.  In particular, the cavity of benzo-15-
crown-5 has a diameter of 1.7–2.2 Å, depending on conformation (98).  This cyclic ether 
can easily accommodate calcium, which has a radius of 0.99 Å.   
The second functional unit of 15C5-774 is an indolium heptamethine cyanine that 
absorbs in the NIR region.  The crown ether is linked to the central meso position of the 
cyanine.  The wavelength and intensity of absorption of heptamethine cyanine 
chromophores are greatly affected by a substituent at the meso position as shown by 
our collaborator (110).   More importantly, the equilibrium conformation of an electron 
donating meso-substituent, such as an amino group, greatly influences the absorption 
by affecting conjugation of the substituent with the electron deficient cationic 
chromophore.  Accordingly, this finding was explored in the design of 15C5-774.  It was 
reasoned that a conformational change of the crown ether moiety upon binding calcium 
ion would induce absorption changes at the NIR chromophore, thereby providing a 
basis for the metal determination (111).   
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Fig 3.1 Synthesis of 15C5-774 
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3.3 Solution properties of 15C5-774 
When stored in a solid form at −20 °C, in the dark, and under a dry atmosphere, 
15C5-774 is stable indefinitely.  Stock solutions in methanol or other organic solvents 
are stable for at least a month when protected from light and oxygen and stored at 4 °C, 
as monitored by Vis-NIR spectroscopy.  In aqueous methanol at 23 °C in the presence 
of oxygen and in the dark, the compound is stable for at least 7 days, as shown by 1H 
NMR spectroscopy.  On the other hand, at 23 °C in the presence of light and oxygen, 
the solutions are less stable.  A slight decrease in the NIR absorption was observed 
under these conditions after several hours.  Accordingly, freshly made solutions in a 
methanol:aqueous solvent mixture (20:80 v/v) were used in this work to minimize 
environmental factors that influence dye degradation.   
3.4 Metal binding affinities and selectivity of 15C5-774 
The Vis-NIR absorption spectra of 15C5-774 in a Tris/MeOH buffer at 
physiological pH 7.4 in the absence of calcium and as a function of calcium 
concentration are shown in figure 3.2.  The metal-free compound has a NIR absorption 
band centered at 774 nm with a Sorens shoulder at about 710 nm and two visible bands 
at 566 and 445 nm.  The visible absorption at 566 nm is unusual in that it is normally not 
observed for heptamethine cyanines.  This phenomenon is discussed in more detail in 
Section 3.5.   
The addition of calcium ion results in the decrease of absorbance at all 
wavelengths (Fig 3.2).  The fractional changes of the absorptions at both 774 and 566 
nm of the dye can be fitted very well using equation 3, suggesting the formation of a 1:1  
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Fig 3.2 Absorbance spectra of 19.52 µM 15C5-774 with increasing concentrations of 
CaCl2 in 10 mM Tris buffer and 20% MeOH (v/v) pH 7.4. 
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dye:metal complex (Fig 3.3) (112, 113).  Since the calculated Kd values based on the 
fractional intensity change at all absorption bands are identical, a summary of the 
affinities based on the NIR absorption is reported in Table 3.1.   
Calcium is the strongest binding metal of the ions examined.  With a Kd average 
of 3.2 µM, the strong affinity of 15C5-774 for Ca2+ indicates that this dye could be used 
for monitoring intracellular calcium concentrations between the physiological resting and 
stimulated cell states since intracellular calcium concentrations vary from 0.1 to 10 µM.  
The strong affinity is consistent with a good molecular fit of calcium ion within a cavity of 
15-crown-5.  With metal ions of other sizes the binding affinity is not as strong.  With a 
decrease in the ionic radii of metal ions from 0.99 Å for calcium to 0.68 and 0.63 Å, this 
dye shows a slightly weaker binding affinity to zinc and magnesium with Kd values of 
11.4 and 7.2 µM, respectively.  These smaller ions may not be able to form bonds 
efficiently with all of the oxygens in the crown.  Strontium has an ionic radius of 1.12 Å, 
which is larger than that for calcium, and the affinity of this dye for strontium decreases 
about 4-fold.  Its larger size prevents the ion from fitting efficiently into the cavity in the 
crown.  Therefore, 15C5-774 shows metal selectivity for metal ions with ionic size close 
to the size of a crown cavity (Table 3.1).  In comparison to these divalent metal ions, the 
size selectivity of 15C5-774 is smaller for monovalent ions.   
In summary, the results for both divalent and monovalent metal ions suggest that 
both the size and charge are the two key determinants contributing to the metal affinity 
of 15C5-774.  For similarly sized ions such as calcium and sodium, the dye binds 2.5 
fold stronger to divalent calcium than monovalent sodium.  The binding affinity of  
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Fig 3.3 Fractional change of the absorbance at 774 nm as a function of Ca2+ 
concentration in 10 mM Tris and 20% MeOH (v/v) pH 7.4. The solid line was generated 
by using the fractional change equation 3 assuming the formation of a 1:1 metal:dye 
complex.  A virtually identical function was obtained by using the wavelength of 566 nm 
under otherwise identical conditions. 
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Table 3.1 Binding affinities of 15C5-774 and the 
ionic radii of the metals studied with the affinity 
measured at 774 nm. 
Metal Kd (µM) Ionic radius (Å) 
Zn2+ 11.4 ± 4.6 0.63 
Mg2+ 7.2 ± 2.3 0.66 
Li+ 21.8 ± 3.1 0.68 
Na+ 10.7 ± 0.9 0.97 
Ca2+ 3.2 ± 2.3 0.99 
Sr2+ 10.1 ± 0.2 1.12 
K+ 10.6 ± 1.1 1.33 
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monovalent lithium is about 3-fold weaker than that of magnesium, despite the similar 
ionic size.   
3.5 pH dependence 
To test the pH dependence of 15C5-774, the Vis-NIR spectra of the metal-free 
compound and in the presence of calcium or magnesium were taken in the appropriate 
Tris buffer at a lower and higher pH than the physiological pH of 7.4.  The spectra of the 
dye change with pH (Fig 3.4).  The spectra at pH 8.7 lack absorption at 566 nm and are 
typical for a heptamethine cyanine chromophore.  The unusual absorption at 566 nm 
appears with decreasing pH, gradually increases in intensity, and becomes dominant at 
pH 6.  These spectral changes are fully reversible with subsequent increases in pH of 
the acidified solution.  On the other hand, the binding affinities of magnesium remain 
unchanged from pH 6–9 while the calcium affinity at pH 6 is identical to that at pH 7, 
and the affinity at pH 8.7 is decreased only 1.5-fold.  These results are highly 
encouraging for our planned development studies of 15C5-774 as a practical reagent 
for metal determination in vivo.  More specifically, variations in physiological pH will 
have a negligible effect on the calcium determination under different pH conditions in 
vivo that, at present time, are difficult to monitor.  Interestingly, in addition to calcium 
determination, the strong pH dependence of the 566 nm absorption of 15C5-774 may 
be simultaneously used as the basis for the pH estimate in vivo.   
Additional studies are needed to understand the presence of the 566 nm 
absorption in the spectrum of 15C5-774 under low pH conditions.  It appears that, in 
addition to the normal s0→s1 transition at 774 nm, a new electronic excitation becomes  
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Fig 3.4. A comparison of the Ca2+ free (—) and Ca2+ loaded (---) spectra of 15C5-774 at 
pH 6 (•), pH 7.4 (▪), and pH 8.7 ( ) in Tris:MeOH (80:20 v/v). 
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important for the protonated compound.  Most likely, the 566 nm absorption results from 
excitation of the intramolecular complex between the protonated crown ether and the 
cyanine chromophore.  Consistent with this suggestion are the results of our previous 
experimental and computational studies that showed the presence of net negative 
charges on carbons 1′ and 7′ of the heptamethine chain of cyanines (114).   
3.6 Comparison of 15C5-774 and commercially available dyes 
The binding affinity of 15C5-774 for calcium is in the same range as 
commercially available indicators that are frequently used for intracellular study.  Dyes 
such as FURA-2, INDO-1, and Mag-FURA-2 have nanomolar to micromolar dissociation 
constants for calcium (92, 115, 116).  Our dye is well within this range.  However, these 
dyes have maximum absorbance in the ultraviolet to visible regions of the spectrum 
where background interference is high.  Our dye has maximum absorbance in the near 
infrared region where background interference is nearly nonexistent.  Also, illuminating 
in the near infrared avoids the tissue damage that is seen with ultraviolet irradiation.   
Much like FURA-2 and INDO-1, 15C5-774 should be protected from light 
whenever possible since it will undergo photodegradation.  In normal working 
conditions, however, photodegradation does not severely affect the results since it takes 
90 min of constant illumination for a loss of absorbance to be observed whereas INDO 
has been shown to lose absorbance within 10 min of constant exposure (117).  If the 
dye is protected from light, it is stable over several days, longer in organic solvents.  
Like FURA-2 and INDO-1, 15C5-774 should be stored at −20 °C, but, when protected 
from light, storage in solution at room temperature over several days does not affect the 
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dye's stability.  Unlike FURA-2 and INDO-1, the binding affinity of 15C5-774 is not 
greatly affected by pH.   
As a means of transporting the dye into the cell for metal analysis, the dye can 
be made into ester derivatives in a similar manner as with commercially available dyes.  
The synthesis of ester-substituted near-infrared cyanine dyes has been previously 
reported by our collaborators (111, 118).  Also, microinjection, a technique often used, 
can be used as a means to transport the dye into the cell (43).  Once inside the cell, 
concentration can be monitored by near UV absorbance (~290 nm), which does not 
change upon calcium binding.  The absorbance at this wavelength is only concentration 
dependent from the indolium portion of the dye.  The development of a dye with a 
wavelength shift upon calcium binding, by closer coupling of the cyanine chromophore 
and the metal binding moiety, is currently underway.   
3.7 Conclusions 
A novel metal binding near-infrared dye with the advantage of avoiding 
background interference and possible damage from illumination in the UV-Vis region, 
15C5-774, was designed, synthesized, and analyzed for its metal binding properties.  
The solution properties were examined, and the spectral properties of 15C5-774 were 
investigated by absorbance and NMR spectroscopy.  The solubility of 15C5-774 is 
comparable to commercially available dyes, and 15C5-774 has been shown to be 
somewhat more stable.  The metal binding affinities of 15C5-774 are in micromolar 
range for all metals tested and follow the order Ca2+>Mg2+>Sr2+≈K+≈Na+>Zn2+>Li+.  The 
calcium affinity of 15C5-774 is in the same range as FURA and INDO derivatives, 
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indicating that 15C5-774 can be used to monitor intracellular calcium concentrations.  
The dye could also be used for in vitro work, such as for protein competition assays, 
since its metal binding affinities are in the region needed to compare to many calcium 
binding proteins (119, 120).  An additional advantage of 15C5-774 is that, while the 
binding affinities change only slightly with a pH change, the spectral properties do alter 
with pH allowing the dye to be used to monitor pH fluxes.   
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Chapter 4 Design of Calcium-binding Sensors: the first generation 
4.1 Rationale for Engineering Calcium Biosensors by Design 
 As discussed in Chapter 1, although the literature has detailed several 
researchers’ attempts at this task, there is still a strong need to develop calcium sensors 
with a large range of calcium binding affinities to sense calcium signal changes in 
different cellular compartments.  One of the first steps to design calcium sensors is to 
engineer calcium binding sites in fluorescent proteins with different calcium binding 
affinities.  The goal of the project discussed in this chapter is to create calcium binding 
sites in green fluorescent protein using our established design approach.  There are 
numerous reasons to engineer a calcium biosensor by design.  The use of small 
molecule dyes has been prevalent in the past, but the desire to understand the temporal 
and spatial changes in calcium concentration in relation to events in the cell 
compartments necessitates the creation of a new type of sensor.  The creation of a 
calcium-binding fluorescent protein that can be directly expressed by cells, targeted to 
specific cell compartments, directly measured for fluorescence changes caused by 
calcium binding, and designed in a multitude of emission wavelengths will greatly 
enhance the study of calcium in living systems.  In this chapter, the design strategy 
employed in devising calcium-binding green fluorescent proteins will be discussed.  The 
chosen sites will be detailed, and the biophysical properties of bacterially expressed and 
purified GFP variants will be discussed. 
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4.2 Design of Potential Calcium Binding Sites 
 4.2.1 Computational Design 
 There are 80 structures of green fluorescent protein available in the protein data 
bank to date.  Most of these files contain mutations for various purposes.  Three of 
those pdb files, 1B9C, 1GFL, and 1EMM, were utilized as the base structures for the 
design to ascertain if any difference would be found in the computation.  The 1B9C 
structure is known as the cycle 3 mutant (or GFPuv) and contains F99S, M153T, and 
V163A (121).  This structure is reported to be a tetramer, and the fluorescence of this 
mutant is 30,000 times brighter than the wild type protein.  This structure was chosen 
for the basis of design due to its apparent better folding.  The 1EMM file contains the 
F64L mutation and is reported to be a dimer (122).  The 1GFL file contains the Q80R 
random mutation.  This structure was the first structure solved by Yang and Phillips 
shortly after the discovery of green fluorescent protein (123).  The first chain in the 
dimers or tetramers in the pdb file was utilized for the computation since the structures 
of the oligomers.  Initially, the possible calcium binding sites were identified by computer 
algorithms with the desired parameters, including the oxygen-calcium-oxygen angle, the 
oxygen-calcium distance, the ligand type, and the number of ligands (86-89).  The 
ligands for the binding site were one bidentate Asp and four unidentate ligands from 
Asp, Asn, Glu, and Gln.  The calcium-oxygen length was allowed to be in the range of 
2.0 to 3.0 Å.  The oxygen-calcium-oxygen angles are theoretically 72°, 144°, and 90° so 
the ranges of 30°-120°, 90°-180°, 45°-135° were allowed for the calculations.  We chose 
the most popular geometry for a calcium binding site of pentagonal bipyramid as the 
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calcium coordination site.  As shown in figure 4.1, one of the coordinating ligands was 
unfilled to allow water to serve as a ligand.  These parameters were input into the 
computer program, Dezymer, to search along the backbone of the protein to find 
possible locations for a design site.  However, the program does not take electrostatic 
interactions into account.  Also, to distinguish between Asp and Asn and between Glu 
and Gln, bench experiments would have to be performed.  After Site-search, refinement 
was performed where the sites were minimized based on the ideal geometry of 
pentagonal bipyramid.   
4.2.2 Selection of putative calcium binding sites 
After the computer algorithms were complete, several criteria were utilized to 
rank and finally choose sites.  Initially, the computer algorithms provided a data set of 
~10,000 sites for the pdb 1B9C.  These sites were examined and inappropriate sites 
were removed.  First, any sites that involved the central helix (i.e. amino acids 56 to 71), 
especially the chromophore, were removed from the data set.  Second, sites that 
contained mutation of hydrophobic residues, especially those that were involved in the 
hydrophobic core, were removed to avoid folding disruptions caused by replacing 
hydrophobic residues with charged residues.  Third, solvent inaccessible residues, such 
as Phe8 with a solvent accessibility of 2.6, were removed since a solvent accessibility is 
necessary for calcium binding.  The solvent accessibility was evaluated with GetArea 
and is shown in Table 4.1 (124).  Residues with low solubility or those pointing inside 
the barrel were not considered.  However, it must be noted that GetArea does not 
always correctly identify residues pointing in or out of the barrel as observed by close 
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Fig 4.1 The ideal pentagonal bipyramidal geometry of a calcium 
binding site with the oxygen-calcium-oxygen angles of 72° for the 
ligands located in the pentagon (ϕ1), 90° for the X position in relation 
to the pentagon (ϕ2), and 144° for the X-Ca(II)--X angle (ϕ3)
illustrated.  The ideal distance between calcium and oxygen is 2.4 Ǻ.  
During the design process, ϕ1 was allowed to range from 30° to 120°, 
ϕ2 ranged from 45° to 135°, and ϕ3 ranged from 90° to 180°.
ϕ1 = 72°
ϕ3 = 144°
ϕ2 
= 
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°
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Table 4.1 Solvent accessibility of GFP using the 1B9C pdb file and calculated 
with the GetArea program (124). “Total” is the total solvent accessibility of the 
residue, “apolar” is the solvent accessibility of the backbone for each amino 
acid, “sidechain” is the solvent accessibility of the amino acid sidechain, “ratio” 
is the ratio of the sidechain surface area to the random coil value, “In/Out” is the 
cutoff for solvent exposure with “out” being a ratio of >50% and “in” being a 
ratio of <20%. 
Residue Residue Number Total Apolar Sidechain 
Ratio 
(%) In/Out 
GLY 4 30.41 3.86 0 34.9  
GLU 5 65.85 26.57 63.85 45.2  
GLU 6 123.5 65.7 107.24 75.9 o 
LEU 7 58.29 48.94 45.43 31.1  
PHE 8 2.6 0.23 0.23 0.1 i 
THR 9 93 64.54 82.03 77.2 o 
GLY 10 42.71 41.51 0 49  
VAL 11 81.24 58.88 58.88 48.1  
VAL 12 7.07 7.07 6.46 5.3 i 
PRO 13 59.58 59.58 59.51 56.6 o 
ILE 14 1.36 0 0 0 i 
LEU 15 66.15 66.15 66.15 45.2  
VAL 16 0 0 0 0 i 
GLU 17 52.99 15.46 52.19 37  
LEU 18 3.61 0.86 0 0 i 
ASP 19 89.23 25.64 86.65 76.7 o 
GLY 20 6.32 1.62 0 7.2 i 
ASP 21 36.34 12.24 36.34 32.2  
VAL 22 0 0 0 0 i 
ASN 23 56.69 21.4 26.82 23.5  
GLY 24 51.8 35.31 0 59.4 o 
HIS 25 91.22 73.68 86.35 55.9 o 
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LYS 26 154.6 103.08 146.02 88.8 o 
PHE 27 3.29 2.22 1.28 0.7 i 
SER 28 27.09 15.28 27.09 35  
VAL 29 1.46 0 0 0 i 
SER 30 36.17 21.08 34.54 44.6  
GLY 31 0.15 0.01 0 0.2 i 
GLU 32 92.57 43.33 91.13 64.5 o 
GLY 33 16.12 6.45 0 18.5 i 
GLU 34 81.52 16.03 80.94 57.3 o 
GLY 35 0.97 0.97 0 1.1 i 
ASP 36 19.8 4.16 19.8 17.5 i 
ALA 37 4.79 2.89 2.89 4.4 i 
THR 38 68.17 55.73 49.11 46.2  
TYR 39 144.86 96.68 133.93 69.4 o 
GLY 40 0.17 0.17 0 0.2 i 
LYS 41 65.15 30.27 64.33 39.1  
LEU 42 3.56 3.56 3.56 2.4 i 
THR 43 46.84 43.9 46.84 44.1  
LEU 44 1.23 1.23 0.72 0.5 i 
LYS 45 41.49 26.83 41.16 25  
PHE 46 0 0 0 0 i 
ILE 47 14.97 14.97 14.97 10.2 i 
CYS 48 2.8 0 0 0 i 
THR 49 83.02 51.15 47.59 44.8  
THR 50 72.74 46.75 35.4 33.3  
GLY 51 44.32 41.42 0 50.8 o 
LYS 52 154.29 122.04 140.99 85.7 o 
LEU 53 5.77 1.82 1.82 1.2 i 
PRO 54 25.46 25.3 14.18 13.5 i 
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VAL 55 0.53 0 0 0 i 
PRO 56 9.23 9.23 4.33 4.1 i 
TRP 57 10.71 10.48 10.48 4.7 i 
PRO 58 3.39 2.49 2.49 2.4 i 
THR 59 3.04 1.3 0 0 i 
LEU 60 0 0 0 0 i 
VAL 61 3.88 1.87 1.87 1.5 i 
THR 62 29.19 21.71 12.26 11.5 i 
THR 63 4.89 2.1 0 0 i 
PHE 64 5.06 5.06 0 0 i 
VAL 68 13.07 1.15 1.14 0.9 i 
GLN 69 16.48 14.88 16.44 11.4 i 
CYS 70 0 0 0 0 i 
PHE 71 0 0 0 0 i 
SER 72 0 0 0 0 i 
ARG 73 88.41 30.57 86.57 44.3  
TYR 74 3.42 0.13 0.29 0.2 i 
PRO 75 28.42 28.42 25.97 24.7  
ASP 76 124.72 40.62 107.85 95.4 o 
HIS 77 101.26 81.68 74.97 48.5  
MET 78 0.9 0.9 0.71 0.4 i 
LYS 79 64.59 48.63 62.7 38.1  
GLN 80 109.46 45.54 103.84 72.3 o 
HIS 81 8.31 8.29 8.29 5.4 i 
ASP 82 1.53 0.96 1 0.9 i 
PHE 83 0.23 0.23 0.23 0.1 i 
PHE 84 0.05 0.05 0.05 0 i 
LYS 85 6.02 6.02 6.02 3.7 i 
SER 86 22 11.65 4.89 6.3 i 
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ALA 87 3.58 3.03 0 0 i 
MET 88 6.22 0 0 0 i 
PRO 89 71.2 68.08 68.08 64.7 o 
GLU 90 67.74 35.12 59.54 42.2  
GLY 91 0 0 0 0 i 
TYR 92 0 0 0 0 i 
VAL 93 17.88 17.55 17.55 14.3 i 
GLN 94 9.03 2.36 8.96 6.2 i 
GLU 95 61.6 18.39 60.96 43.2  
ARG 96 7.84 2.28 3.61 1.8 i 
THR 97 52.95 32.51 52.95 49.9  
ILE 98 0.71 0.71 0.71 0.5 i 
SER 99 38.69 6.87 36.76 47.5  
PHE 100 1.76 0.01 0.01 0 i 
LYS 101 116.25 82.41 105.31 64 o 
ASP 102 100.3 42.1 75.62 66.9 o 
ASP 103 27.28 5.72 1.74 1.5 i 
GLY 104 2.55 2.01 0 2.9 i 
ASN 105 25.32 3.02 25.32 22.2  
TYR 106 0 0 0 0 i 
LYS 107 79.04 73.65 73.88 44.9  
THR 108 8.29 1.73 2.4 2.3 i 
ARG 109 90.48 54.53 88.97 45.5  
ALA 110 3.38 3.38 3.11 4.8 i 
GLU 111 44.17 8.86 44.17 31.3  
VAL 112 1.13 1.13 1.13 0.9 i 
LYS 113 52.3 36.47 52.3 31.8  
PHE 114 22.63 6.57 6.57 3.6 i 
GLU 115 66.97 47.8 55.24 39.1  
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GLY 116 70.69 52.96 0 81.1 o 
ASP 117 108.76 47.75 97.94 86.7 o 
THR 118 34.19 33.65 34.19 32.2  
LEU 119 0 0 0 0 i 
VAL 120 4.79 4.79 4.79 3.9 i 
ASN 121 2.68 0 2.68 2.3 i 
ARG 122 103.13 51.62 99.83 51.1 o 
ILE 123 5.28 0.34 0.17 0.1 i 
GLU 124 108.78 40.15 107.43 76.1 o 
LEU 125 5.26 1.34 0 0 i 
LYS 126 94.79 88.91 94.79 57.6 o 
GLY 127 0 0 0 0 i 
ILE 128 67.17 67.17 65.47 44.4  
ASP 129 107.94 30.31 71.35 63.1 o 
PHE 130 11.87 0.01 0 0 i 
LYS 131 95.64 60.16 84.41 51.3 o 
GLU 132 146.23 52.83 137.25 97.2 o 
ASP 133 105.46 52.85 88.95 78.7 o 
GLY 134 8.87 8.87 0 10.2 i 
ASN 135 31.08 0.31 30.77 26.9  
ILE 136 0 0 0 0 i 
LEU 137 23.45 11.79 11.79 8.1 i 
GLY 138 31.61 14.74 0 36.3  
HIS 139 87.74 70.13 74.13 47.9  
LYS 140 65.26 55.81 65.16 39.6  
LEU 141 14.89 0.35 0.29 0.2 i 
GLU 142 67.25 28.09 57.3 40.6  
TYR 143 65.8 47.49 47.07 24.4  
ASN 144 44.86 30.46 41.32 36.1  
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TYR 145 21.17 5.39 6.09 3.2 i 
ASN 146 42.23 18.09 32.56 28.5  
SER 147 56.78 35.43 50.43 65.2 o 
HIS 148 8.98 8.06 2.84 1.8 i 
ASN 149 48.48 4.28 44.4 38.8  
VAL 150 4.82 4.82 4.82 3.9 i 
TYR 151 119.33 94.44 118.67 61.5 o 
ILE 152 1.68 0.17 0.15 0.1 i 
THR 153 47.7 34.17 47.7 44.9  
ALA 154 25.57 8.08 8.07 12.4 i 
ASP 155 1.39 0.78 0.62 0.5 i 
LYS 156 139.66 110.5 124.92 75.9 o 
GLN 157 155.26 66.58 111.97 77.9 o 
LYS 158 107.36 62.38 87.03 52.9 o 
ASN 159 62.44 31.08 62.42 54.6 o 
GLY 160 0 0 0 0 i 
ILE 161 0 0 0 0 i 
LYS 162 71.36 53.53 71.36 43.4  
ALA 163 0.15 0 0 0 i 
ASN 164 67.34 28.57 67.12 58.7 o 
PHE 165 13.3 13.02 3.08 1.7 i 
LYS 166 107.05 85.49 97.48 59.3 o 
ILE 167 3.18 3.18 3.18 2.2 i 
ARG 168 92.51 55.79 92.51 47.3  
HIS 169 2.69 2.69 1.9 1.2 i 
ASN 170 35.81 4.19 35.44 31  
ILE 171 1.63 1.61 1.61 1.1 i 
GLU 172 120.14 37.8 90.44 64 o 
ASP 173 115.7 54.16 71.38 63.2 o 
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GLY 174 61.56 40.05 0 70.6 o 
SER 175 65.38 55.68 53.7 69.4 o 
VAL 176 60.18 42.82 42.82 35  
GLN 177 6.73 4.03 2.82 2 i 
LEU 178 36.28 36.28 36.28 24.8  
ALA 179 0 0 0 0 i 
ASP 180 27.65 1.1 27.65 24.5  
HIS 181 2.08 1.89 1.93 1.2 i 
TYR 182 110.21 80.51 104.29 54 o 
GLN 183 4.54 0.06 0 0 i 
GLN 184 40.15 4.35 40.03 27.9  
ASN 185 0.24 0.24 0 0 i 
THR 186 31.29 21.78 31.29 29.5  
PRO 187 24.32 7.8 7.8 7.4 i 
ILE 188 68.5 48.14 40.83 27.7  
GLY 189 18.41 3.04 0 21.1  
ASP 190 143.85 48.65 97.31 86.1 o 
GLY 191 33.12 30.24 0 38  
PRO 192 135.61 129.39 118.7 100 o 
VAL 193 20.09 3.28 1.6 1.3 i 
LEU 194 82.96 82.96 79.91 54.7 o 
LEU 195 58.72 40.71 40.71 27.8  
PRO 196 5.29 0.38 0.03 0 i 
ASP 197 90.93 33.7 84.58 74.8 o 
ASN 198 104.17 37.21 91.63 80.2 o 
HIS 199 5.54 4.44 0.06 0 i 
TYR 200 58.73 22.45 58.73 30.4  
LEU 201 0 0 0 0 i 
SER 202 31.8 11.75 31.01 40.1  
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THR 203 16.51 13.03 15.94 15 i 
GLN 204 86.2 20.03 85.61 59.6 o 
SER 205 14.36 2.64 2.46 3.2 i 
ALA 206 63.62 63.15 57.26 88.2 o 
LEU 207 17.83 0 0 0 i 
SER 208 54.5 46.12 49.78 64.3 o 
LYS 209 88.39 71.16 76.88 46.7  
ASP 210 49.18 11.91 43.01 38.1  
PRO 211 135.61 108.12 97.94 93.1 o 
ASN 212 130.16 31.83 104.91 91.8 o 
GLU 213 29.68 3.49 15.14 10.7 i 
LYS 214 196.05 131.43 165.09 100 o 
ARG 215 125.76 68.56 115.23 58.9 o 
ASP 216 31 8.5 23.09 20.4  
HIS 217 6.52 6.15 6.48 4.2 i 
MET 218 0 0 0 0 i 
VAL 219 24.72 24.71 24.71 20.2  
LEU 220 2.17 2.17 2.17 1.5 i 
LEU 221 52.1 51.84 51.84 35.5  
GLU 222 21.6 0.7 21.6 15.3 i 
PHE 223 86.22 86.15 86.15 47.8  
VAL 224 0.99 0.9 0.67 0.6 i 
THR 225 43.81 34.09 43.81 41.3  
ALA 226 0.25 0 0 0 i 
ALA 227 31.18 31.18 27.55 42.5  
GLY 228 50.96 26.21 0 58.4 o 
ILE 229 42.73 36.58 31.83 21.6  
THR 230 175.21 111.51 122.69 100 o 
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examination of the crystal structure.  For example, Val120 points out of the barrel in the 
crystal structure, but it is noted as inside by GetArea.  Therefore, examination of the 
crystal structure was also utilized during this process to examine the potential calcium 
binding residues.  Fourth, the remaining sites were then ranked based on their location 
in the protein.  Sites in the loop regions with higher flexibility were considered “safe” to 
mutate without disrupting the protein folding while sites involving the β-strands were 
considered more aggressive.  Fifth, since fewer mutations will more likely allow proteins 
to retain their native conformation, sites with natural pockets but inappropriate residues 
were examined as possible mutation positions.  The sites were ranked for the number of 
required mutations in these natural pockets.  Sixth, the distance from the chromophore 
was also evaluated since the requirement for a sensor is that calcium binding must 
cause a change in the fluorescence of the protein.  Lastly, the clash with close residues 
was considered to decide if further mutations would be necessary.   
Once all of these steps were achieved, six sites were chosen for study.  They 
are Site 120, Site 120b, Site 177, Site 194a, Site 194b, and Site 229 (Table 4.2 and Fig 
4.2).  Sites 120 and 120b are located in the middle of the barrel very near the 
chromophore.  They differ by two residues, 120 includes K113D and E17 whereas 120b 
includes L15N and E111.  These two sites were chosen due to their proximity to the 
chromophore and to the natural pocket that the residues form.  Since they are located 
on the β-strands, they could feasibly cause a large change in chromophore 
fluorescence upon calcium binding.  Site 177 is located on the end of the barrel in the 
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13D197, H199D, M78N, H81D, I229D229
15E5, D82, K79D, L194N, S86D194b
15E5, D82, K79D, L194N, K85D194a
22Q177N, I171D, D173, S175D, N135177
14E115, V120N, R122D, E111, L15N120b
14E115, V120N, R122D, K113D, E17120
Average 
Distance to 
the 
Chromophore 
(Å)
Calcium-binding LigandsDesign Site
Table 4.2 A table of the design sites engineered into Green Fluorescent 
Protein.
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120 120b
177
Fig 4.2 Illustrations of the models highlighting the locations of the designed 
proteins with the ligands illustrated in red and the chromophore in green.  
The pdb 1b9c and the program Pymol were utilized for these depictions.
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194a
229
194b
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loop regions.  This site was chosen to reduce possible misfolding of the protein since 
the loops are more flexible, and mutations in the loop regions are less likely to interrupt 
the fold.  In addition, the flexible loops should more easily form the proper calcium 
binding geometry.  Sites 194a and 194b are also located in the loop region on the 
opposite side of the barrel from 177.  These sites differ by one residue; 194a contains 
K85D whereas 194b contains S86D.  These two sites with one amino acid difference 
were chosen to provide a way to test the variation in the properties of the pocket without 
drastically changing the location since K85 interacts with different residues than S86.  
Also, the change of this single residue shifts the calcium binding pocket, which allows 
us to further test and understand the outcome of our design process and may provide 
different chromophore effects upon calcium binding.  Including sites that are in nearly 
the same location with only one residue difference allowed us to test the ability of the 
designed site to form the proper calcium pocket, to modulate the binding affinities by the 
location of the binding residue, and, in the event that one or more of the residues 
caused misfolding, to narrow down which residues were the cause.  For example, the 
lysine to aspartate mutation in sites 120 and 194a could cause misfolding due to charge 
repulsion.  This would be immediately recognized if the site without this mutation were 
fluorescent, but the site with it was not or if it failed to express well.  Site 229 is located 
in the loop region on the same side lengthwise of the barrel as the 194 sites but is 
shifted widthwise.  This site was chosen due to its natural pocket and its location.  The 
sites in differing locations in the protein were chosen also to elucidate the chromophore 
sensitive locations for further modifications to the designed sensors. 
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4.3 Engineering a Calcium-binding Protein 
 To engineer the designed calcium-binding sites into the host protein, site-directed 
mutagenesis was employed.  The host protein, EGFP, was a kind gift from Dr. Teryl 
Frey of GSU.  EGFP contains the mutations F64L/S65T, which enhance the 
fluorescence, and V22L/M218I/H231L, which seem to be silent mutations.  The 
sequence is illustrated in figure 4.3.  The numbering of the sequence is in accordance 
with the pdb numbering to keep in agreement with the computer algorithm output. The 
oligonucleotide primers were devised to incorporate the desired mutations and to match 
the rest of the DNA so that the polymerase would only include the desired mutations.  
Standard polymerase chain reaction (PCR) was utilized, as detailed in Chapter 2, 
section 2.2, to change the nucleotides to the ones that would code for the designed 
ligands.  The primers are listed in Table 2.1.  Sites 120 and 120b required two rounds of 
PCR each.  Site 177 was created with only one round of PCR.  Sites 194a and 194b 
were engineered with two rounds of PCR.  Site 229 required three rounds of PCR.  
These mutations were performed in the cloning vector pGEM11 due to the length 
limitations of the pfu polymerase available at that time. 
 For expression, the designed sites were subcloned into the pet28a vector, which 
includes an N-terminal 6 histidine tag for purification (Fig 4.4).  The vector can also code 
for a 6 histidine tag on the C-terminal with the insertion of a single nucleotide for the 
proper frame.  The DNA utilized for this project contains a stop codon (TAA) so that no 
tag is included at the C-terminal.  There are ~30 amino acids between the N-terminal 
tag and the start of EGFP since the vector contains a thrombin cleavage site to remove 
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1/1                                                           31/11
atg gtg agc aag ggc gag gag ctg ttc acc ggg gtg gtg ccc atc ctg gtc gag ctg gac
M   V    S    K     G    E    E     L   F   T    G    V    V   P    I    L    V   E     L   D
61/21   91/31
ggc gac gta aac ggc cac aag ttc agc gtg tcc ggc gag ggc gag ggc gat gcc acc tac
G    D    L   N    G     H   K    F   S    V    S   G    E    G    E     G   D    A    T   Y
121/41 151/51
ggc aag ctg acc ctg aag ttc atc tgc acc acc ggc aag ctg ccc gtg ccc tgg ccc acc
G    K    L    T   L    K   F    I     C   T    T    G     K  L   P    V    P    W   P    T
181/61 211/71
ctc gtg acc acc ctg acc tac ggc gtg cag tgc ttc agc cgc tac ccc gac cac atg aag
L    V    T    T    L    T   Y    G    V    Q    C   F   S    R Y   P    D    H    M   K
241/81 271/91
cag cac gac ttc ttc aag tcc gcc atg ccc gaa ggc tac gtc cag gag cgc acc atc ttc
Q    H    D   F   F   K     S   A    M   P    E     G   Y   V  Q    E     R    T    I    F
301/101 331/111
ttc aag gac gac ggc aac tac aag acc cgc gcc gag gtg aag ttc gag ggc gac acc ctg
F   K    D     D    G    N   Y    K    T     R    A    E    V  K    F   E     G   D     T    L
361/121 391/131
gtg aac cgc atc gag ctg aag ggc atc gac ttc aag gag gac ggc aac atc ctg ggg cac
V    N    R    I    E      L   K    G    I     D   F    K    E D    G    N    I     L   G     H
421/141 451/151
aag ctg gag tac aac tac aac agc cac aac gtc tat atc atg gcc gac aag cag aag aac
K     L   E     Y   N    Y    N   S     H    N    V    Y   I   M   A    D    K     Q   K     N
481/161 511/171
ggc atc aag gtg aac ttc aag atc cgc cac aac atc gag gac ggc agc gtg cag ctc gcc
G     I     K    V   N   F    K    I     R    H    N    I    E D    G    S     V   Q     L   A
541/181 571/191
gac cac tac cag cag aac acc ccc atc ggc gac ggc ccc gtg ctg ctg ccc gac aac cac
D     H   Y    Q    Q    N    T    P    I      G   D     G    P V    L    L   P    D    N   H
601/201 631/211
tac ctg agc acc cag tcc gcc ctg agc aaa gac ccc aac gag aag cgc gat cac atg gtc
Y    L   S    T     Q    S   A    L   S     K    D    P    N   E    K     R   D    H    I    V
661/221 691/231
ctg ctg gag ttc gtg acc gcc gcc ggg atc act ctc ggc atg gac gag ctg tac aag taa
L    L    E    F   V    T    A    A    G    I     T   L   G    M   D    E     L   Y    K    *
Fig 4.3 DNA and protein sequence of the host EGFP with the numbers 
referring to the nucleotide and amino acid, respectively.
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Fig 4.4 The vector map of pet28a with the details of the multiple cloning site 
is shown as taken from Novagen at www.novagen.com.
107
  
the histidine tag if necessary, a T7 tag coding region to facilitate protein detection 
through western blot or immunoprecipitation and/or to improve protein expression yield, 
and a multiple cloning site as shown in figure 4.4.  The subclone was completed by 
double digestion with restriction enzymes that form sticky ends for ligation, BamHI and 
EcoRI.  After the subclone was verified through automated sequencing, the DNA was 
transformed into DH5α E. coli for DNA amplification and into BL21(DE3) E. coli cells for 
expression. 
4.4 Expression and Purification of EGFP and Calcium-binding Variants 
 4.4.1 Expression of EGFP and the designed proteins 
EGFP expresses very well in BL21(DE3) E. coli grown in Luria-Bertani medium 
and is strongly fluorescent when the temperature is reduced to 30 °C after induction 
with 0.2 mM IPTG at an optical density (OD) of 0.6.  The protein expresses at 37 °C, but 
it is not fluorescent, which has been well documented in the literature (63).  However, 
with expression at 30 °C after induction, it is common to obtain 20-30 mg of pure protein 
per 1 L of medium (Chapter 2.5).  As shown in figure 4.5, the EGFP band just above the 
28 kDa marker band increases with time after induction.  The cell pellet is colored 
yellow under room lights and glows green under a handheld UV light at 354 nm due to 
EGFP expression, as illustrated in figure 4.5. 
When the full designed sites—120, 177, and 194a—were expressed under the 
same expression conditions as EGFP in BL21(DE3) and LB medium with the 
temperature reduced to 30 °C after induction, they were not colored.  As shown in figure 
4.6, the cell growth and SDS-PAGE results indicate that the cells grew well and that the 
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14 KDa
28 KDa
66 KDa
Fig 4.5 SDS-PAGE gel of the expression (top) of EGFP when expressed 
with the pet28a vector in LB media.  The lanes in the gel are before 
induction and 1-5 hr after induction.  Pictures of EGFP under standard room 
lights (middle) and under UV excitation handheld light at 366 nm (bottom) 
indicating the strong fluorescence of EGFP even when still in the cell pellet.
Marker      BI           AI1        AI2        AI3        AI4   AI5
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14 KDa
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Fig 4.6 SDS-PAGE gel of the expression of 120 (left) and 177 (right) in LB-
kanamycin and BL21(DE3) E. coli.  The lanes are labeled for marker (M), 
before induction (BI), and after induction for 1-3 hrs (AI1, AI2, AI3).  The 
band just above 28 kDa is the EGFP variant.  The cell growth curve (bottom) 
illustrates that the cells grew well during the expression with induction (0.2 
mM IPTG) at approximately 0.6 OD.
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protein expressed at high levels as indicated by the large band above 28 kDa.  
However, the pellet after expression did not emit fluorescence.  Fluostar, a microarray 
fluorescence instrument, was utilized with the appropriate filters for GFP fluorescence to 
ascertain if the variants were fluorescent as shown in figure 4.7.  The intensities from 
these trials were the same as the baseline.  As demonstrated in Table 4.3, expression 
trials were completed to determine the optimal conditions so that the proteins would 
gain color--including different E. coli strains, various media, different IPTG 
concentrations at induction, expression time, and leading protein—but none of these 
trials demonstrated colored designed protein.  Different E. coli strains were tested 
because each strain has its own unique properties that could allow the proteins to fold 
better, such as a reducing or oxidizing cytosolic environment.  JM109 E. coli did not 
express the protein well nor did Rosetta-GAMI cells.  Different media were also tested 
due to their different environmental properties.  It has been found that adding salt to the 
media allows for better protein production (125)(unpublished observations), but the 
increased salt concentration in the SV media did not produce fluorescent protein 
although the proteins were well expressed.  IPTG (isopropyl β-D-thiogalactoside) is a 
commonly used chemical to induce expression of vectors containing the lac operon.  
The concentration of IPTG is protein, vector, and cell strain dependent so the amount 
for the variants was tested.  Concentrations from 0.1 mM to 0.8 mM did not yield 
fluorescent protein although a large amount of protein was produced.    In addition, the 
proteins were expressed without induction with IPTG and grown for 24-48 hrs to 
ascertain if less protein in the cells would allow the proteins to fold properly and become 
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Fig 4.7 A graph of the Fluostar microplate assay results for the expression of 
designed protein 194a and four of its variants, K85D, S86D, L194N/K85D, 
and L194N/S86D, is shown to illustrate the use of the microplate reader in 
determining if protein fluorescence is indicated.  Site 194a does not become 
fluorescenct even after 21 hr of expression.  These results are similar for 
sites 120 and 177.  The variants containing K85D also do not indicate 
fluorescence, implying that this mutation is detrimental to chromophore 
formation.  The variants containing the S86D mutation are fluorescent, 
indicating that this mutation does not disrupt chromophore formation.
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Expression with GST at the N-term
Expression up to 48 hrs
0.1-0.8 mM IPTG
Temperature at 25 °C after induction
JM109 in LB media
BL21(DE3) in SV media
BL21(DE3) in LB media
Condition
Table 4.3 Summary of the conditions tested to provide 
EGFP variant fluorescence.
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fluorescent.  The amount of IPTG could influence protein folding because it affects the 
rate of protein expression.  If the protein is expressed too quickly in large amounts, it 
may not have time to fold properly and be sent to inclusion bodies too quickly.  Varying 
the amount of IPTG could help the protein fold since GFP is known to need time to 
mature, up to several days for the wild type protein from jellyfish.    This is also the 
reason why the protein was expressed over several days with induction, to ascertain if 
extra maturation time was necessary.  In addition, expression trials were performed by 
Dorinda Nelson, a summer McNair student.  The expressed site 229 indicated no 
fluorescence with each of the above conditions tested. 
Although several growth conditions were varied, the designed proteins 120, 177, 
194a, and 229 remained colorless when expressed in bacteria.  Waldo and Terwilliger 
indicated the use of a leading protein that is known to fold well under a variety of 
conditions to improve the folding of the desired protein (126).  In that study, they 
employed glutathione-S-transferase (GST) fused to a GFP variant and monitored the 
expression and folding rates of the variant.  They found that an N-terminal fusion of 
GST to GFP remained soluble and increased in brightness, indicating better tertiary 
packing, while the GFP variant without the leading protein aggregated as inclusion 
bodies.  The variant proteins were expressed with GST at the N-terminus.  EGFP 
indicated color and fluorescence when expressed with GST with the temperature 
reduced to 30 °C after induction, but the designed proteins did not.  However, the 
variant proteins express in high yield with large bands indicated on the SDS-PAGE 
except for expression in the JM109 cells. 
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 4.4.2 Purification of EGFP and the designed proteins 
As illustrated in figure 4.8, to purify EGFP for biophysical studies, the protein was 
released from the cell pellet by sonication after the pellet was suspended in lysis buffer 
(section 2.5) and centrifuged to separate the soluble protein from the insoluble cell 
elements.  The protein was then loaded onto a previously prepared nickel chelating 
column (Amersham Biosciences).  Histidine tagged proteins will bind to chelated nickel 
allowing for contaminant proteins to be washed away.  EGFP was then removed from 
the column by competition with imidazole, which binds to the nickel by virtue of its 
similarity to histidine.  The eluted protein was then dialyzed against 10 mM Tris, 1 mM 
DTT, 1% glycerol, pH 7.4 to remove the imidazole.  The host protein, EGFP, purifies 
very well with high yield, 20-30 mg/L, with this method as indicated in figure 4.9.  
Storage of the protein in 20% glycerol at -20 °C allowed the protein to remain in good 
condition for up to 1 year. 
EGFP has a known tendency to oligomerize in solution.  This process was 
observed after purification of the protein by SDS-PAGE, as shown in figure 4.10.  The 
monomer is observed just above 28 KDa and a dimer band is observed next to the 66 
KDa marker band.  Addition of 5% β-mercaptoethanol removes the dimer band, as 
shown in the bottom gel in figure 4.10.  Before staining the gel, a yellow color was also 
observed in both bands, indicating the presence of the chromophore in both bands.  
Previous reports have suggested that the two surface cysteines (48 and 70) contribute 
to the dimerization by forming disulfide bonds (127).  The use of β-mercaptoethanol 
reduces the disulfide bonds so that the protein does not dimerize. 
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Fig 4.8 Purification scheme for EGFP utilizing the Hitrap nickel chelating 
column.  The tope indicates the overall method and the bottom indicates the 
preparation of the column.
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14 KDa
28 KDa
66 KDa
Fig 4.9 SDS-PAGE gel of the purification of EGFP after expression in 
E. coli.  The lanes in the gel are the FPLC fractions after elution from 
the His tag chelating column.   The pictures are under room lights and 
under a handheld UV light illustrating the fluorescence of GFP after 
purification.
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Fig 4.10 SDS-PAGE gel of purification fractions after FPLC of EGFP 
expressed with thepet28a vector in LB-kanamycin media and BL21(DE3) 
E. coli cells.  The band above 66 KDa is the dimer formation of EGFP 
while the band just above 28 KDa is the monomer band.  Addition of 5% β-
mercaptoethanol reduced the dimer formation so that the bands became 
one as shown in the bottom gel of the purification of 177.
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EGFP FPLC fractions
177 FPLC fractions
M        F6         F7           F8        F7 no β-mercapoETOH
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Although the variant proteins were not fluorescent, the binding of calcium to the 
designed pocket was still of interest to validate our design process.  In addition, it was 
possible that the proteins could be refolded into fluorescent protein after they were 
purified; therefore, the designed proteins were purified.  After the cell pellet was 
sonicated, the variant protein remained in the cell pellet, presumably as inclusion 
bodies, as shown in figure 4.11.  The pellet was dissolved with 8 M urea to solubilize the 
protein.  After the protein was refolded by 10x dilution into buffer (10 mM Tris, 1 mM 
DTT, pH 7.4), the variant protein remained in solution.  It should be noted that the 
dilution into buffer had to progress slowly, drop by drop, to keep the protein from 
precipitating.  To remove contaminant proteins, size exclusion FPLC with a Superdex-
75 column and 10 mM Tris buffer, pH 7.4 was employed since the purification of the 
variant proteins was problematic utilizing the nickel chelating column.  First, the variant 
protein eluted in many fractions at different imidazole concentrations, unlike EGFP, 
which would elute in 3 or 4 fractions in a narrow range of imidazole concentration.  
Hence, the concentration of the purified variants was quite low due to such a large 
volume (~20 µM).  This was likely a result of interference from denaturants allowing 
non-specific binding of contaminants.  Unfortunately, the proteins would precipitate 
during the concentration process even with the addition of glycerol from 1% to 20%.  
When the variant proteins were purified with the size exclusion column, they generally 
eluted in 3 fractions so that the concentration was much higher (~100 µM), and there 
was no need to concentrate the protein.  Second, dialysis of the variant proteins tended 
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M           1         2                                        3         4
Fig 4.11 SDS-PAGE gels of site 120 purification.  Lane 1 is the cell 
pellet after sonication.  Lane 2 is the supernatant after sonication.  
Lane 3 is the supernatant after refolding with 8 M urea.  Lane 4 is 
the pellet after refolding with 8 M urea.  These results indicate that 
the protein is insoluble until refolded with urea, after which the 
protein remains in solution.
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to result in precipitation.  Purification with the size exclusion column did not require 
dialysis.  The variant proteins were purified to >95% purity, as shown in Figure 4.10, 
before they were utilized for biophysical characterization and stored in 1% glycerol on 
ice at 4 °C or in 20% glycerol at -20 °C. 
4.4.3 Purification optimization and degradation reduction with Hitrap Q  FPLC 
 The fluorescent proteins, EGFP and the partial sites discussed in section 4.6, 
were observed to degrade over time, especially when stored at 4 °C on ice, and to lose 
fluorescence gradually.  The molecular weight was observed by SDS-PAGE and mass 
spectrometry to be reduced to two fractions at 20 KDa and 10 KDa.  In addition, the 
histidine tag was cleaved during storage.  Two approaches were taken to resolve this 
problem.  First, glycerol concentrations were tested to avoid induced spectral changes 
and precipitation upon thawing of the protein were tested (by a coworker Ning Chen).  It 
was found that 20% glycerol could be added to the stock protein for storage at -20 °C.  
Second, the protein was further purified (after the Ni2+ chelating column) with a Hitrap Q 
column and a NaCl gradient to remove any contaminants that may be contributing to the 
degradation.  The Hitrap Q column is an anion exchanger with positively charged 
functional groups.  These functional groups will bind to negatively charged proteins 
while other proteins are washed away.  Once bound, the protein can be eluted with a 
salt gradient.  Contaminants will not elute at the same salt concentration as the desired 
protein.  We hypothesized that a protease was copurifying with our proteins and causing 
the degradation, which is not unlikely due to the number of proteases in bacteria. 
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The degradation of protein samples before and after purification with the Hitrap Q 
column was tested weekly by SDS-PAGE.  The samples were stored both on ice at 4 °C 
and on the bench.  After 9 days, the Hitrap Q purified protein stored on the bench had 
degraded much like the protein that did not undergo the Hitrap Q column (but was 
stored on ice at 4 °C) while the protein stored at 4 °C was still intact.  After 20 days, the 
protein that had undergone the Hitrap Q column and was left on the bench at room 
temperature had not degraded further while the protein that had not undergone the 
Hitrap Q column was degraded further.  The protein kept cold was still largely intact.  At 
4 weeks, the protein stored on the bench was completely degraded to ~27 KDa while 
the protein kept cold had not degraded.  This trend continued until 6 weeks later when 
all of the proteins had degraded to ~27 KDa.  Further degradation was not observed.  
During this time, another protein sample that had not undergone the Hitrap Q column 
but had been stored in 20% glycerol at -20 °C was also tested for degradation.  No 
degradation was observed after one month.  Due to these observations, proteins were 
further purified with the Hitrap Q column and then stored with 20% glycerol at -20 °C to 
prevent degradation.  No further degradation was observed except for loss of the His 
tag after more than one year of storage with a molecular mass reduction from 34 kDa to 
28 kDa, which is the molecular weight for GFP without the histidine tag.  The protein 
was still intact and exhibited its normal spectral behavior but would not bind to the Ni2+ 
chelating column.  This loss of the His tag has been reported in the literature and does 
not effect the function of the protein. 
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4.5 Investigation of Histidine Tag Interference by Interactions with Metal Ions  
Since a 6x histidine tag was utilized to purify the proteins and we are conducting 
metal binding analyses, the histidine tagged GFP was tested for fluorescence changes 
in the presence of metal ions.  For protein purification, 6x histidine tags have been 
shown to be quite useful for obtaining large quantities of protein through binding to 
metal chelating columns.  Amersham Biosciences, the manufacturers of the Hitrap 
Chelating column for His tag purification, list 232 references about protein purification 
utilizing their product.  A Science Direct (www.sciencedirect.com) search for histidine 
tag yields 249 articles that largely deal with the use of histidine tags, but none of these 
articles address the metal interference of histidine tagged metal-binding proteins.  
Mohanty and Wiener studied the affects of the length and placement of the histidine tag 
on the expression and oligomeric state of a membrane protein, but do not discuss the 
effects of various metals on the protein (128).  Niccolai and coworkers studied the 
structural effects of histidine tags on a peptide and found that the tag helps to stabilize 
the peptide’s structure when bound to nickel (129).  They also calculated the peptide 
structure with the histidine tags, in which it is apparent that the nickel ion is bound by 
the histidines.  They do not, however, discuss effects of other metals or the binding 
affinity of nickel.  With the widespread use of histidine tags for protein research, it is 
useful to investigate the effects of metal ions on the tagged proteins.  It is important to 
carry out a detailed evaluation on whether the histidines could interfere with the study of 
designed metal binding proteins since the tags bind to metals. The binding affinities 
have been calculated, and metals that do not produce a fluorescence change are noted 
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to cause no interference in the study.  A note of caution should be taken, however, that 
metal binding proteins have been observed to aggegrate more readily upon introduction 
of certain metals.  In this laboratory, cluster of differentiation 2 (CD2) variants were 
observed to precipitate upon introduction of the His tag (data not shown), but no 
precipitation was observed for GFP-S65T.  Eleven metals were tested for interference 
with the histidine tag. 
The effect of metal on N-terminal 6x histidine tagged GFP-S65T was tested by 
monitoring the fluorescence change of the protein upon addition of various metals.  As 
shown in figure 4.12, the addition of 10 mM calcium, magnesium, potassium, and 
sodium (only calcium is shown) did not cause a fluorescence change of the emission 
spectrum with excitation at 482 nm, suggesting that these metal ions do not interfere 
with the histidine tag on GFP.  On the other hand, as shown in figures 4.13 and 4.14, 
the fluorescence of 10 µM GFP-S65T at 509 nm was observed to decrease with 
increasing nickel concentration.  A similar effect has also been observed for zinc, cobalt, 
cadmium, and copper.  Since these metal ions share similar coordination chemistry with 
similar ionic radii, they prefer to bind nitrogen from the histidine sidechain as chelating 
atoms.  In the purification of histidine tagged proteins, metals are bound to the chelating 
column that will interact with the 6 histidines to immobilize the protein on the column.  
This interaction is known to occur with zinc, nickel, cobalt, and cadmium.  Figure 4.14 
shows the effect on fluorescence intensity of GFP-S65T at 509 nm (excitation at 482 
nm) without metal and at saturating concentrations of the metals studied.  It is clear that 
calcium does not have any effect on GFP-S65T fluorescence, suggesting that this metal 
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Fig 4.12 Emission spectra (excitation at 482 nm) of 10 µM GFP in 10 
mM Tris, 1 mM DTT, pH 7.4 without and with 1 mM calcium.  The 
complete overlap in the spectra illustrates that calcium has no effect on 
the histidine tagged protein.  The same profile is observed for 
magnesium, sodium, and potassium.
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Figure 4.13  Fluorescence spectra and metal binding fit of the nickel titration 
of histidine tagged GFP-S65T (10 µM) indicating binding of the nickel to the 
histidine tag.  The buffer conditions were 10 mM Tris, 1 mM DTT, pH 7.4, and 
the excitation was 482 nm.  The fractional change data was fit with a 1:1 
metal:protein binding equation given in Chapter 2.
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Fig 4.14 The graph indicates the overall fluorescence emission decrease at 
510 nm when excited at 482 nm of 10 µM GFP-S65T (in 10 mM Tris, 1 mM
DTT, pH 7.4) caused by interference of the histidine tag with the metals 
presented.  The bar on the left (blue)  for each metal is protein without 
metal and the bar on the right (purple) is the protein fluorescence in the 
presence of saturating metal.
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ion does not bind to the protein.  On the other hand, zinc, cobalt, cadmium, nickel, and 
copper significantly quench the fluorescence.  Although the chromophore is buried 
inside the protein and there is a distance of approximately 80 Ǻ from the chromophore 
to the histidine tag (provided the His tag is not interacting with the protein), the binding 
of the metal to the tag results in a decrease of fluorescence.  In the study of metal 
binding proteins, any interference from the histidine tag must be taken into account to 
ensure that binding affinities are measured correctly.  Also, the histidine tag can cause 
aggregation of the protein, especially at higher metal concentrations. 
By monitoring the fluorescence change at 510 nm as a function of metal ion 
concentration, we have obtained the metal binding affinities of histidine tagged GFP-
S65T for zinc, nickel, cobalt, cadmium, and copper.  Figure 4.13 illustrates the 
fluorescence and fractional change at 509 nm (excitation at 482 nm) as a function of 
nickel concentration.  The Kd, calculated with the 1:1 metal binding equation (Eq. 2.3) in 
section 2.11, for nickel is 6.2 +/- 1.6 µM.  Table 4.4 summarizes the metal binding 
affinities.  Cadmium, cobalt, and zinc exhibit similar affinities to nickel while copper is 
about 8 times weaker than nickel.  This result correlates with the suggested metals 
utilized in purification of histidine tagged proteins and a chelating column.  Copper is not 
generally suggested, likely because it binds weaker than the other metal ions, which is 
also observed in practical applications of the purification method. 
Another metal, iron, was tested for its effect, but precipitation was quite evident 
each time it was examined even in different buffering conditions normally considered to 
reduce protein aggregation.  However, precipitation did not occur until the metal 
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4, 5, 6, 81.72No effectMagnesium
4, 5, 6, 7, 82.23No effectSodium
4, 6, 7, 8
6, 8
6, 8
6, 8
2, 4, 5, 6
4, 5, 6
4, 5, 6, 8
4, 5, 6, 7, 8
4, 5, 6
Coordination 
Number
No effect
No effect
No effect
No effect
50.5 ± 3.5
17.4 ± 2.8
14.5 ± 2.1
7.5 ± 2.4
6.2 ± 1.6
Kd (µM)
2.77
2.74
2.51
2.23
1.57
1.53
1.67
1.71
1.62
Ionic 
radius (Ǻ)
Potassium
Lanthanum
Terbium
Calcium
Copper
Zinc
Cobalt
Cadmium
Nickel
Metal
Table 4.4.  A list of the metals studied for interference with 
histidine tagged proteins with the ionic radius and coordination
numbers.
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concentration was greater than 100 µM, and fluorescence changes were observed 
below 100 µM, indicating that iron does have an effect on the histidine tagged protein.  
The exact binding affinity simply could not be calculated due to the precipitation. 
4.6 Metal-binding of Designed Proteins 
4.6.1 Terbium binding analysis of designed proteins 
Since calcium is a silent metal ion and most of the first generation of designed 
calcium binding GFP variants are not fluorescent, terbium sensitized fluorescence 
resonance energy transfer is utilized to monitor the metal binding capability of our 
designed proteins.  Terbium is a calcium analog with similar ionic size and binding 
geometry.  From studies in the Yang lab, terbium has a stronger binding affinity than 
calcium, but the binding depends on the geometry of the binding pocket and on the 
value and placement of the negative charges of the ligands (86).  Terbium is intrinsically 
fluorescent at 545 nm and can undergo energy transfer with the aromatics in a protein 
when it is bound to that protein and within Förster’s distance of the aromatics.   
4.6.2 Metal binding analysis procedure 
 To obtain the metal binding affinities of the designed proteins, two routines were 
utilized.  Initially, all data were baseline corrected following Dr. Wei Yang’s protocol.  
The data were then examined by Specfit/32, a global fitting program, and by fitting the 
fractional change of the integrated area with Eq 2.3.  Specfit/32 utilizes a user chosen 
metal:ligand binding model.  This model allows the user to input the number of 
components in the system, how the components interact with one another, which 
components are colored and contribute to the obtained spectra, and any known binding 
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affinities in the case of multiple binding components.  The detailed protocol is presented 
in Chapter 2, section 2.12. 
This method has been widely applied to obtain the terbium binding affinity for the 
designed proteins by titration of the protein with increasing concentrations of terbium at 
a constant protein concentration.  As shown in figure 4.15, EGFP contains 10 tyrosines 
and one tryptophan.  The Trp is located approximately 15 Ǻ from the designed pocket 
177, 17 Ǻ from the 120 pocket, and 30 Ǻ from the 194 pocket.  The tyrosines are 
located throughout the protein with 5 of them within 20 Ǻ of the 194 pocket.  Figure 4.16 
shows the enhancement of terbium fluorescence when bound to site 177 with excitation 
at 280 nm.  The terbium binding was carried out in 20 mM PIPES, 10 mM KCL, 1 mM 
DTT, 1% glycerol, pH 6.8 to increase the solubility of the proteins and terbium.  The 
terbium fluorescence enhancement was monitored at 545 nm when excited at 280 nm.  
Terbium has inherent weak fluorescence under this condition.  It was corrected by using 
a terbium blank to ensure that enhancement of the fluorescence was only observed with 
protein binding.  Once the data were obtained, it was baseline corrected following a 
protocol from Dr. Wei Yang in our laboratory and fit with the program Specfit/32.  This 
program is a global fitting program that takes the entire spectrum into account.  The 
binding affinity attained with this program and the traditional method of fitting the 
fractional change of the integrated area to a 1:1 binding equation (Eq 2.2) are in good 
agreement, indicating that the program can be used for this type of binding. 
Figures 4.16, 4.17, and 4.18 illustrate the metal binding titration and fit curves of 
site 177, 120, and 194a.  The designed proteins exhibit strong terbium binding affinities 
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Fig 4.15  Structure of EGFP with the chromophore in green, the tyrosines
in yellow, and the tryptophan in magenta.
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Fig 4.16 Fluorescence spectra with excitation at 280 nm and binding curve 
of terbium bound to a designed variant, 177 in 20 mM PIPES, 10 mM KCl, 1 
mM DTT, 1% glycerol, pH 6.8.  The increase in fluorescence at 545 nm 
indicates binding of the protein to the metal.
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Fig 4.17 Fluorescence spectra with excitation at 280 nm and binding curve 
of terbium bound to a designed variant, 120 in 20 mM PIPES, 10 mM KCl, 1 
mM DTT, 1% glycerol, pH 6.8.  The increase in fluorescence at 545 nm 
indicates binding of the protein to the metal.
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Fig 4.18 Fluorescence spectra with excitation at 280 nm and binding curve 
of terbium bound to a designed variant, 194a in 20 mM PIPES, 10 mM KCl, 
1 mM DTT, 1% glycerol, pH 6.8.  The increase in fluorescence at 545 nm 
indicates binding of the protein to the metal.
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listed in table 4.5.  Each binding affinity was obtained by averaging of 4 to 6 titrations.  
Site 177, with a binding affinity of 1.9 µM, has the strongest affinity of the three proteins 
tested.  Site 120 is only slightly weaker with a binding affinity of 4.9 µM.  However, Site 
194a exhibits a relatively weaker affinity of 31.6 µM.   
A binding affinity for 194b and terbium was attempted but conclusive results were 
not obtained.  Initially, 3.5 µM of protein was titrated in duplicate with terbium in 10 mM 
Tris, 1 mM DTT, 1% glycerol, pH 7.4 as shown in figure 4.19.  The Kd’s for these two 
titrations were 3.2 µM and 2.6 µM for an average of 2.9 µM ± 0.3.  This binding affinity is 
on par with 177 and 120 and not similar to 194a, as would be expected since there is 
only one ligand difference between 194a and 194b.  The terbium titrations were 
repeated in 20 mM PIPES, 10 mM KCl, 1 mM DTT, 1% glycerol, pH 6.8 so the binding 
affinities would be in the same buffering system as 177, 120, and 194a.  Four trials in 
this system resulted in precipitation when greater than 10 µM Tb(III) was reached, with 
or without DTT.  The titrations were then repeated in 50 mM Tris, 1 mM DTT, 1% 
glycerol, pH 7.0 so that the environment would be closer to that of the other three 
proteins with a pH of 7.0.  This experiment resulted in a Kd of 26 µM but the fit of the 
data points were not very good with the fitting curve not following the data points.  
Repetition in these conditions with 1.5 µM and 3 µM of protein resulted in precipitation 
above 20 µM terbium.  In summary, 194b exhibits a binding affinity for terbium of 2.9 µM 
in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4 but reliable binding affinities could not be 
obtained in the same conditions as 120, 177, and 194a.  This binding affinity can not be 
compared with the other sites as the conditions are not the same. 
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37.7 ± 4.52.9 ± 0.3-4E,D,D,N,D194b
Table 4.5 The binding affinities, ligands, and charge of the amino acids in 
the binding pocket are shown.  The terbium tirations were performed in 20 
mM PIPES, 10 mM KCl, 1 mM DTT, 1% glycerol, pH 6.8 except for 194b, 
which was in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4.  The calcium 
titrations were performed in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4 
for all of the designed proteins.
E,D,D,N,D
N,D,D,D,N
E,N,D,D,E
Ligands
95.5 ± 6.6
59.7 ± 4.8
57.2 ± 1.6
Ca(II)
Kd (µM)
31.6 ± 12.9
1.9 ± 0.4
4.9 ± 0.2
Tb(III)
Kd (µM)
-4
-3
-4
Charge 
of a.a.
194a
177
120
Design 
Site
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Fig 4.19 Fluorescence spectra with excitation at 280 nm and binding curve 
of terbium bound to a designed variant, 194b in 10 mM Tris, 1 mM DTT, 1% 
glycerol, pH 7.4.  The increase in fluorescence at 545 nm indicates binding 
of the protein to the metal.
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 4.6.2 Metal selectivity of designed proteins  
The designed proteins were investigated for metal selectivity through competition 
with terbium by calcium, magnesium, and lanthanum.  If these other metals bind to the 
same pocket, the terbium fluorescence will be decreased upon addition of the metals, 
indicating a competition between the two metals for the same binding pocket.  Calcium 
indicated the largest decrease in fluorescence, suggesting that calcium binds to the 
designed proteins and can compete for terbium binding.  Magnesium at 10 mM also 
exhibited a decrease, but it was not as large as the calcium with 100 times more 
magnesium.  As shown in figure 4.20, 1 mM calcium nearly abolished the terbium 
fluorescence enhancement for site 177, but the fluorescence is only decreased by half 
at 10 mM magnesium.  Therefore, although magnesium can bind to the protein, it does 
not compete as well as calcium, indicating a relatively weaker binding affinity for 
magnesium.  Addition of 100 µM lanthanum indicated a decrease that was not as large 
as the calcium and comparable with the magnesium decrease.  Of the designed 
proteins, site 177 indicated the largest decrease in terbium fluorescence upon 
introduction of calcium with nearly all fluorescence eliminated.  Site 120 exhibits a half 
maximal decrease in fluorescence with 1 mM calcium as shown in figure 4.21.  Addition 
of 10 mM magnesium to 120 with terbium indicated the same decrease in fluorescence 
as calcium, suggesting that 120 is not as selective for calcium over magnesium as 177. 
4.6.3 Calcium-binding affinity through dye competition 
Calcium binding dye competition was further utilized to obtain calcium binding 
affinities.  Calcium does not exhibit a spectroscopic signal that can be monitored 
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Fig 4.20 Fluorescence spectra of the binding competition of 177 with terbium 
for other metals in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4.  The spectra 
details the calcium competition.  Excitation was at 280 nm for energy 
transfer.
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Fig 4.21  The decrease in terbium FRET enhancement observed when
other metals compete for binding to site 120 is shown (10 mM Tris, 1 mM
DTT, 1% glycerol, pH 7.4).  Site 120 is not as selective for calcium over 
magnesium as site 177.
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directly.  Calcium isotopes, such as calcium45, can be used in NMR experiments but 
the large quantities of protein that are needed exceed the concentration limits of these 
designed proteins in addition to the high cost.  Concentrating these proteins causes 
precipitation that is not relieved by additives allowed in NMR experiments.  Since the full 
designed sites do not exhibit fluorescence and the aromatics do not change signal upon 
calcium addition, dye competition is a valuable method to ascertain the calcium binding 
affinity.  Rhodamine-5N (Molecular Probes, Inc.) is a commercially available calcium 
binding dye indicates a large fluorescence signal increase when calcium is bound 
(section 1.3).  Rhodamine-5N is perfectly suited for use with green fluorescent proteins 
since it is a red fluorophore and the excitation and emission are far from the GFP 
derivatives’ excitation and emission wavelengths.  The protein and dye excite at 
different wavelengths since Rhodamine-5N is a red fluorophore so no interference was 
observed between the two fluorophores.  This method can be employed to obtain the 
true binding affinity in addition to monitoring the calcium-dependent chromophore 
fluorescence change.   
The calcium titration was performed in buffer chelexed with Chelex-100 resin 
(BioRad) to remove background calcium.  The protein was pretreated with the 
CalciumSponge (Invitrogen) to remove background calcium.  Addition of calcium 
gradually enhances the fluorescence signal at 578 nm when excited at 552 nm as 
shown in figure 4.22.  When the calcium concentration is greater than 400 µM, no 
further fluorescence increase is observed, indicating saturation.  Rhodamine-5N 
indicates a 500 fold increase in fluorescence signal upon calcium binding.  The 
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Fig 4.22  The spectra (top) of the titration of Rhodamine-5N with calcium 
with excitation at 552 nm in 10 mM Tris, 1 mM DTT, pH 7.4.  The fit of the 
fractional change with the 1:1 metal binding equation is shown (bottom).
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fractional change of the integrated area of the fluorescence is well fitted by a 1:1 binding 
equation, demonstrating a binding affinity of 54.13 +/- 3.7 µM in our conditions (10 mM 
Tris, 1 mM DTT, 1% glycerol, pH 7.4) using equation 2.3.  This affinity is in a good 
range for our designed proteins since their Tb(III) binding affinities are low micromolar 
as detailed in table 4.5.  The obtained Kd of 54 µM is different from the reported value 
by the manufacturer, Molecular Probes, Inc.  They report a binding affinity for calcium of 
320 µM, but their buffer conditions contain a large amount of salt, weakening the 
measured binding affinity (10 mM MOPS, 100 mM KCl, pH 7.2).  A note of caution 
should be made here that the measured binding affinity of Rhodamine-5N varies with 
small changes in buffer conditions.  Rhod-5N alone should be titrated with calcium each 
time a competition assay is performed so that the conditions are the same as for the 
protein-dye solution.  Failure to do so could yield not only incorrect binding affinities but 
fits that appear incorrect due to improper calculation when the data points are actually 
satisfactory. 
The dye competition assay was carried out for designed proteins 194a, 194b, 
120, and 177 in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4 utilizing twice as much 
protein as dye.  The titration was performed with constant dye (~20 µM) and protein 
concentration (~40 µM) and increasing calcium concentration until saturation of the 
signal was observed, as demonstrated in figure 4.23.  The binding affinities for the 
designed proteins were calculated utilizing a global fit of the spectra from 560 nm to 650 
nm in Specfit/32 with the metal and two ligand model as detailed in section 2.12.  An 
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Fig 4.23 Fluorescence spectra and Specfit/32 fit of Rhod-5N in competition 
with Site 177 for calcium binding with the excitation wavelength of 552 nm 
and in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4.
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example of the spreadsheet created for input into Specfit/32 is shown in table 2.4.  After 
reading the data into Specfit, a model is chosen based on the type of experiment.  The 
model utilized for the dye competition assay include free metal, protein, and dye along 
with dye bound to metal and protein bound to metal.  The calculated binding affinity of 
Rhodamine-5N was included as well (as obtained in our laboratory).  An example of the 
data fit obtained for sites 177 and 194a are shown in Figures 4.23 and 4.24.  The 
reported affinities are the average of two titrations for site 120, three titrations for site 
194b, and four titrations for sites 177 and 194a.  As shown in table 4.5, all four full 
design sites exhibit reproducible binding affinities of 95.5 ± 6.6 µM for 194a, 37.7 ± 4.5 
µM for 194b, 57.2 ± 1.6 µM for 120, and 59.7 ± 4.8 µM for 177.   
The designed site 194b contains three mutations, L194N/S86D/K79D (Table 
4.2), with the binding pocket proposed to be formed by those three mutations and the 
native residues E5 and D82.  The difference between 194b and 194a is the mutation 
S86D in 194b and K85D in 194a.  The binding affinity of 194b at 37.7 µM is stronger 
than the similar design site 194a with a binding affinity of 95.5 µM.  Part of the reason 
for this strengthening could be that the S86D mutation in 194b is not as drastic as the 
K85D mutation in 194a.  Mutation of a hydroxyl to a carboxylic acid introduces one 
additional polar oxygen with a partial charge shared between the two oxygens.  The 
size of the Asp and Ser sidechains are highly similar with both containing only one 
methylene group.  Hydrogen bonds with the surrounding residues would not be 
disrupted.  Mutation of the positively charged lysine to aspartate both reduces the size 
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Fig 4.24 Fluorescence spectra and Specfit/32 fit of Rhod-5N in competition 
with Site 194a for calcium binding with the excitation wavelength of 552 nm 
and in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4.
147
  
of the sidechain and introduces an opposite charge.  Lysine contains 4 methylene 
groups in addition to the NH3+ group versus the small methylene and carboxylate of 
Asp.  The hydrogen bonds or ionic contacts that Lys would make would not necessarily 
still be intact with the mutation to Asp due to both the size and the charge.  K85D may 
cause repulsion in the binding pocket so that the binding affinity is not as strong as 194b 
with S86D. 
The partial site of 194b missing the K79D mutation, L194N/S86D is fluorescent 
when expressed in bacteria.  The inherent binding affinity was tested with Rhodamine-
5N competition to compare the intrinsic affinity of the binding site with the effects on the 
chromophore fluorescence upon calcium binding.  L194N/S86D exhibits an average 
binding affinity of 5.9 ± 0.2 µM for duplicate samples when fit with the global fitting 
program, Specfit/32.  However, the program attempts to fit to a double exponential 
model, as indicated by figure 4.25, which is not suitable for the data.  Fitting the data 
with a competition binding equation and obtaining the Kd produces 2.2 µM, but the data 
do not fit this equation well either as shown in figure 4.26.  Examination of the data 
indicated that saturation was not reached.  The binding affinity of this protein is actually 
weaker than 120, 177, and 194a so that saturation of the dye’s signal will be reached at 
much higher calcium concentration (> 400 µM).  This result indicates that Rhodamine-
5N is not a suitable competition dye for L194N/S86D.  Since L194N/S86D exhibits 
green fluorescence, the direct chromophore emission change was monitored upon 
addition of calcium to obtain a calcium binding affinity, as shown in figure 4.27.  The 
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Fig 4.25 Specfit/32 global fit of the competition of 45 µM L194N/S86D and 
20 µM Rhod-5N for calcium binding with the excitation wavelength of 552 
nm and in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4.  The program 
globally fits the entire spectrum to a double exponential model, which is 
not the best fit for the data.
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Fig 4.26 Fit of the competition of 45 µM L194N/S86D and 20 µM Rhod-5N 
for calcium in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4 with the 
equation
F = Kd1 * [M2]T / ((Kd1 * Kd2) + ([M1]T * Kd2) + ([M2]T * Kd1))
where Kd1 is the Rhod-5N binding affinity, Kd2 is the protein affinity, and 
M is metal.  This equation does not fit the data well, and examination of 
the data indicates that saturation was not reached.
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increase in fluorescence with excitation at 398 nm is concurrent with a decrease in 
fluorescence with excitation at 482 nm.  This ratiometric change indicates a change in 
the chromophore’s ionic state due to calcium binding with a shift to the neutral state 
evident.  Fitting the fractional change vs. calcium with a 1:1 metal binding equation 
indicates a Kd of 2.6 mM, which is in the same range as calcium buffer proteins and 
extracellular calcium binding proteins.  This protein possesses very bright fluorescence, 
similar to wild type, and may be useful for the study of extracellular calcium changes 
due to signaling events. 
In summary, using different metal binding assays, such as Tb(III)-FRET and dye 
competition, we have shown that the designed GFP calcium binding proteins, sites 120, 
177, and 194a, exhibit calcium and terbium binding with a selectivity for calcium over 
magnesium.  These results were promising and exciting because they demonstrate the 
feasibility of our design approach and illustrate that the approach can be used in 
different proteins.  Our laboratory initially established the design approach utilizing CD2 
domain 1 from rat (cluster of differentiation 2).  The net charge and ligand type, the 
electrostatic environment, and the location of the binding pocket have been tested in 
CD2.  The terbium and calcium binding affinities for the same calcium binding pocket 
with different ligands followed the trend of strongest affinity for the most negatively 
charged pocket (-5) and weakest for the least charged (-2).  In addition, differences 
were observed for the ligand types of Asn, Asp, Gln, and Glu for 7E15 variants.  The 
change of Asn to Gln weakened the terbium binding but strengthened the calcium 
affinity due to the increased size of the sidechain, which allows the coordination 
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geometry to change.  The use of this approach in multiple proteins signifies that the 
approach is working as hypothesized, and that it can be employed to study the intrinsic 
properties of calcium binding in differing protein environments as well as to engineer 
calcium binding proteins for multiple purposes.  Table 4.5 summarizes the metal binding 
affinities for sites 177, 120, 194a, and 194b.  Overall sites 177 and 120 exhibit similar 
binding affinities for terbium and calcium with the terbium affinity approximately 10 times 
greater than calcium.  Site 194a exhibits the weakest affinity for both terbium and 
calcium.  Sites 120 and 194a have a -4 charge while site 177 has a -3 charge.  This 
seems counter to the expected result of a more negatively charged pocket exhibiting a 
stronger binding affinity, but the location and surrounding environment of the binding 
site also plays a role in binding affinity.  Site 194a has fewer surrounding negative 
charges (4) than 177 (8) as shown in figure 4.28 and summarized in table 4.6, which 
likely plays a role in its reduced affinity.  Also, site 194a has only two surrounding 
positive charges, which are likely not enough to stabilize the surrounding negative 
charges once the mutations were present to form the calcium binding pocket.  The 
presence of the negative charges without stabilizing positive charges likely results in 
repulsion of the negative charges so that the pocket can not correctly form to bind 
calcium with as strong an affinity as 177 and 120.  Site 177 has 8 surrounding negative 
charges and 7 surrounding positive charges.  The presence of so many charged ligands 
likely allows for a greater extent of hydrogen bonding and salt bridges so that the 
binding pocket is more stable, hence the stronger binding affinity than 194a.  Site 120 
does not have many surrounding charges, 2 negative and 1 positive.  With so few 
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Fig 4.28 Illustrations of the three studied binding sites with the binding 
ligands shown in orange except for the natively negative ligands, which are 
shown in magenta.  The surrounding negative charges are shown in red, 
and the surrounding positively charged amino acids are shown in blue.  Site 
177 has many negative (8) and positive (7) charges surrounding the pocket 
while sites 120 (2 negative, 1 positive) and 194a (4 negative, 2 positive) 
have fewer of both.
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charges, the repulsion is likely less than for site 194a so that the binding affinity is 
stronger.  In addition, the ability of the residues to form the correct binding geometry 
through the flexibility of the ligands and/or through the flexibility of the backbone affects 
the binding affinity.  Site 120 is the least flexible of the design sites because the ligand 
residues are all located in β-sheets.  Site 177 is in the middle range of flexibility with two 
ligands in the β-sheets and the rest in the loops.  Site 194a is the most flexible with all of 
its residues located in the loop regions.  Site 120’s reduced flexibility likely allows the 
geometry to correctly form whereas the high flexibility, combined with the repulsion of 
the negative charges, of 194a may not allow for the correct pentagonal bipyramid for 
calcium to bind with strong affinity.  Although site 177 contains largely backbone flexible 
residues, the combination of the surrounding positive and negative charges likely 
reduce the flexibility with formation of salt bridges and hydrogen bonds so the geometry 
is formed.  The ligand type plays a role in calcium binding.  If the sidechains are too 
long to form the correct geometry and distort the pocket, calcium can not bind as 
strongly as if the pocket forms the ideal pentagonal bipyramid.  Although the variants 
were designed to form this geometry, the computer algorithms utilized do not take into 
account the effect of the surrounding residues or the ability for the residues to reposition 
in response to repulsion or attraction by surrounding residues.  For example, L194N of 
site 194a is located on a separate, quite long loop that is away from the other ligands.  
Perhaps this residue is not long enough to make full contact with calcium, reducing the 
affinity, or the residue is pushed further away from the other ligands due to repulsion.  
Sites 120 and 177 likely have such similar binding affinities because the difference in 
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the net negative charge in the binding pocket is overcome by the flexibility aspects of 
the pocket and the surrounding charge environment.  The combination of the local 
surrounding charge, the flexibility of the backbone, and the ability of the residues to form 
the preferred geometry contribute to the range of binding affinities measured for the 
designed sites.  The different terbium and calcium binding affinities for the three sites is 
likely due to several factors since calcium binding affinity is dependent on local 
environment, ligand type, overall binding pocket charge, and formation of the correct 
geometry. 
4.7 Optical Properties of EGFP and the Designed Proteins 
 4.7.1 Absorbance of EGFP and its variants 
The absorbance and fluorescence of bacterially expressed and purified EGFP 
and the variant proteins was examined.  EGFP exhibits a maximum absorbance peak at 
482 nm with a shoulder centered at 398 nm in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 
7.4 as illustrated in figure 4.29.  These two peaks represent the anionic and neutral 
state of the chromophore, respectively (63).  EGFP has two mutations, S65T and F64L, 
with S65T thought to cause the shift of the chromophore’s state from neutral, as 
observed in the wild protein, to anionic.  The Ser65Thr has been hypothesized to 
stabilize the ionized form of Glu222, which hydrogen bonds to Tyr66 in the wild protein, 
so that the phenolate absorbs light around 470 nm.  In addition, Thr203 is thought to 
stabilize the hydroxyl form of the chromophore, causing light to be absorbed at 400 nm.  
Since Thr203 is not mutated in EGFP, the small shoulder at 398 nm is observed.  When 
the fluorescence excitation profile of EGFP was examined, it was noticed that there are 
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Fig 4.29 Absorbance spectra of EGFP (top) in 10 mM Tris, 1 mM DTT, 1% 
glycerol, pH 7.4 with the chromophore absorbance observed at 482 nm and 
the aromatics’ absorbance at 280 nm. The neutral (left) and anionic (right) 
states of the chromophore of GFP are illustrated (bottom).
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several peaks in close proximity that all cause emission at 510 nm.  These excitation 
peaks, 470 nm, 482 nm, and 490 nm are likely excitations of different intermediate 
states of the chromophore.  These states can not be observed in absorbance.  The 
overall peak centered at 482 nm is observed. 
The three bacterially expressed variants, 120, 194a, and 177 were examined for 
absorbance from 220 nm to 600 nm.  As detailed above, the chromophore should 
exhibit a peak at 398 nm and/or 482 nm if the protein is folded and the chromophore is 
shielded.  If the protein is unfolded, a peak at 387 nm should be observed as it is for 
EGFP at low pH (Fig 4.30).  Sites 120, 194a, and 177 did not exhibit a chromophore 
absorbance peak but do demonstrate an aromatic absorbance peak at 280 nm, as 
shown in figure 4.31.  Since even the unshielded chromophore peak at 387 nm was not 
present, it is likely that the chromophore did not form during folding of the protein in 
bacterial cells.  This can be attributed to slight repulsion of the negatively charged 
calcium pocket, which likely causes some rearrangement of the sidechains so that 
Ser65 and Gly67 are not in close enough proximity to undergo the initial nucleophilic 
attack that cyclizes the backbone amide of Gly67 with the sidechain of Ser65 to form 
the imidazolidine ring.   
4.7.3 Chromophore fluorescence of EGFP and its variants 
 EGFP contains one Trp and 10 Tyr residues as shown in figure 4.15.  These 
residues would normally intrinsically fluoresce.  With excitation at 280 nm, emission 
could be observed between 300 (tyrosine emission) and 350 nm (free tryptophan 
emission) for the aromatics.  When the aromatic fluorescence was first measured, it was 
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Fig 4.30 Absorbance spectra of EGFP at pH 4 (0.5 M acetate, 1 mM DTT, 
1% glycerol) and pH 7.4 (10 mM Tris, 1 mM DTT, 1% glycerol) illustrating 
the absorbance of the chromophore at 387 nm when the protein is unfolded 
as opposed to the peaks at 398 nm and 482 nm at pH 7.4.
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Fig 4.31 Absorbance spectra of EGFP and the designed protein 177, in 
10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4, illustrating the lack of 
chromophore absorbance.  Designed proteins 120, 194a, and 194b 
exhibit similar absorbance spectra.
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observed that the water scattering peak was stronger than the aromatic emission with a 
peak observed at 313 nm for water when excited at 280 nm (Fig 4.32).  Raman 
scattering of water occurs 3382 cm-1 red shifted from the excitation, which is calculated 
to be 313 nm for excitation at 280 nm with the equation c = λυ.  As the excitation 
wavelength was changed, the water emission shifted accordingly.  To overcome this 
problem, it was observed that placing a glass plate with a long pass of 300 nm in front 
of the emission lens removed the water scattering peak.  Emission of the aromatics in 
EGFP was observed at 320 nm, indicating that the tryptophan is largely buried since 
free tryptophan emits at 350 nm.  Tyrosine fluorescence is much weaker than 
tryptophan so it is likely overcome by tryptophan’s emission.  Interestingly, L194N/S86D 
indicates a Trp peak at 340 nm, suggesting that this mutant has a slightly opened 
tertiary structure so that Trp is more exposed to solvent than in EGFP (Fig 4.33).  
Intriguingly, the aromatics also undergo energy transfer with the chromophore with 
emission of the chromophore observed at 510 nm when the aromatics are excited at 
280 nm.  The fluorescence of the energy transfer is about 10% larger than when the 
protein is excited at 398 nm (Fig 4.34).  The energy transfer was observed by exciting 
the chromophore from 260 nm to 488 nm while measuring the emission at 510 nm.  A 
profile of the energy transfer is shown in figure 4.35.  It is clear that emission of EGFP at 
510 nm contains contributions from the aromatics with excitation at 280 nm and from 
the neutral state of the chromophore with excitation at 398 nm with each of these 
exhibiting fluorescence an order of magnitude less than excitation at 482 nm.   
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Fig 4.32 Emission spectra of GFP with the water scattering peak evident 
as it changes emission wavelength along with a change in the excitation 
wavelength.  The peak at 320 nm that is apparent with excitation at 265 nm 
is the emission of the aromatics of GFP.  The water scattering peak is 
more intense than the aromatics.  Addition of a glass plate filter, LP300, 
removes the water scattering peak.
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Fig 4.33 Aromatic fluorescence emission with excitation at 280 nm of 
L194N/S86D (10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4) illustrating the 
ability of the glass plate filter to remove the water scattering peak from the 
spectrum.  The emission of the aromatics at 337 nm indicates that the 
aromatics are partially exposed to solvent.
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Fig 4.34  Emission of EGFP L194N/S86D with varying excitations to 
illustrate the energy transfer from the aromatics to the chromophore.
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When the designed proteins were examined by fluorescence, no peak was 
observed at 510 nm with excitation at 488 nm.  An excitation profile from 300 nm to 490 
nm with the emission monitored at 510 nm did not reveal a chromophore excitation 
peak.  There are two possibilities in the loss of the chromophore fluorescence of the 
designed proteins: 1) the chromophore fails to form or 2) the chromophore forms but is 
non-fluorescent.  In case 1, if the sidechains of the chromophore-forming amino acids 
are not in close enough proximity, the reaction will not occur to allow for the cyclization 
and chromophore formation.  In this case, the tertiary packing must decreased, which 
may be due to repulsion from the negative sidechains introduced into the protein to form 
the binding site.  In case 2, the protein is packed enough to allow the chromophore to 
form but the tertiary packing is loose enough to permit solvent interaction with the 
chromophore.  The chromophore when free in solution only exhibits very weak 
fluorescence due to energy loss by interaction with the solvent.  Work in our laboratory 
by Ning Chen has shown that the chromophore is still intact even when the protein with 
a preformed chromophore has been cleaved into two pieces, but only very weak 
fluorescence is observed if the chromophore-containing portion is isolated from the 
other half.  Since no chromophore absorbance or fluorescence was observed for sites 
120, 194a, and 177, it is most plausible that the chromophore did not form during folding 
of the protein in bacteria.  This explanation is further supported by the results that these 
designed proteins are located in the cell pellet forming insoluble inclusion bodies.  As 
shown in figure 4.11, refolding of the proteins is required for purification. 
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4.8 Conformation Analysis of Secondary Structure by CD 
 After the variant proteins were purified, several biophysical methods were 
employed to ascertain the proteins’ secondary and tertiary structure in comparison to 
the wild type protein, EGFP.  Figure 4.36 illustrates the far UV CD spectra of EGFP, 
which exhibits a β-sheet secondary structure with a negative maximum at 216 nm, 
consistent with its secondary structure elucidated by X-ray crystallography.  The variant 
proteins all exhibit the same CD profile as EGFP with negative maxima at 216 nm (Fig 
4.37).  Under the same conditions, the secondary structure of the modified proteins is 
intact although the modified proteins are not fluorescent.  EGFP and the variant proteins 
were examined for CD changes upon the addition of metal ions as shown in figure 4.38 
for 194a, but no overall changes were observed with the addition of calcium, lanthanum, 
or terbium. 
 4.8.1 pH effects on GFP variants  
The pH profile of the variant proteins was also studied by Far UV CD from pH 4 
to 9.  It has been accepted in the literature that GFP unfolds below pH 5 because the 
green color and fluorescence is no longer observed below this pH.  However, this 
conclusion in literature does not make use of CD and is solely based on absorbance 
and fluorescence properties.  To test the pH effects on the secondary structure of the 
proteins, 15 µM protein was incubated with a series of buffers from pH 4 to 9 as given in 
table 2.5.  Their CD spectra were acquired and the spectra of the background 
contribution from buffer was subtracted.  Utilizing CD, EGFP and the variant proteins do 
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Fig 4.36 Circular dichroism of EGFP in 10 mM Tris, 1 mM DTT, 1% 
glycerol, pH 7.4 and 25 °C.  The negative maxima at 216 nm indicates β-
sheet secondary structure.
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Fig 4.37  Circular dichroism of 120, 177, and 194a in 10 mM Tris, 1 mM
DTT, 1% glycerol, pH 7.4 illustrating the β-sheet secondary structure of the 
designed proteins.
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Fig 4.38 CD spectra of designed protein 194a with calcium, lanthanum, 
and terbium in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4.  Designed 
sites 120 and 177 and the host protein EGFP exhibit similar results.  The 
negative maxima at 216 nm indicates β-sheet secondary structure, which 
does not change upon introduction of metals.
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not completely unfold below pH 5.  In fact, the β-sheet secondary structure is still 
observed at pH 4 although no color is detected (Fig 4.39).  The signal is slightly more 
negative at pH 9 than pH 4, but no other differences are observed.  At higher pH’s, 
there is a slight 2 nm blue shift, but this does not seem to indicate a significant change 
in the secondary structure.  When the spectrum was observed in the presence of 1 mM 
calcium, there were no evident changes at the various pH values.  This finding indicates 
that the protein is not completely unfolded and still maintains its secondary structure.  It 
is likely that the protein loses its tertiary packing, therefore causing the loss of the 
chromophore fluorescence, but maintains the β-sheet formation.  Since the 
chromophore requires the shielding of the barrel to exhibit fluorescence, this could likely 
be a reason that the full site variant proteins do not exhibit fluorescence although their 
secondary structure is intact.  This could also contribute to the reversible folding of GFP 
reported in the literature.  It has been reported that GFP reversibly unfolds in 8 M urea.  
Perhaps this state aids in the refolding if the tertiary packing is not stringent so the 
protein able to reform the tertiary packing when the urea is removed. 
 Since the full site variants indicated secondary structure that did not change upon 
addition of metal or with varying pH but no fluorescence was indicated, several 
endeavors were undertaken to reform the tertiary packing so the chromophore would 
fluoresce.  The proteins were refolded with 8 M urea after purification and with 6 M 
GuHCl, but no fluorescence was observed. 
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Fig 4.39 CD spectra of designed protein 120 at various pH values to study 
the effect of pH on the protein’s secondary structure.  There appears to 
be very little effect of pH from 4 to 9 on the structure.  The complete loss 
in structure proposed by the literature certainly does not occur for these 
mutants at low pH.  The pH dependence with 1 mM calcium is the same.
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4.9 Endeavoring to Understand Fluorescence Loss of the Designed Proteins 
4.9.1 Partial design sites  
In an effort to understand which residues caused the fluorescence loss of the 
designed proteins so a) the residues could be removed from the design site and 
replaced with other residues and b) the residues would not mutated in the future, partial 
sites were engineered and their spectral properties were examined.  The partial sites 
were largely taken from initial products from PCR.  Since 177 was mutated all in one 
step, there are no partial products for it.  These partial sites are listed in table 4.7. 
The single mutations L15N, L194N, V120N, R122D, K85D, and S86D have all 
been expressed as well as the double mutations L15N/R122D, L194N/S86D, 
L194N/K85D, and L15N/V120N.  The Fluostar microplate reader was utilized to 
quantitate the formation of the chromophore as shown in figure 4.7.  One mL samples 
were taken from the 1 L flask of E. coli growth expressing each protein.  The solution 
was centrifuged at 14 K rpm for 1-2 min until pelleted.  The supernatant was removed 
and the pellet was dissolved in 200 µL of 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4.  
This solution was placed into a Corning 96 well plate.  The plate was placed into the 
microplate reader, and the protocol detailed in section 2.5.1 was followed with excitation 
at 460 nm and emission at 520 nm, which are the available filters for the instrument.  
L15N, L194N, S86D, L15N/R122D, and L194N/S86D indicate a strong green color upon 
expression.  L15N, L194N, and L194N/S86D have been purified and studied.  Their 
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M78N, 
H81D, 
I229D
M78N, 
H81DD197, H199D, M78N, H81D, I229D229
L194N/
S86D
L194N
S86DE5, D82, K79D, L194N, S86D194b
L194N/
K85D
L194N
K85DE5, D82, K79D, L194N, K85D194a
Q177N, I171D, D173, S175D, N135, V176A177
L15N/
V120N
L15N/
R122D
L15N
V120N
R122D
E115, V120N, R122D, E111, L15N120b
E115, V120N, R122D, K113D, E17120
Partial 
Site 2
Partial Site 
1Calcium-binding Ligands
Design 
Site
Table 4.7. A table of the partial sites studied with the final fluorescent 
mutations shown in green.
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chromophores are comparable to wild type in absorbance and fluorescence profile and 
exhibit similar quantum efficiency, although the efficiency is slightly smaller than EGFP.   
V120N exhibits a weak green fluorescence upon expression, and L15N/V120N 
exhibits no color upon expression.  K85D indicates no color upon expression.  Mutating 
the lysines causes some disruption in the fold of the protein, especially when the lysine 
mutation is coupled with other mutations.  Also, the V120N mutation is too drastic for 
the protein.  When the protein structure was examined, it was noted that V120 is buried 
under the other ligands in the design site, likely to shield the hydrophobic residue from 
water as shown in figure 4.40.  When the residue is mutated to an Asn, there is likely 
repulsion between the Asn sidechain and the other close residues R122D and L15N.  
Since this site is in the middle of the barrel and close to the chromophore, the repulsion 
causes a more drastic fluorescence loss.  Summer work by Dorinda Nelson indicated 
that none of the partial sites of 229 were fluorescent.  It is likely that mutating His81 
severely disrupts the fold of the protein. 
The 194 family of designed proteins, as illustrated in figure 4.41, contains two 
mutations that lead to fluorescence loss.  Mutation of K79D should be avoided since it 
alone causes fluorescence loss.  This is likely a result of mutating a long, positively 
charged sidechain to a shorter, negatively charged sidechain.  The hydrogen bond and 
charge contacts that K79 makes with other amino acids in the protein can not 
necessarily be made by 79D, which could disrupt the tertiary packing and/or 
chromophore formation.  Mutation of K85D also exhibits the same result, likely for the 
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Fig 4.40 Pymol picture of EGFP site 120 to illustrate the position of V120 in 
the design site.  The residue is buried beneath the other residues in the 
design site, which likely shields is from water since it is a hydrophobic 
residue.  The fluorescence loss of this protein is likely due to repulsion of 
this residue and the others in the site.
177
Fig 4.41 An illustration of the 194 family of designed proteins with 194 shown 
in pink, 86 in magenta, and 85 and 79 in blue.  The two native amino acids, 
E5 and D82 are shown in orange.   Repulsion of K85D with the surrounding 
residues likely causes the fluorescence loss.  S86D is more solvent exposed 
and less likely to disrupt charge and hydrogen bond contacts that help to keep 
the fold of the protein intact.  Also, K85D is in closer proximity to the 
chromophore than S86D, which may affect the hydrogen bond network 
observed of the chromophore.
194
86 79
85
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same reason.  When S86D is mutated, the change is not as severe as the K to D 
mutations so the tertiary packing is disrupted as significantly. 
4.9.2 pKa measurements of EGFP and partial site mutants 
 The pKa values of EGFP and the variants L15N and L194N, summarized in table 
4.8, were measured by absorbance and fluorescence spectra from pH 4 to 9 in various 
buffers to maintain the pH.  The absorbance was monitored from 600 nm to 220 nm.  As 
shown for EGFP in figure 4.42, the neutral peak at 398 nm increases upon acidification 
while the anionic peak at 482 nm decreases upon acidification.  The chromophore peak 
blue shifts at pH 4, indicating that the protein is unfolded so that the chromophore is no 
longer shielded from the solvent.  A global fit of absorbance spectra from 325 nm to 600 
nm for pH 4 to 9 revealed a pKa of 5.83 ± 0.02, but the global fit excluding pH 4, since 
the absorbance peak is blue shifted and does not share the same isosbestic point, 
yields a pKa of 5.95 ± 0.02.  The absorbance at 398 nm and 488 nm was also fit with an 
equation for two asymptotes at the low and high pH values with a slope of -1 (Eq. 4.1) 
or +1 (Eq. 4.2) (130): 
        Eq 4.1 
 
pHpK
pHpK
a
a BAY
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−−
+
+
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6.10 ± 0.08
6.11 ± 0.06
Average of 
emission at 
450 nm, 
excitation 
398 nm
5.83 ± 0.02 L194N
5.67 ± 0.025.63 ± 0.105.79 ± 0.015.95 ± 0.02L15N
5.72 ± 0.005.65 ± 0.01 5.93 ± 0.016.04 ± 0.01EGFP
Average of 
emission at 
510 nm, 
excitation 
482 nm
Average of 
emission at 
510 nm, 
excitation 
398 nm
Average of 
Absorbance 
at 488 nm
Average of 
Absorbance 
at 398 nm
Protein
Table 4.8 The pKa values of EGFP, L15N, and L194N as measured by 
absorbance and fluorescence in various buffers to maintain the pH at each 
desired value.
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Fig 4.42 Absorbance spectra of EGFP at various pH demonstrating the 
pH dependence of the chromophore.  The various buffers utilized to 
control the pH are listed in table 2.5.
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The equations for input into Kaleidagraph are: 
 
(m1+m2*10^(-m3)/10^(-m0))/(1+10^(-m3)/10^(-m0));m1=max;m2=min;m3=pKa estimate 
(m2*10^(-m0)+m1*10^(-m3))/(10^(-m0)+10^(-m3));m1=max;m2=min;m3=pKa estimate 
 
with the minimum and maximum values taken from the data.  The pKa obtained from the 
fit of the absorbance at 398 nm was an average 6.04 ± 0.01 for duplicate samples as 
shown in figure 4.43.  Fitting the 488 nm absorbance yielded an average of 5.93 ± 0.01 
for duplicate samples (Fig 4.43).  These two pKa values are in good agreement, as they 
should be for two titrating species as indicated by the isosbestic point.   
The fluorescence was also monitored from pH 4 to 9 between 420 nm and 580 -
nm with excitation at 398 nm and between 500 and 580 nm for excitation at 482 nm as 
shown in figure 4.44.  Fitting of the single wavelength data does not agree with the 
global fit of the data with Specfit/32 for the fluorescence data.  For the 510 emission 
with excitation at 398 nm or 482 nm yields nearly identical pKa values of 5.65 ± 0.01 and 
5.72 ± 0.00, respectively, when fit with the two asymptote equations 4.1 and 4.2 as 
shown in figures 4.45 and 4.46.  However, the emission at 450 nm with excitation at 398 
nm does not agree with the pKa value obtained for the 510 nm emission with an 
average pKa of 6.11 ± 0.06 at 450 nm as shown in figure 4.45.  The emission has been 
proposed to be due to the neutral state of the chromophore, which is able to fluoresce at 
lower pH but not at higher pH due to fast internal proton transfer that leads to the 
anionic state and emission in the green rather than blue spectrum (131-133).  The pKa 
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Fig 4.43 Plots of the absorbance at 398 nm (top) and 488 nm (bottom) of 
10 µM EGFP at various pH to calculate the pKa of the protein’s 
chromophore.
Ave pKa = 6.04 ± 0.01
Ave pKa = 5.93 ± 0.01
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Fig 4.44 EGFP pH dependence by fluorescence with excitation at 398 nm 
(top) and 482 nm (bottoms) and all slit widths set to 2 nm bandwidth. The 
pH was maintained by various buffers with the correct  pKa to hold the pH 
near the desired value.  The emission at 510 nm decreases as the
emission at 450 nm increases upon acidification with excitation at 398 nm.
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Fig 4.45 Plots of the fluorescence at 510 nm (top) and 450 nm (bottom) with 
excitation at  398 nm of 1 µM EGFP at various pH to calculate the pKa of the 
protein’s chromophore.  The pKa values differ for emission at 510 nm and 
450 nm, which is explained in the literature as excited state proton transfer.
Ave pKa = 6.11 ± 0.06
Ave pKa = 5.65 ± 0.01
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Fig 4.46 Plot of the fluorescence at 510 nm with excitation at  482 nm of 1 
µM EGFP at various pH to calculate the pKa of the protein’s chromophore.  
The pKa values differ for emission at 510 nm for the two different excitations 
are within error of one another.
Ave pKa = 5.72 ± 0.00
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calculations for fluorescence data are convoluted by this proton transfer so that the 450 
nm emission does not match the 510 nm emission exactly, although the difference is 
only ~0.3.  A global fit of the spectra produces a pKa of 6.9, but this difference between 
the global fit and the single wavelength fit is likely due to the contribution of the 
intermediate state confounding the data and the discrepancies due to the excited state 
proton transfer.  
 Measurement of L15N and L194N mutants of EGFP indicated similar results.  
The absorbance of L15N at 398 nm produced an average pKa of 5.95 ± 0.02 for 
duplicate samples, and the absorbance at 488 nm generated a pKa of 5.80 ± 0.01.  The 
fluorescence at 510 nm when excited at 482 nm indicated an average pKa of 5.67 ± 
0.02 for duplicate samples.  The pKa measured with 398 nm excitation and emission at 
510 nm was 5.63 ± 0.10.  The emission at 450 nm does not match the pKa for emission 
at 510 nm similar to wild type EGFP with an average pKa of 6.10 ± 0.08.  L194N was not 
tested as in depth as L15N, but the pKa with fluorescence at 510 nm and excitation at 
482 nm was measured to be an average of 5.83 ± 0.02 for duplicate samples.  This 
value is in good agreement with L15N and EGFP. 
4.9.3 Quantum yield measurements of partial sites and EGFP 
The literature reports the quantum yield of EGFP as 0.60.  EGFP was initially 
measured in duplicate to ensure that the experimental conditions were appropriately 
designed.  Quantum yields were obtained by measuring the emission at 510 nm with 
excitation at 488 nm and absorbance at 488 nm of EGFP and the variants with protein 
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concentrations from 0 to 2 µM.  The quantum yields, summarized in table 4.9, 
calculated from in-house experiments were 0.606 and 0.59996 (~0.6) (Fig 4.47).  The 
measured quantum yield of L15N indicated an average of 0.44 ± 0.0007 (Fig 4.48).  The 
quantum yield for L194N was an average of 0.43 ±0.0014.  The extinction coefficients at 
488 nm were also calculated from this data with EGFP at 49,311 M-1cm-1 (similar to 
literature values) (63), L194N at 44,804 M-1cm-1, and L15N at 51, 015 M-1cm-1, all with R 
values of 0.99 or better (Fig 4.49).  The calculated extinction coefficient of EGFP, 
21,890 M-1cm-1, is generally utilized to calculate the protein concentration and to ensure 
that all of the protein has a formed chromophore.  The extinction coefficients of the 
variants were calculated at 280 nm to be 20,792 and 21,412 M-1cm-1 for L15N (Fig 4.50) 
and L194N, respectively.  These proteins still maintain large quantum yields to allow for 
bright imaging.  In preliminary in vivo studies in HeLa cells, these proteins still indicate 
bright fluorescence on par with EGFP with very short exposure times necessary for 
imaging. 
4.10 Disulfide Bonds and Chromophore Reduction 
 Dimerization of GFP has been reported to be due to the two surface cysteines in 
GFP at positions 48 and 70 (134).  Also, recently developed redox sensors indicate that 
disulfide bond formation could affect chromophore fluorescence (135).  The 
fluorescence emission of L194N/S86D was tested in the presence of a disulfide bond 
reducer, β-mercaptoethanol, to ascertain the effects of disulfide bond formation on our 
designed protein.  As expected, increasing concentrations of β-mercaptoethanol 
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Table 4.9 A summary of the quantum yield and extinction coefficient 
measurements for EGFP, L15N, and 194N.
Extinction 
Coefficient at
280 nm
(M-1 cm-1)
Extinction 
Coefficient at 
488 nm 
(M-1 cm-1)
Quantum 
YieldProtein
21,41244,8040.43 ± 0.001L194N
20,79251,0150.44 ± 0.001L15N
21,89049,3110.603 ± 0.004EGFP
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Fig 4.47 Absorbance and fluorescence spectra of EGFP in 10 mM Tris, 1 
mM DTT, 1% glycerol, pH 7.4 at various concentrations to calculate the 
quantum yield of the protein.  The fluorescence vs. absorbance fit it also 
shown in the inset.
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Fig 4.48 Absorbance and fluorescence spectra of L15N in 10 mM Tris, 1 mM
DTT, 1% glycerol, pH 7.4 at various concentrations to calculate the quantum 
yield of the protein.  The fluorescence vs. absorbance fit it also shown in the 
inset.
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Fig 4.49 Extinction coefficient calculation for EGFP at 488 nm for two sets 
of data.  The slope of the linear regression fit is equivalent to the extinction 
coefficient.  The extinction coefficients for L194N and L15N were 
calculated in the same manner.
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Fig 4.50 Extinction coefficient calculation for L15N at 280 nm for two sets 
of data.  The slope of the linear regression fit is equivalent to the extinction 
coefficient.  The extinction coefficient for L194N was calculated in the 
same manner.
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decreased the fluorescence of the protein with complete loss observed at 50% v/v (Fig 
4.51).  Above ~10% v/v, the fluorescence decrease is likely due to reduction of the 
chromophore.  However, at low percentages (<10% v/v) of β-mercaptoethanol, addition 
of calcium (1 and 10 mM) indicated an increase in the fluorescence over the emission 
with just the reducer (Fig 4.51).  This could possibly be due to calcium binding which 
allows the chromophore to be shielded from the β-mercaptoethanol so it is not reduced 
to as large an extent.  This chromophore reduction is not yet completely understood, but 
it is likely that low concentrations will reduce disulfide bond formation while larger 
concentrations will reduce the chromophore.  
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Fig 4.51 L194N/S86D in 10% β-mercaptoethanol with and without calcium 
excited at 398 nm.  The decrease in chromophore fluorescence due to 
reduction of the chromophore is less with calcium than without. This may be 
due to some protection of the chromophore caused by the binding.
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Chapter 5 The Evolution of Sensor 177 
5.1 Mammalian Screening of Designed Proteins 
 We have constructed and studied green fluorescent proteins with designed 
calcium binding sites and have shown that they bind calcium with a range of affinities.  
One of the possible reasons for the lack of fluorescence of our designed proteins is that 
proteins fold differently in bacteria than in mammalian cells.  GFP is a protein native to 
cold water jellyfish, which is a eukaryotic organism.  Alberti and coworkers 
demonstrated that various GFP mutants exhibit differing folding efficiencies in bacteria 
and mammalian cells (136), indicating a difference in prokaryotic and eukaryotic protein 
folding mechanisms.  These variants also demonstrated differing folding efficiencies 
from each other, and additional tags attached to the variants induced differing folding 
efficiencies.  Sakikawa et. al. demonstrated that GFP and its variant BFP binds to the 
cis-cavity of the GroEL chaperone and undergoes folding inside the cis-cavity (137).  
Mammalian cells with subcellular compartments contain much better machinery for 
protein folding than bacteria, including many more folding chaperones.  Since the 
designed proteins exhibit β-sheet secondary structure, indicating some folding, and it 
appears that the tertiary structure of the barrel is not well packed, the proteins were 
expressed in mammalian cells to ascertain if the tertiary structure would pack better 
allowing for formation and/or fluorescence of the chromophore.  In this chapter, we will 
demonstrate the better folding of designed calcium binding green fluorescent proteins in 
mammalian cells through expression in four cell lines, HeLa, HEK293, Vero, and CHO 
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as shown in table 5.1.  Mutations to create a brighter sensor will be detailed.  The 
calcium response in vivo of these mutants will also be discussed. 
5.1.1 Choice of cell lines 
For mammalian cells, there are numerous cell lines available.  The accessible 
cell lines for our laboratory are listed in table 5.1.  HeLa cells are cervical carcinoma first 
discovered in the 1960’s.  Hek293 are human embryonic kidney cells that have been 
extensively reported in the literature as the cell line for many different applications.  
CHO are Chinese hamster ovary cells, which have also been considerably reported.  
Vero cells are kidney cells from an African monkey, which are widely used in viral 
research.  They are much larger cells than the other 3 types, and it was thought that 
their subcompartments may be easier to monitor due to the larger size.  Each of these 
cell lines has their own uniqueness that lead us to incorporate them into our study.  If 
cancerous cells handle calcium differently than normal cells, comparison of the calcium 
response in HeLa and CHO cells could provide clues to that difference.  Hek293 cells 
have been shown to produce muscarinic receptors, much like muscle and neural cells, 
which cause calcium spikes when stimulated with acetylcholine or carbachol.  This 
provides another way to measure the calcium response of our designed sensors and 
also provides information on calcium handling in the cell.  The expression of the 
designed sensor had to be optimized for each of the cell lines as the transfection 
efficiency and expression yield could vary for each. 
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Table 5.1 A summary of the four mammalian cell lines utilized in the 
characterization of the designed GFP calcium-binding proteins.
Normal cells but different type 
than others for comparison of 
calcium spatial and temporal 
changes
Chinese hamster 
ovary
CHO
Normal cells, grow well, larger 
cells for ease of imaging
African monkey 
kidney cells
Vero
Normal cells, grow well, 
transfection conditions known, 
previously used for calcium 
measurements
Human embryonic 
kidney
HEK293
Easy growth and transfection, 
calcium response previously 
monitored with calcium-binding 
dyes and proteins
Cervical carcinomaHeLa
Reasons for useOriginCell line
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5.2 Expression of Designed Proteins in Mammalian Cells 
5.2.1 Engineering mammalian cell expression constructs for expression of the 
designed proteins 
Sites 177, 120, 194a, 229 and L194N/S86D along with EGFP were subcloned 
into pcDNA3.1+ vector for expression in mammalian cells (Fig 5.1).  This vector 
contains a CMV (cytomegalovirus) promoter site that allows for expression in the 
mammalian system.  The CMV promoter has activity in a large variety of cells so it is 
often utilized in initial testing of new proteins and has been shown to produce more 
protein than other commonly used promoters, such as SV40 (138).  The vector also 
contains an ampicillin resistance site for preparation of the DNA in bacteria and a 
neomycin/geneticin resistance to allow for stable transfectants to be made.  A multiple 
cloning site for insertion of the desired gene is also located in pcDNA3.1+.  The 
subclone of these sites into pcDNA3.1+ proceeded as detailed in section 2.4 with no 
difficulties. 
5.2.2 Transient transfection and expression of designed proteins 
Sites 177, 120, 120b, 194a, 229, L15N/R122D and L194N/S86D were all 
transfected into HeLa or CHO cells with EGFP as the control as detailed in the materials 
and methods section 2.19.  Sites 120 and 194a only exhibited an extremely weak 
fluorescence after 72 hrs of expression at 30 °C that quickly bleached before images 
could be obtained (Figs 5.2 and 5.3).  The fluorescence could be seen through the 
binoculars on the scope and could be watched while it bleached.  Expression of Site 
120 for up to 10 days at 30 °C in CHO cells did not yield fluorescence.  Site 120b 
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Fig 5.1 Vector map and details of the pcDNA3.1+ vector from Invitrogen.  
The vector allows for expression of proteins in mammalian cells with the 
utilization of the CMV promoter.
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Fig 5.2 Images of site 120 in HeLa cells 72 hrs after transfection with 
expression at 30 °C at 40x magnification with 1500 ms exposure indicating 
the very weak fluorescence observed with this site.  The left image was 
obtained with the FITC filter (490/510), and the left image is the transmitted 
light.
Fig 5.3 Images of 194a in HeLa cells 72 hrs after transfection with 
expression at 30 °C at 40x magnification with 1500 ms exposure indicating 
the only very weak fluorescence observed with this designed site. The left 
image was obtained with the FITC filter (490/510), and the left image is the 
transmitted light.
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exhibited weak fluorescence in CHO cells after 72 hrs of expression (Fig 5.4).  Site 229 
exhibited no fluorescence after expression for 72 hrs at 30 °C (Fig 5.5).  On the other 
hand, the partial sites L15N/R122D (full site is 120b) and L194N/S86D (full site 194b) 
were as bright as EGFP and did not exhibit bleaching with exposure up to 1 s (Figs 5.6 
and 5.7).  More importantly, the fluorescence of Site 177 that was bright enough to 
obtain images and did not bleach instantly as the full sites 120 and 194a did (Fig 5.8).  
Site 177, along with 120, 194, and 194b did not exhibit fluorescence when expressed in 
bacteria (chapter 4).  The observation of green fluorescence for site 177 was very 
significant since it clearly demonstrates that mammalian cells have a much stronger 
capacity to express GFP variants with mature chromophores.  Expression trials were 
performed on Site 177 to ascertain the expression time needed to obtain fluorescent 
cells, if the protein could be expressed at 37 °C, and if the protein were brighter in 
different cells lines.  
5.2.3 Optimization of transfection conditions 
Initially, the transfection and expression of EGFP was learned and optimized 
before the designed proteins were assessed.  Further, EGFP was utilized as a control 
when new conditions were tested for each cell line.  Sensor 177 was transfected into 
HeLa, Hek293, CHO, and Vero cells and the conditions were optimized for each.  
During the optimization of expression of any protein, several factors must be 
considered.  The type of transfection (liposomes or calcium phosphate), brand of 
transfection reagent, amount of DNA, DNA:liposome ratio, expression time, and the cell 
line.  In addition, for our designed sensors, the temperature had to be considered since 
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Fig 5.4 Images of Site 120b in CHO cells 72 hrs after transfection with 
expression at 30 °C with the FITC filter (left) and transmitted light (right) at 
20x magnification with 2 s exposure.  Very little fluorescence is observed 
and the exposure time required to capture the fluorescence is very long.
Fig 5.5 Images of Site 229 in HeLa cells 72 hrs after transfection with 
transmitted light and 488 nm excitation/510 nm emission at 20x 
magnification with 2 s exposure.  No fluorescence is observed.
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Fig 5.6 Images of L15N/R122D in CHO cells 72 hrs after transfection at 
20x magnification with 100 ms exposure indicating strong fluorescence of 
the partial design site with short exposure time necessary to capture 
strong fluorescence.  The top left image is transmitted light.  The bottom 
image is UV excitation at 340 nm with emission at 450 nm, and the top 
right image is excitation at 488 nm with emission at 510 nm.  These 
images also indicate that this protein exhibits some UV fluorescence, 
which is not seen with all of the mutants.
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Fig 5.8 Images of Site 177 expressed in HeLa cells 72 hrs after transfection 
with expression at 30 °C at 40x magnification with 2 s exposure.  The left 
image is with 488 nm excitation/510 emission, and the right image is 
transmitted light.
Fig 5.7 Images of L194N/S86D in HeLa cells 72 hrs after transfection with 
expression at 30 °C at 20x magnification with 200 ms exposure indicating 
fluorescence of this partial site that is as bright as EGFP.
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they do not exhibit fluorescence at 37 °C.  In the past, calcium phosphate was the 
transfection protocol most largely followed, but with the advent of liposomal reagents, 
many researchers have moved away from calcium phosphate.  We chose to pursue the 
liposome avenue. 
Liposomes contain charged and hydrophobic portions.  These molecules 
surround negatively charged DNA and allow the DNA to move across the hydrophobic 
cell membrane.  There are many liposomes available from many companies, and the 
choice depends upon the cell type.  Lipofectamine2000 was initially chosen for two 
reasons: 1) Invitrogen recommended this reagent for use with HeLa cells and had 
available literature indicating the use of this reagent with HeLa cells, and 2) Our 
collaborators on this project who taught us the mammalian protocols had previously 
indicated great success with this reagent.  Once decided upon, the transfection reagent 
ratio must be optimized along with the amount of DNA to be applied per plate. 
This optimization is two-fold, varying the amount of DNA and the ratio of DNA to 
liposome.  For EGFP, 1 µg in a 1:1 ratio was more than sufficient to provide for very 
bright cells with high transfection efficiency (>80%).  However, transfection of 177 with 
these conditions yielded very weakly fluorescent cells with low efficiency.  The DNA 
amount was increased to 3 µg and the ratios from 1:1 to 1:5 were tested.  It was found 
for HeLa cells that 3 µg with a 1:3 ratio worked very well providing fluorescent cells with 
>60% efficiency.  The amount of DNA was then tested by keeping the DNA:liposome 
ratio at 1:3 and varying the amount of DNA from 2 µg to 5 µg.  The increased amount of 
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DNA increased the fluorescence, but there were more dead/dying cells in the 4 and 5 
µg dishes, likely due to the use of so much liposome during the transfection (Fig 5.9).  
Therefore, 3 µg of DNA in a 1:3 DNA:liposome ratio was employed for further 
experiments in HeLa cells with an observed transfection efficiency of 70-80%. 
Initial studies on the transfection of Vero cells yielded very little fluorescence in 
only 10% of the cells.  To improve the transfection efficiency and protein expression, 
different ratios of DNA and Lipofectamine2000 were investigated.  It was found that the 
1:4 ratio produced the best results with approximately 40% efficiency for EGFP 
expression (Fig 5.10).  For sensor 177 using a 1:4 ratio, it was observed that 4 µg 
generated the largest number of fluorescent cells at approximately 50% efficiency, but 
the fluorescence was still quite weak for 177 with 2 and 4 s exposure times necessary 
to obtain fluorescence (Fig 5.11).  However, fluorescence was observed after 
expression for 72 hrs, which is better than the initial studies produced. 
Optimization of CHO cells proceeded as stated for the HeLa cells.  A ratio of 1:3 
with 3 µg of DNA produces a high efficiency (>80%) with fluorescent cells (Fig 5.12).  
However, one factor was discovered for CHO cells that changed the protocol for 
working with these cells.  Transfection studies were normally performed on plastic 
dishes with images taken through a long working distance, plastic corrected objective.  
After the best conditions were established, dishes were prepared for calcium response 
studies.  It was found that CHO cells, unlike HeLa, do not adhere to glass cover slips.  
The cells would initially adhere, but would separate from the coverslip after 24-48 hrs 
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3 µg
4 µg
5 µg
Fig 5.9 Site 177 with different  amounts of DNA transfected into HeLa cells in 
a 1:3 DNA:lipofectamine2000 ratio 72 hrs after transfection at 20x 
magnification with 2 s exposure.
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1:1
1:2
1:3
1:4
Fig 5.10 Images of EGFP transfected into Vero cells at different
DNA:liposome ratios with 1 µg of DNA 48 hrs after transfection at 20x 
magnification with 1 s exposure.
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2 µg
3 µg
4 µg
5 µg
Fig 5.11 Images of Site 177 expressed in Vero cells at different DNA 
concentrations in a 1:4 DNA:liposome ratio 72 hrs after transfection at 20x 
magnification with 2 s exposure.
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2 µg
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4 µg
Fig 5.12 Images of Site 177 expressed in CHO cells at different DNA 
concentrations with a 1:3 DNA:liposome ratio 72 hrs after transfection at 
20x magnification with 2 s exposure.
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and within 16 hrs after transfection.  Coating the glass coverslips with fibronectin and 
collagen eliminated this problem by giving the cells attachment points.  Fortunately, 
fibronectin and collagen do not interfere with fluorescence studies of our sensors so 
coated cover slips were employed in further experiments by growth of the cells on 
coated plates.   
For HeLa, CHO, and Vero cells, Lipofectamine2000 was utilized with great 
success.  The transfection efficiency of this liposome is >70%, which is quite a bit higher 
than most other transfection means.  However, when Lipofectamine2000 was utilized to 
transfect Hek293 cells, the cells repeatedly died 24-48 hrs after transfection.  The cells 
round up, lifted from the plate, and could not be resuspended.  Although the liposomes 
manufacturer stated that the liposome could be used with Hek293 cells, a search of the 
literature revealed that no one had published transfection of Hek293 cells with 
Lipofectamine2000.  In general, Lipofectin was utilized.  Transfection of Hek293 cells with 
Lipofectin yielded live, healthy cells, but the transfection efficiency is much lower than 
the harsher Lipofectamine2000.  A ratio of 1:4 was necessary for transfection with 2 to 3 
µg of DNA, but the efficiency was ~30%, much less than Lipofectamine2000. 
5.3 Engineering a Brighter Sensor: incorporation of the cycle 3 mutations 
 5.3.1 Rationale for further modifying the designed proteins 
 Extensive work has been reported in the literature to try to increase the 
expression temperature of GFP with some success.  Cycle 3 GFP with the mutations 
F99S, M153T, and V163A has been observed to increase the folding of the protein at 
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37 °C, allowing for the chromophore to demonstrate fluorescence when expressed at 37 
°C (139, 140).  In addition, these mutations increase the fluorescence efficiency when 
the protein is expressed at 30 °C.  Cycle 3 GFP is estimated to be 30,000 times more 
fluorescent than wild type GFP.  A computational study by Zimmer et. al. indicated that 
the three mutations in cycle 3, F99S, M153T, and V163A play a role in the maturation of 
the chromophore (141).  They propose that these mutations decrease the distance 
between the Gly67 amide nitrogen and the Ser65 carbonyl carbon of the immature 
protein when compared to GFP-S65T, which allows for more efficient nucleophilic attack 
by the amide nitrogen of Gly67.  Since there are multiple steps involved in the folding of 
the protein, it is likely that these mutations allow for better arrangement of the 
sidechains, which decreases the distance for the reaction.  It is doubtful that the 
increased thermostability of chromophore formation is only due to the distance 
decrease, but likely involves many steps that lead to the decreased distance.  Although 
there have been copious efforts in fully understanding the chromophore formation and 
the factors that affect the formation, no conclusive results have yet been obtained.  
However, there is consensus that the cycle 3 mutations aid in the formation of the 
chromophore, increasing the brightness and thermostability.  In light of this, the cycle 3 
mutations were added to Sites 177, 120, and 194a to increase the brightness at 30 °C 
and to try to obtain fluorescence when expressed at 37 °C (Fig 5.13). 
 5.3.2 Incorporation of mutations F99S, M153T, and V163A 
F99S was first engineered into the variants, and then M153T and V163A were 
engineered together.  The forward primer for the F99S mutation was                            
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Fig 5.13 EGFP with Site 177 ligands in red and the cycle 3 mutations (F99S, 
M153T, V163A) in various colors to illustrate the location of these mutations 
in comparison to the chromophore and the designed site.
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5’-CGCACCATCTCCTTCAAGGACG-3’, and the reverse primer was                            
5’- CTCCTGGACGTAGCCTTCCC-3’.  The F99S mutation was obtained after several 
attempts at PCR.  The reaction was optimized by utilizing only distilled water, not 
deionized water, and by adjusting the primer and DNA concentrations until the 
appropriate conditions were discovered for the reaction to generate product with the 
correct mutation.  The forward primer for the M153T/V163A mutations was                  
5’-GAACGGCATCAAGGCGAACTTCAA-3’, and the reverse primer was                       
5’-TTCTGCTTGTCGGCCGTGATATAGA-3’.  The M153T mutation is incorporated into 
the reverse primer, and the V163A mutation is incorporated into the forward primer.  In 
this way, both of the mutations could be engineered with one PCR.  The initial reaction 
for M153T and V163A yielded DNA with a single base deletion at the junction of the two 
primers for the 153 and 163 mutations.  The PCR was repeated on the DNA that 
contained the correct 153 and 163 mutations to reinsert the deleted base, which was 
successful. 
5.3.3 Mammalian cell expression and tests of cycle 3 designed proteins 
 Sites 120 and 194a with the cycle 3 mutations, termed 120c3 and 194-c3, were 
transfected into HeLa cells.  Neither of these variants exhibited fluorescence 72 hrs 
after transfection.  Much of the work in the literature suggests that expression of GFP 
variants for longer periods of time, up to 10 days in some reports (50), allows for 
eventual chromophore formation.  Sites 120c3 and 194a-c3 were expressed in CHO 
cells for 7 days, but no fluorescence was observed (Fig 5.14).  Apparently, the 
incorporation of the mutations for these designed sites disrupts the protein packing 
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Fig 5.14 Images of 120c3 (A) and 
194a-c3 (B) 72 hrs after transfection 
into HeLa cells at 40x magnification 
with 2 s for 120c3 and 3 s for 194a-
c3 exposure.  Panel C is 120c3 
expressed for 5 days in CHO cells 
and panel D is 194a-c3 expressed in 
CHO cells for 5 days.
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enough so that the chromophore does not form, even with the aid of the cycle 3 
mutations.  Since Site 120 is located in the middle of the β-barrel, the introduction of the 
two negative charges, especially at location 120 feasibly disrupts the β-strands so the 
residues involved in forming the chromophore can not come into close enough contact 
to begin the formation reaction.  This result is more surprising for 194a since this site is 
located at the end of the barrel, relatively far away from the chromophore.  One 
possibility is that the mutations, especially at K79 and/or K85, disrupts the H-bond 
network inside the barrel of the protein.  With the mutations from positive to negative 
charges, perhaps there is electrostatic repulsion and a disruption in H-bonds so that the 
two together do not allow the protein to form the chromophore even with the cycle 3 
mutations. 
5.3.4 Optimization of time and temperature for expression 
The expression time and temperature are largely protein dependent, although the 
cell line does play a role, so these two factors were initially tested in HeLa and CHO 
cells for Site 177 and 177c3.  After transfection, the cells were incubated for 48 and 72 
hrs, and images were taken at these times.  After 48 hrs, Site 177 exhibited very weak 
fluorescence that required very long exposure times to capture (>2 s).  After 72 hrs, Site 
177 exhibited fluorescence that was easily captured by the camera without extensive 
exposure times (<2 s) (Figs 5.15 and 5.16).   
Site 177c3 was expressed after transfection into HeLa cells with Site 177 as a 
comparison control.  The cells were examined after 48 and 72 hrs of growth at 30 °C 
(Fig 5.17) with the DAPI, FITC, and TexasRed filter sets.  Site 177c3 is approximately 
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Fig 5.15 Images of site 177 in HeLa cells 48 hrs (top) and 72 hrs (bottom) 
after transfection at 40x magnification with 2 s exposure.  Transmitted images 
are on the right.
218
Fig 5.16 Images of Site 177 in CHO cells 48 hrs (top) and 72 hrs (bottom) 
after transfection with the transmitted light images on the right.  The images 
were taken with 2 s exposure at 40x magnification.
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177
177
177c3
177c3
Fig 5.17 Expression of 177 and 177c3 in HeLa cells 48 hrs (top) and 72 
hrs (bottom) after transfection with expression at 30 °C.  Images were 
taken at 20x magnification with 2 s exposure.
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ten times brighter than 177 when expressed at 30 °C as observed with the FITC filter 
set and the 40x oil objective.  To test the temperature, the proteins 177 and 177c3 were 
expressed for 72 hrs at 30 °C and 37 °C.  No fluorescence with the three filter sets 
(DAPI, FITC, TexasRed) was observed for the expression of 177 at 37 °C, but 
fluorescence was observed for expression at 30 °C.  As shown in figure 5.18, when 
expressed at 37 °C, weak fluorescence is observed for 177c3 with the FITC filter set 
although none is observed for 177.  It is likely that the introduction of the binding site 
with three negative charges negates a small part of the cycle 3 amino acids’ effect on 
the chromophore formation so there is only a weak fluorescence at 37 °C.  However, 
with a robust imaging system, 177c3 could be expressed at 37 °C and imaged.  A 
strong light source coupled with little light loss from optimized arrangement of the 
equipment, such as a camera in direct line with the objective, could allow for imaging of 
177c3 with expression at 37 °C.  This work also suggests that it is possible to 
incorporate other “stable mutants” to increase the optical properties of GFP variants at 
37 °C. 
The wild type GFP has been reported to need many days to “mature” and 
become fluorescent.  Also, EGFP does not exhibit fluorescence at 37 °C.  GFP was 
isolated from cold water jellyfish so its gene was adapted for the temperatures 
experienced by the jellyfish.  Since the designed protein obviously disrupts the fold to 
some extent—as observed by the expression in bacteria—it is not surprising that 
several days are needed for the designed protein to exhibit fluorescence.  In addition, 
HeLa cells require about 16 hrs after transfection to begin to produce protein.  
221
Fig 5.18 Images of 177c3 expressed in HeLa cells 72 hrs after transfection 
at 30 °C (left) and 37 °C (right).  Images were taken at 10x magnification 
with 2 s exposure.
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Expression of the protein for longer than 72 hrs was tested, but HeLa cells do not grow 
well without passaging for longer than 72 hrs.  The cells begin to pile up and form 
plaques, eventually rounding up and detaching from the plate.  It is possible that the 
protein would be more fluorescent with longer expression time as many articles have 
reported expression of their particular variant for up to 10 days, but comparisons among 
cell lines should include expression for the same amount of time. 
Although the sensors are most fluorescent with expression at 30 °C, the 
temperature sensitivity of the chromophore formation is not detrimental to further testing 
in animal models since there are organisms that live at 30 °C, such as C. elegans and 
zebrafish.  The expression at lower than physiological temperatures is consistent with 
other reported GFP sensors, such as the pericam and cameleon series (51).  In 
addition, measuring the temporal and spatial changes of calcium in living cells is not 
hindered by growth at 30 °C.  One of the eventual goals of this project is to understand 
the changes of calcium at the cellular level and to ascertain the differences in calcium 
changes for different cell types, such as between cancer and normal cells.  These 
experiments can be performed at room temperature or at physiological temperature 
after expressing the protein at lower temperatures since EGFP does not lose its 
fluorescence at 37 °C once the chromophore is formed due to its relatively high melting 
temperature of 78 °C.  Further improvements could be formulated by incorporating other 
mutations that have been reported to improve the chromophore formation or by carrying 
out random mutagenesis and selecting for brighter clones.  The drawback to random 
mutagenesis would be loss of the calcium binding site that would need to be 
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reincorporated and tested for calcium response.  In addition, folding chaperones could 
be coexpressed with the sensor to aid in the folding if the correct chaperones could be 
ascertained for GFP folding. 
5.4 Calcium response of 177 and 177c3 in the cytosol 
 Once the expression conditions were optimized, the in vivo calcium response 
was tested for 177 and the brighter 177c3.  There are many ways to test calcium 
response, as detailed in Chapter 1, but the easiest to perform and monitor is through 
the use of ionomycin.  Ionomycin is a calcium ionophore that exchanges protons for 
calcium across the plasma membrane.  This process can theoretically change the pH of 
the cytosol, which has been observed in BHK fibroblasts.  However, studies by Dr. 
Louis and Dr. Lurtz of UC Riverside (private communication) using pH indicators 
demonstrated that the pH of HeLa cells does not change upon introduction of ionomycin 
and calcium.  Ionomycin is easier to monitor calcium induced changes because 
increasing the outside calcium in the bathing medium can further increase the calcium 
in the cytosol.  Although, the calcium pumps are continuously working to remove the 
calcium from the cytosol in order to keep the cell healthy so high concentrations of 
calcium do not remain in the cell, a quick increase in the outside calcium allows for the 
cytosolic calcium concentration to be artificially raised enough to monitor calcium 
response of new sensors (142, 143).  The use of physiological responses, such as 
binding of an agonist (ATP or histamine) and causing IP3 production does not raise the 
calcium concentration as high as can be accomplished with ionomycin.  Therefore, if the 
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designed sensor does not respond to small calcium changes, the IP3 pathway would 
not be useful. 
 Sites 177 and 177c3 were tested for calcium response initially in HeLa cells.  Our 
collaborators, Dr. Monica Lurtz and Dr. Charles Louis, first tested 177 on a Nikon 
inverted epifluorescence microscope with standard FITC filters with excitation centered 
at 490 nm and emission at 520 nm as detailed in Chapter 2, section 2.21.  The initial 
results were promising with increases in fluorescence observed for the designed 
sensors that were not observed for the wild type protein, EGFP (Fig 5.19), when the 
outside calcium was increased after ionomycin addition.  As shown in figure 5.20, the 
addition of 2 µM ionomycin does not alter the baseline fluorescence of the cells but 
fluorescence increases are observed by addition of 20 mM calcium, which continue until 
the addition of 60 mM calcium.  The calcium pumps removing calcium from the cell are 
highly efficient and do not allow the cytosolic calcium to become very large so large 
calcium concentrations are need in the bathing medium to overwhelm the calcium 
pumps.  Removal of the extracellular calcium by buffer exchange indicates a reduction 
in the fluorescence, suggesting that the process is reversible.  Further addition of 
ionomycin and calcium again indicates a fluorescence increase.  Figure 5.21 indicates 
the averaged and normalized fluorescence changes observed for 177 as detailed in 
figure 5.20.  The data was evaluated for statistical relevance by Kristy Welshhans in Dr. 
Vincent Rehder’s laboratory as shown in figure 5.22.  The t-test indicated that the data 
were statistically valid.   
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Fig 5.19 Imaging on the inverted Nikon microscope of EGFP expressed in 
HeLa cells at 30 °C.  No calcium response is observed with addition of 
ionomycin and extracellular calcium for the wild type protein.
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Fig 5.20 Calcium response of Sensor 177 expressed in the cytosol of 
HeLa cells as generated by addition of ionomycin and calcium to the 
bathing medium.  The reduction in sensor fluorescence when the outside 
calcium is washed away indicates the reversible response of the sensor.  
This measurement was performed on an inverted Nikon microscope by 
Dr. Monica Lurtz.
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Fig 5.21 Averaged and normalized data for the previously shown calcium 
response of Sensor 177 expressed in the cytosol of HeLa cells as
generated by addition of ionomycin and calcium to the bathing medium.  
Increases in the fluorescence are observed beginning with 20 mM
outside calcium and continue with additional calcium up to 60 mM.  This 
measurement was performed on an inverted Nikon microscope by Dr.
Monica Lurtz.
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Fig 5.22 Statistical evaluation of the calcium response imaging of 
cytosolically expressed 177 in HeLa cells on the inverted Nikon 
microscope.  The evaluation was performed with the student t-test by a 
collaborator, Kristy Welshhans.  The results indicate that the calcium 
response observed for 177 is statistically valid.
-40
-20
0
20
40
60
80
de
lta
 F
Baseline Avg - Baseline Avg
Iono Avg - Baseline Avg
Iono 1min Avg - Baseline Avg
Iono 2min Avg - Baseline Avg
20mM Ca Avg - Baseline Avg
40mM Ca Avg - Baseline Avg
60mM Ca Avg - Baseline Avg
60mM Ca 1min Post Avg - Baseline Avg
60mM Ca 2min Post Avg - Baseline Avg
1.8mM Ca 1 Avg - Baseline Avg
1.8mM Ca 2 Avg - Baseline Avg
1.8mM Ca 3 Avg - Baseline Avg
20mM Ca Avg - Baseline Avg
40mM Ca Avg - Baseline Avg
60mM Ca Avg - Baseline Avg
60mM Ca 1min Post Avg - Baseline Avg
60mM Ca 2min Post Avg - Baseline Avg
60mM Ca 3min Post Avg - Baseline Avg
229
  
 Sensor 177 was also evaluated for physiologically response by addition of 50 µM 
ATP to induce calcium release from the ER through the IP3 pathway, as shown in figure 
5.23.  The fluorescence response reaches a plateau that is not further changed by 
addition of more ATP, but a decrease is observed when the ATP is removed so that 
calcium is no longer being released from the ER into the cytosol.  The increase in 
fluorescence observed for the cytosolically expressed sensor indicates that the calcium 
release from the ER can be monitored by this protein for physiological processes. 
 Another experiment was performed with sensor 177 expressed in the cytosol with 
addition of thapsigargin to block the calcium reuptake pumps in the ER allowing for a 
slow leak of calcium and calmidazolium to inhibit the calcium exchangers in the plasma 
membrane.  This experiment should result in an increase in fluorescence for sensor 177 
over time as calcium leaks from the ER and can not be taken back up.  However, as 
shown in figure 5.24, the calcium released is not a large enough concentration to cause 
an increase in 177’s fluorescence.  Addition of ionomycin and calcium at the end of the 
experiments indicates that the sensor is functioning and responding to calcium. 
 Calcium response of sensor 177 was also tested on the Zeiss Axiovert 200 at 
GSU.  As shown in figure 5.25, EGFP expressed in HeLa cells does not indicate a 
fluorescence response to calcium.  However, as shown in figure 5.26, sensor 177 
indicates a fluorescence increase with addition of ionomycin and calcium.  Fluorescence 
response is observed with 20 mM extracellular calcium that continues up to 60 mM 
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Fig 5.23 Imaging of cytosolically expressed 177 in HeLa cells.  Addition of 
50 µM ATP induces calcium release from the ER by the IP3 pathway, 
which can be observed by the increase in fluorescence for 177 as it binds 
the calcium released into the cytosol.
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Fig 5.24 Imaging of cytosolically expressed 177 in HeLa cells on the 
inverted Nikon microscope.  Addition of thapsigargin empties ER calcium 
while calmidazolium blocks the reuptake calcium pumps in the ER.  This 
process should allow for a fluorescence increase of 177 to be monitored, 
but the calcium released by this pathway is very low concentration and is 
likely out of the sensing range for 177.
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Fig 5.25 Traces of the imaging of cytosolically expressed EGFP in HeLa 
cells on the Zeiss Axiovert 200 microscope with the 40x dry objective, 100 
ms exposure, and the FITC filter set.  Addition of ionomycin and calcium 
does not indicate a fluorescence change for the wild type protein, as it 
should not since the protein does not bind calcium.
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Fig 5.26 In vivo calcium response of 177 as imaged by the Zeiss Axiovert 200 
inverted epifluorescence microscope at 40x magnification (oil objective) and 
300 ms exposure with the FITC filter set.
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calcium.  Over time, bleaching is observed for the protein, which can likely be remedied 
by exposure for less time and reducing the power on the Fluoarc light box. 
The data obtained with the confocal instrument indicates the same increase, but 
the wild type protein, EGFP, also indicates some increase in fluorescence upon addition 
of calcium.  This is likely due to some cell shape changes or swelling of the cell due to 
the calcium.  Since confocal is confined to one very small plane in the Z-axis, any cell 
swelling and shape changes could indicate a change in the fluorescence that is artificial.  
The change for EGFP is not as large as for the designed sensors with EGFP indicating 
10-20% fluorescence increase and the designed sensors exhibiting 20-30% 
fluorescence increase.  However, further tests must be performed to find the correct 
conditions for imaging of calcium changes on the confocal instrument so that the wild 
type protein does not indicate change but the designed proteins do.  Trials of taking 
stacks at each time point and opening the pinhole up completely did not solve this 
dilemma. 
In addition, real further testing by Dr. Aldebaran Hofer at Harvard University of 
this sensor expressed in BHK fibroblasts cells confirmed that the sensor was indeed 
responding to calcium.  With the same results from three labs on four instruments, we 
can definitively say that our sensor is successful.  Repeated experiments indicated the 
same calcium dependent increase, therefore, our designed sensor responds to calcium!  
Control experiments were performed by adding only calcium without ionomycin and no 
fluorescence increase was observed indicating that the sensor indeed responds to the 
increase calcium in the cytosol caused by ionomycin.  This is the first instance of a 
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designed sensor with the calcium binding site incorporated into the frame of the host 
protein by site directed mutagenesis that responds to calcium changes in vivo.   
 The brighter sensor 177c3 was also monitored for calcium response in vivo.  It 
was expressed in the cytosol of HeLa cells and observed with inverted epifluorescence 
at 40x magnification on both the Nikon inverted epifluorescence microscope and on the 
Zeiss Axiovert 200 inverted epifluorescence microscope, as shown in figures 5.27 and 
5.28.  An increase in the fluorescence is observed upon addition of ionomycin and 
calcium with both microscope setups.  Up to 100 mM calcium was added to the bathing 
medium to test how large the outside calcium concentration needed to be to no longer 
see additional changes.  From the data, 60 mM outside calcium is sufficient.  After 
removal of calcium from the bathing medium, the sensor indicates a decrease in 
fluorescence.  This result suggests that the fluorescence response to calcium is 
reversible.  The calcium stimulated fluorescence increase is comparable or better in 
percent change to 177, but much less exposure time is necessary since the protein is 
much brighter.  The shortest exposure time possible is desirable to monitor quick 
calcium changes in the cell and to reduce photobleaching as much as possible. 
 To ascertain if the non-fluorescent calcium-binding mutants would become 
fluorescent upon binding calcium, Sites 120 and 194a were expressed in HeLa cells 
and tested for calcium response.  Ionomycin and calcium were added to the bathing 
medium and images were obtained.  After addition of 60 mM outside calcium, no 
fluorescence was observed with the FITC or TexasRed filters.  Unfortunately, binding to 
calcium did not induce chromophore formation of these proteins. 
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Fig 5.27 In vivo calcium response of 177c3 as imaged by inverted 
epifluorescence on the Nikon microscope, performed by Dr. Monica Lurtz, at 
40x magnification.
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Fig 5.28 In vivo calcium response of 177c3 in HeLa cells as imaged on 
the Zeiss Axiovert inverted epifluorescence microscope at 40x 
magnification (oil objective) with 50 ms exposure.  The top images are 
before and after calcium addition.  The different traces are different cells 
in the region being monitored with the regions of interest being drawn 
around the entire cell for the best average fluorescence.  The data was 
normalized by dividing each start point by itself so that the beginning 
would be 1.  The remaining data was divided by the same number. 
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5.5 Calcium Response of Sensors 177 and 177c3 when Expressed in the ER 
 5.5.1 Addition of ER targeting signal peptides 
 In order to express the designed sensor in the ER of mammalian cells, two tags 
were added to the gene encoding 177 and 177c3.  The N-terminal tag is a peptide from 
calreticulin, MLLSVPLLLGLLGLAAAD, which directs the expression of the gene to 
commence in the ER.  The C-terminal tag, KDEL, is a retention sequence that retains 
the expressed protein in the ER and does not allow it to be shuffled to the Golgi.  The 
use of these two tags has been demonstrated by Tsien, Miyawaki, and others in the 
literature (50, 62).  The C-term tag was added by PCR utilizing primers that contained 
the DNA sequence for the KDEL tag and matched the GFP sequence (Table 5.2).  In 
this way, the polymerase will incorporate the insert during the PCR.  The tag was added 
between the last amino acid codon and the stop codon.  After this was confirmed 
through automated sequencing at the core facility at GSU, the calreticulin signal 
sequence was initially added by PCR in the same manner as the KDEL.  A vector 
containing the calreticulin sequence was later engineered for ease of multiple insertions.  
Inserting the calreticulin sequence by PCR required two rounds of PCR, but product 
was not always obtained due to the large insert.  The experiment was repeated until the 
correct sequence was verified. 
To target 177c3 to the ER, the same signal peptides were used as those used for 
177.  The C-terminal KDEL sequence was inserted by PCR between the last amino acid 
and the stop codon.  However, addition of the calreticulin signal sequence was 
performed by a subclone rather than PCR into a modified pcDNA3.1+ vector.  The 
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GTC CTT CTT GTA CAG CTC GTC CAT GCC GKDEL2
GAG CTG TAA GAATTC TGC AGA TAT CCA GCC ACKDEL1
Insertion for KDEL sequence is:
AAG GAC GAG CTG
GAG CAG CAA CGG CAC GGA TAG CAG CAT GGATCC GCal4
GGC CTC CTC GGC CTG GCC GCT GCA GAC GGA TCCal3
CAC GGA TAG CAG CAT GAG CTC GGT ACC AAG CTT AAG TTCal2
CTG GCC GCT GCA GAC GGATCC ACT AGT CCA GTG TGG TCal1
SequencePrimer Name
Insertion for Calreticulin sequence is:
ATG CTG CTA TCC GTG CCG TTG CTG CTC GGC CTC CTC GGC CTG 
GCC GCT GCA GAC
Table 5.2 Primers to insert the ER signal tags into EGFP variants.
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vector was modified by PCR to include the calreticulin signal sequence before the 
BamH1 site.  In this way, any gene will have the calreticulin sequence included by a 
simple subclone with BamH1 and EcoR1 restriction enzymes, which is a much quicker 
and easier method than insertion by PCR.  The primers and DNA base insertions are 
shown in table 5.2.  The modified vector is termed pcDNA-CalR. 
5.5.2 ER localization of sensors 177-ER and 177c3-ER 
 The ER tagged constructs of Site 177 and 177c3 were termed 177-ER and 
177c3-ER.  To test if the construct indeed localizes to the ER, double transfection of it 
and a purchased vector DsRed2-ER was performed.  DsRed2-ER from Clontech has 
been shown to localize to the ER through immunohistochemistry (personal 
communication).  If the 177-ER and 177c3-ER constructs’ fluorescence perfectly 
overlays the fluorescence of DsRed2-ER, then it can be concluded that the two localize 
in the ER.  Previous work in our laboratory demonstrated the necessity of the 
calreticulin sequence and the KDEL sequence in localizing to the ER (144).  As shown 
in figures 5.29 and 5.30, when 177-ER and 177c3-ER were expressed with DsRed2-
ER, it was observed that the two fluorophores completely overlapped forming an orange 
color in the image with no lone red or green observed.  The green fluorescence is 
measured by excitation with the 488 nm Argon laser line, and the red fluorescence is 
measured by excitation with the 543 nm line of the He/Ne laser.  The filters are set to 
only encompass the appropriate fluorescence, i.e. the green fluorescence is obtained 
with the BP 505-530 nm filter.  This result indicates that both constructs indeed localize 
in the ER. 
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Fig 5.29 Confocal images of Sensor 177-ER cotransfected with DsRed2-
ER in HeLa cells 72 hrs after transfection at 100x magnification.  The 
overlay image on the bottom indicates that 177-ER is indeed localizing to 
the ER.
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Fig 5.30 Colocalization of 177c3-ER and DsRed2-eR in HeLa cells 72 hrs 
after transfection as imaged by inverted epifluorescence with the FITC 
and TexasRed filters and automatic exposure. 
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5.5.3 Calcium response in the ER 
To test the calcium response of 177-ER and 177c3-ER, the protein was 
expressed for 72 hrs at 30 °C in HeLa cells.  ATP and/or histamine (100 µM final 
concentration each) were added to the bathing medium.  The addition of these two 
agonists should cause a large decrease in the ER fluorescence as the calcium stores 
are dumped.  Small changes were observed when ATP was added, but the percent 
change is quite small (Fig 5.31).  The experiments for 177c3-ER were performed on the 
laser scanning confocal instrument at GSU at 100x magnification.  When 177c3 was 
tested for calcium response, a small reduction in chromophore fluorescence due to 
calcium release was observed but bleaching was also observed for this construct as 
shown in figure 5.32.  The changes detected were small, similar to those detected for 
177.  This could be due to several factors.  First, the fluorescence of 177-ER is weak in 
comparison to EGFP and Dr. Zou’s sensors.  This may contribute to the small change 
observed since a decrease when the fluorescence is already weak is difficult to 
accurately observe and requires more intense excitation light to be applied to obtain 
images in the dynamic range.  This sensor does indicate some photobleaching during 
experiments, which may be overwhelming the calcium induced response.  Second, ATP 
generated IP3 calcium release is a relatively small response.  Third, the in vitro binding 
affinity of 177 is 59.7 µM.  Since the calcium concentration has been estimated to be 0.5 
to 1 mM, such a strong binding constant in comparison may not be able to sense the 
relatively small change in calcium concentration through IP3 action.  Evidence of this 
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experiment was performed by Dr. Lurtz on the Nikon inverted microscope 
at 40x magnification.
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has been observed in our laboratory by Dr. Jin Zou, whose grafted sensors exhibit 
response when expressed in the ER.  The binding affinities of the grafted sensors are 
100 to 300 µM, in a much better range for the higher ER calcium concentration.  Hofer’s 
work on ER calcium release using Mag-Fura-2, which has a calcium binding affinity of 
53 µM, indicates very little response with ATP but a large response with other methods, 
such as soponin and IP3 addition (30).  In addition, the Kd for calcium may be stronger 
when the protein is expressed in HeLa cells.  The protein is definitely better folded since 
it is fluorescent, which was not observed for bacterially expressed protein, so the 
binding affinity may be stronger than that measured for bacterially expressed protein.  
This idea is supported by the cytosolic response observed for 177 and 177c3, where the 
calcium concentration reaches 10-20 µM.  In this case, another method to measure the 
ER calcium changes with 177c3 is to express the sensor in the cytosol, where the 
binding affinity is more adept for the calcium concentration range, and cause a calcium 
release from the ER as was performed for sensor 177.  The calcium increase in the 
cytosol can then be correlated to the ER release activation.   
5.6 Calcium response of 177c3 in vitro 
 5.6.1 Expression of 177c3 in HeLa suspension 
 In order to obtain enough folded, fluorescent protein for in vitro characterization 
of 177c3, it was expressed in HeLa cells in suspension.  The DNA was first transfected 
into attached HeLa cells, as detailed in section 2.23, the cells were harvested, and they 
were placed in suspension for growth.  In this way, a much larger number of cells can 
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be obtained without needing to grow on many plates or flasks, and, therefore, much 
more protein can be acquired.  In addition, suspension growth was optimized so that the 
cells could be expressed for 4-6 days without cell death so that more protein could be 
obtained (section 2.23).  This was accomplished by the use of a 1 L MantaRay bottle, 
which creates a constant stirring when placed on a stir plate so that the cells can not 
attach to the sides of the bottle, and by suspending the harvested cells in only 400 mL 
of media.  The reasons for this are several fold.  First, HeLa cells need to be a certain 
cell density to produce enough CO2 for survival without growth in a CO2 incubator.  The 
initial use of a smaller amount of media allowed for a high enough cell density for CO2 
production.  If 1 L of media was initially employed, more plates (atleast 14) and much 
more DNA would have needed to be transfected to reach the needed cell density.  
Second, simply adding media each day without separating the cells and media and 
removing the old media reduces the possibility for contamination and cell destruction.  
Also, the addition of the media allows for more space for the cells to grow, which is 
needed as the cells double every 28 hrs. 
 After 4-6 days, the cells were harvested and sonicated to break the cell 
membrane, releasing the designed protein into the supernatant.  The designed protein 
was then measured with fluorescence spectroscopy to ascertain the chromophore 
spectrum and for calcium response.  The fluorescence excitation spectrum of 177c3 is 
highly similar to EGFP except that the peak at 398 nm is not evident (Fig 5.33).  
Fluorescence at 510 nm is produced by excitation at 450 nm, 469 nm, and 483 nm but 
only a small peak is produced by excitation at 398 nm (Fig 5.34).  EGFP produces 
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fluorescence at 510 nm with excitation at 398 nm due to excitation of the neutral state of 
the chromophore with much more intensity than 177c3.  This result indicates that 
177c3’s chromophore is shifted nearly entirely to the anionic state.  This shift could be 
the cause for the change in chromophore fluorescence upon calcium binding.  Emission 
spectra were obtained for excitation at 450 nm, 469 nm, and 483 nm with the addition of 
calcium in 100 µM increments up to 700 µM.  At 700 µM calcium, precipitation was 
observed (Fig 5.34).  Excitation at 450 nm indicates the largest calcium change with 
only 100 µM calcium needed to induce a response whereas excitation at the other 
wavelengths requires 200 µM or more to indicate a change.  EGFP does not exhibit 
these calcium induced changes in chromophore fluorescence (Fig 5.35), suggesting 
that the change is unique to the designed calcium sensor.  Since this protein mixture 
was not pretreated with EGTA, the protein may have contained some calcium since only 
small changes were observed with 100-300 µM.  The binding affinity of this designed 
site is 59 µM when expressed in bacteria.  The affinity may be different with expression 
in mammalian cells, but it is more likely that the effect on the chromophore fluorescence 
is slightly different that the true binding affinity.  Binding events at low concentrations 
may not produce a measurable fluorescence change so that the apparent affinity 
measured by the fluorescence change is not the same as the true binding affinity.  With 
in vitro and in vivo calcium induced changes observed for this protein, it is apparent that 
a calcium sensor has been engineered. 
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5.7 Major Findings 
 Designed proteins 229, 120, 194a, and 177 were expressed in mammalian cells 
in which fluorescence was indicated for sensor 177.  Addition of the cycle 3 mutations, 
F99S/M153T/V163A, increased the brightness of sensor 177 approximately 10 times 
but did not indicate fluorescence for sensor 120 and 194a.  Sensor 177c3 indicates 
weak fluorescence when expressed at 37 °C in HeLa cells that is not observed for 
sensor 177.  Sensors 177 and 177c3, when expressed in the cytosol of HeLa cells, 
indicate an increase in fluorescence signal upon an increase in calcium concentration 
through ionomycin action with increased extracellular calcium and through addition of 
ATP to release calcium from the ER.  Including the calreticulin and KDEL tags in the 
177 and 177c3 constructs produced protein that localized in the ER of HeLa cells.  
Measurements of calcium response of 177 and 177c3 expressed in the ER did not yield 
fluorescence signal change, likely due to a binding affinity that is too strong to sense the 
small calcium changes when release is induced by ATP or histamine.  Expression of 
177c3 in suspended HeLa cells allowed for in vitro fluorescence measurements of the 
protein and observed calcium changes upon introduction of calcium. 
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Chapter 6 Second Generation of Designed Sensors 
6.1 Lessons Learned: design of a second generation of sensors 
6.1.1 New criteria in the design of the second generation 
 In an effort to create better, brighter sensors with a larger calcium response, the 
initial 10,000 sites from the computer algorithm research for possible calcium-binding 
sites were reexamined.  The possible sites were grouped by location in the protein, and 
the various residues (usually 8-10) in each location were considered.  The previously 
studied mutations that caused fluorescence loss (K79D, K85D, and H81D) were 
removed from consideration.  During the inspection of the possible sites, it was noticed 
that many sites were located in similar places as the first generation with a few different 
ligands.  These sites were further contemplated since binding sites in those locations in 
the first generation proved to be fluorescent in mammalian cells and/or demonstrated 
calcium sensitivity.  In this search, the idea of stabilizing the protein with surrounding 
positive sidechains was taken into account.  Since introduction of several negative 
charges disrupts the chromophore formation, balancing the negative charges with 
surrounding positive charges to form salt bridges when not bound to calcium should aid 
in chromophore formation.  When deciding upon which residues should be the final 
amino acids, each pocket was closely examined and distances were measure to 
ascertain the size of the sidechain that would fit into the location without causing steric 
clash with other sidechains.  In addition, lysines and histidines were avoided altogether 
since those mutations have proved detrimental in our work, K79D for example, and in 
the literature.  The final sites chosen for study are listed in table 6.1.  Models of the sites 
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None
None
None except a.a. 
177
None excpet a.a. 
194
120 with 
L15N/R122D,V120N
194b with 
L194N/S86D/K79D
1st generation similar 
site
-3
-3
-3
-5
-4
-5
Charges 
Introduced
L7D, V12N, M88T, F114D, L119ESite 6
L7D, V12N, M88S, F114D, L119ESite 5
T59D, L141N, Q177E, F100E, I136SSite 4
F83D, I161D, A154D, I152E, L194ESite 3
L15D, R122E, V120S, E17, E115Site 2
L194E, S86D, D82, E5, S2DSite 1
LigandsDesign Site
Table 6.1  The second generation designed proteins are detailed with the 
calcium-binding pocket ligands, the charges introduced by mutation to the 
binding ligands, and the similar first generation sites.
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are illustrated in figure 6.1.  Two of the sites, 1 and 2, are based on the 1st generation 
of designed proteins with residue changes to allow for proper chromophore formation.  
Sites 3 and 4 are more aggressive sites than in the past with the hopes that a large 
calcium response would be observed.  Sites 5 and 6 are the same amino acid locations, 
but the ligand types are different. 
Site 1 is very similar to site 194b from the first generation but with a change in 
one of the ligands to avoid fluorescence loss but still obtain a calcium response.  K79D 
caused a complete fluorescence loss in the protein so S2D was included in this 
generation.  Also, 194 was mutated to E instead of N to increase the binding affinity for 
calcium with an additional negative charge incorporated into the site. 
Site 2 is similar to site 120 but V120 was changed to a serine because the valine 
is on the outside but buried inside the other residues.  Mutating 120 to an asparagine in 
the first generation disrupted the chromophore formation so it was mutated to a serine, 
which is also a less frequently used calcium ligand, to reduce the clash from the 
surrounding residues.  L15 was mutated to aspartate and R122 was mutated to 
glutamate to better form the correct calcium binding geometry and to increase the 
binding affinity. 
 Sites 3, 4, and 5 are entirely new sites that were suggested by Dezymer but were 
modified by this researcher and Dr. Wei Yang to better form the calcium binding pocket.  
Site 3 is contained in the upper portion of the barrel with several ligands in the loop 
regions.  The M153T mutation of the cycle 3 variant is near this site so it was thought 
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Site 1
Site 2
Fig 6.1 Pymol models of the second generation of designed calcium-binding 
green fluorescent proteins illustrating the different locations of each site with 
the ligands shown in red and the chromophore in green.
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Site 4 Sites 5 and 6
Site 3
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that binding calcium in this location would likely lead to a large signal change upon 
calcium binding. 
 Site 4 is near the site 177 region and contains residue 177.  This site is slightly 
more inside the barrel than site 177 with the idea that a site closer to the chromophore 
would cause a larger change in fluorescence.  Many of the residues are located in the 
loops so they should be flexible enough to form the correct calcium-binding geometry.  
However, this site does contain a residue that is quite close to the chromophore, T59D, 
which could perturb the chromophore. 
 Sites 5 and 6 are located in an open portion of the barrel with three of the 
residues (12, 114, and 119) at the end of β-strands.  This pocket provides a direct line 
to the chromophore so closing the conformation by calcium binding should cause an 
increase in chromophore fluorescence due to decreased solvent accessibility.  The 
concern for this site was mutating the phenylalanine since it is a large, bulky residue 
and could possibly be involved in π stacking, but there were no other residues in close 
enough proximity that could form the binding pocket.  Therefore, the site was kept to a -
3 charge to reduce the electrostatic repulsion. 
6.2 Protein Engineering of Calcium Sensors 
The second generation variant mutations were performed by site-directed 
mutagenesis directly on the pcDNA3.1+ construct of EGFP so no subclone was 
necessary for mammalian expression.  Table 6.2 details the order in which the 
mutations were completed.  Some of the mutations were carried out in tandem to 
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Site 5 + M88TL7D, V12N, M88T, F114D, L119ESite 6
L7D/V12N
+F114D/L119E
+M88S
L7D, V12N, M88S, F114D, L119ESite 5
T59D
+L141N/I136S
+F100E
+Q177E
T59D, L141N, Q177E, F100E, I136SSite 4
I161D/A154D/I152E
+F83D
+L194E
F83D, I161D, A154D, I152E, L194ESite 3
R122E/V120S
+L15D
L15D, R122E, V120S, E17, E115Site 2
L194E/S86D
+S2D
L194E, S86D, D82, E5, S2DSite 1
Order of MutationsLigandsDesign Site
Table 6.2  The order of the mutagenesis performed for the second
generation.  The proteins that exhibited green fluorescence when expressed 
in HeLa cells are highlighted in green.
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reduce the number of PCR to be performed.  For site 1, the L194N/S86D DNA was 
utilized as the template so that L194N was mutated to E without needing to purchase 
primers and carry out the reaction for S86D.  To engineer site 3, EGFP with the cycle 3 
mutations was utilized since the binding site mutations were located at 152 and 154.  
Sites 5 and 6 were only separated in the last round of PCR when M88 was mutated to 
either S or T. 
Initially, a new polymerase KOD was utilized to engineer the new sites.  After the 
PCR, very large, bright bands were observed in the agarose gel.  Once the samples 
were prepped and received back from automated sequencing, it was realized that only 
one out of 10 samples was correct.  The other samples either did not contain the 
mutations incorporated into the primers or they contained deletions and/or insertions in 
the DNA sequence.  After conferring with other laboratory members, the conclusion was 
drawn that KOD was not as high fidelity as the manufacturer states since only a few 
reactions out of ~40 were correct.  As a note of caution, new reagents should be tested 
stringently before being widely utilized.  Due to these results, turbo pfu was utilized for 
all of the second generation mutations since it has been used for years in our laboratory 
with success. 
6.3 Mammalian Expression of the Second Generation 
          To efficiently identify correctly folded GFP variants, each round of mutations 
was screened for fluorescence by expression in HeLa cells rather than expression in 
bacteria.  In this way, if some mutations caused fluorescence loss, it could be more 
easily identified if there were 1 to 3 mutations in the construct than if it were a full site 
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with 5 or 6 mutations.  The DNA, after being verified through automated sequencing, 
was transfected into HeLa cells and allowed to express at 30 °C for 72 hrs.  Each 
construct was inspected with the three available, standard filters in the inverted 
epifluorescence microscope, DAPI, FITC, and Texas Red. 
  Site 1 with mutations L194E/S86D indicated green fluorescence when expressed 
in HeLa cells at 30 °C for 48 and 72 hrs after transfection with both the UV/DAPI filter 
and the FITC filter (Fig 6.2).  EGFP does not indicate strong fluorescence with the UV 
filter since the UV excitation peak for EGFP is very weak.  This result may indicate 
some shift in the chromophore’s ionic state so that the UV excitation peak is stronger 
than for EGFP.  The full site with L194E/S86D/S2D also indicated fluorescence after 
expression in HeLa cells (Fig 6.3).  The transfection efficiency was approximately 70 to 
80%. 
 Site 2 with mutations R122E/V120S indicated green fluorescence in a few cells, 
but the transfection efficiency was not very high, <20% (Fig 6.4).  Further tests of 
increasing the amount of DNA and varying the DNA:liposome ratio were performed to 
increase the efficiency and obtain more fluorescent cells.  These results are 
encouraging because previous mutations of V120 caused loss of fluorescence of EGFP.  
The mutation to serine should be able to bind calcium but is not disrupting the fold as 
drastically as the mutation to asparagine.  Unfortunately, the addition of the L15D 
mutation caused fluorescence loss.  Likely this additional mutation brought about too 
much electrostatic repulsion or steric clash so that the short distance between Gly67 
and Ser65 could not be achieved.  Since this site is very close to the chromophore and 
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Fig 6.2 Images of the first round of mutations for Site 1, L194E/S86D, 
expressed in HeLa cells taken with the FITC (top left) and DAPI (top right) 
filter and transmitted light (bottom) at 100 ms exposure with the 40x dry 
objective.  The fluorescence observed with the DAPI filter is not evident with 
EGFP, suggesting some change in the spectral profile of Site 1.
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Fig 6.4 Site 2 partial mutations of R122E/V120S expressed in HeLa cells 
with fluorescence observed in one cell.  Other regions were similar with 
one or two fluorescent cells out of ~10 cells.  Images were taken with 1 s 
exposure and a 40x dry objective.
Fig 6.3 Images of Site 1 expressed in HeLa cells with all three mutations, 
indicating fluorescence with the FITC filter and 1 s exposure imaged with 
the 40x dry objective.  These cells were grown at 30 °C for 72 hrs after 
transfection.
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contained in the β-sheets, any repulsion or interference that causes a greater distance 
between the chromophore forming amino acids could prevent the chromophore from 
forming the initial cyclization.  It is likely that the addition of the negative charge from 
L15D was too much for the protein to compensate. 
 The first three mutations in Site 3, I152E/A154D/I161D, were screened in HeLa 
cells as well with expression at 30 °C for 72 hrs.  This variant did not display 
fluorescence.  The cycle 3 mutations were first incorporated into the gene before these 
three mutations were generated.  Apparently, these three mutations disrupt the fold of 
the protein more than the better folding of the cycle 3 mutations can overcome.  
Possibly, the three mutations from hydrophobic residues to charged residues were too 
drastic of a change.  Further mutation of F83D did not yield fluorescent protein. 
 Site 4 with the single mutation T59D did not indicate fluorescence with 
expression in HeLa cells at 30 °C for 72 hrs after transfection.  Since this mutation is 
close to the chromophore, it may have disrupted the fold of the protein or may have 
disturbed the chromophore formation.  Since T59D is located at the end of the central 
helix, mutation of it to a negatively charged residue may have initiated repulsion that 
distorts the α-helix so that the initial cyclization can not ensue.  Further mutation of this 
site to include all of the designed residues did not yield fluorescent protein. 
 Site 5 (and 6) with mutations L7D/V12N indicated fluorescence in HeLa cells with 
the FITC filter as shown in figure 6.5.  However, the fluorescence is weaker than EGFP, 
about 10 times reduced, with a longer exposure time necessary, atleast 2 s.  Since 
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Fig 6.5 Site 5 with mutations L7D/V12N expressed in HeLa cells for 72 hrs 
indicating fluorescence with the FITC filter (left) with 2 s exposure and the 
40x dry objective.
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these two mutations are somewhat precarious due to the change from hydrophobic 
residues to polar residues, the reduced fluorescence is not unexpected.  Further 
mutation to include F114D and L119E failed to produce fluorescent protein.  The M88S 
and M88T mutations were completed as well, but no fluorescence was observed. 
 As indicated in table 6.2, one of the second generation sites indicated 
fluorescence with all of the mutations completed, Site 1.  Site 2 indicated fluorescence 
with the initial two mutations, R122E/V120S, but no fluorescence was observed with the 
addition of the final mutation, L15D.  The first three mutations in Site 3 did not indicate 
fluorescence.  The first mutation, T59D, in Site 4 abolished chromophore fluorescence.  
For Sites 5 and 6, the first mutations, L7D/V12N, indicated fluorescence, but addition of 
F114D and L119E eliminated fluorescence.  Due to Site 1’s fluorescence in HeLa cells, 
it was further studied for calcium response. 
6.4 Site 1 Calcium Response in Vivo 
6.4.1 Cytosolic calcium response of Site 1 
 Since Site 1 indicated fluorescence brighter than 177 and on par with 177c3, it 
was tested for calcium response in HeLa cells.  After transfection optimization, as 
detailed for Site 177 in Chapter 5, it was found that less DNA (1 µg for Site 1 versus 3 
µg for 177) in a 1:3 DNA:Lipofectamine2000 ratio produced fluorescent cells with 60-80% 
transfection efficiency when expressed at 30 °C.  In addition, it was possible to obtain 
fluorescent cells 48 hrs after transfection rather than waiting until 72 hrs.  Site 1 is about 
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ten times less bright than EGFP under the same condition.  Under these conditions, the 
cytosolic calcium response was tested. 
 To test the cytosolic calcium response, the confocal instrument at GSU was 
utilized with the 488 nm line of the Argon laser.  Ionomycin and calcium were added to 
the bathing medium, and images were obtained before and after the additions at regular 
intervals (Fig 6.6).  The cells were monitored for any shape change during the 
experiment.  No fluorescence change was observed when ionomycin was added, but a 
20% increase in fluorescence was observed with addition of 10 mM calcium.  
Concomitant increases were observed with addition of calcium to 20 and 30 mM in the 
bathing medium.  The fluorescence decreased to baseline when the outside calcium 
was removed.  This change is larger than the 177c3 change and occurs at lower outside 
calcium concentrations, promising and exciting results for the second generation of 
designed sensors. 
 The calcium response was also tested by Dr. Monica Lurtz at UC Riverside with 
the inverted Nikon microscope, as shown in figure 6.7.  The fluorescence increases with 
increasing calcium after ionomycin addition very similar to the confocal data obtained at 
GSU.  The fluorescence decreases with removal of the high extracellular calcium. 
6.4.2 Direction of Site 1 to the ER 
 The ER signal peptides were incorporated into Site 1 through the use of PCR for 
the C-terminal KDEL sequence and subcloned into the modified pcDNA3.1+ vector for 
the N-terminal calreticulin sequence.  This vector was discussed in section 5.5 of 
Chapter 5.  In brief, it includes the calreticulin signal peptide at the N-terminal before the 
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BamH1 site so that the gene was simply subcloned into the vector to add the calreticulin 
sequence. 
 After this process was complete, the targeting was tested by cotransfection with 
DsRed2-ER (Clontech).  Imaging of the two proteins revealed complete colocalization, 
implying that the sensor was successfully targeted to the ER (Fig 6.8). 
6.4.3 Response of Site 1 to ER calcium release 
When the ER was stimulated to release calcium by ATP and histamine addition, 
no appreciable change due to the calcium release was observed (Fig 6.8).  Site 1 
illustrated photobleaching that was stronger than the calcium release response.  The 
confocal instrument, due to the use of lasers, is a very strong illuminator so the 
construct was also tested by inverted epifluorescence at UC Riverside.  As shown in 
figure 6.9, the control experiment of EGFP-ER does not indicate a calcium response 
with no appreciable changes in the fluorescence signal upon introduction of high 
ionomycin, utilized to permeate the ER membrane and allow calcium release.  The 
changes observed with an increase in extracellular calcium concentration also occur 
with the baseline cells not expressing EGFP-ER, signifying that the changes are an 
artifact.  As shown in figure 6.10, Site 1-ER responds to calcium changes in the cell by 
exhibiting a decrease in fluorescence signal with ER calcium release.  The fluorescence 
signal then increases with an increase in extracellular calcium, which refills the ER 
stores and likely causes more calcium to enter the ER since the ionomycin permeates 
the ER membrane.  This data strongly suggests that Site 1-ER responds to intracellular 
calcium changes in both the cytosol and in the ER.  In comparison to 177-ER, it is likely 
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Fig 6.8 ER targeted Site 1 cotransfected with DsRed2-ER (top).  The 
intensities of the two proteins are not the same in both cells so one of the 
cells appears more green than orange.  The graph illustrates the imaging 
from calcium release experiments with ATP and histamine.  The inset 
graph is a bleaching control with no additions or induced calcium release.
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Fig 6.9 Control experiments of EGFP-ER expressed in HeLa cells at 30 
°C for 48 hrs after transfection. The only fluorescence signal changes 
observed for this protein are artifacts, as suggested by the changes 
observed for the baseline traces.  Addition of a high concentration of 
ionomycin should permeate the ER membrane and allow calcium release, 
but EGFP does not respond to calcium changes in the cell.
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Fig 6.10 Fluorescence imaging for calcium response of Site1-ER 
expressed in HeLa cells at 30 °C for 72 hrs after transfection.  Addition of 
a high concentration of ionomycin should permeate the ER membrane 
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Site 1-ER.
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that Site 1 has a weaker binding affinity since it is able to indicate calcium response in 
the ER whereas 177 does not display a fluorescence change when expressed in the 
ER. 
6.5 Site 1 in Vitro Profile and Calcium Response 
 6.5.1 Preparation, expression and purification from HeLa cells 
 To express Site 1 in mammalian cells for purification, another vector His/pcDNA4 
was utilized.  This vector is very similar to pcDNA3.1+ but it encodes a 6x histidine tag 
at the N-terminal of the protein for ease of purification.  Since the histidine tag 
purification protocols were well established in our laboratory, this vector and means of 
purification were chosen.  Site 1 in the His/pcDNA4 vector was expressed in HeLa cells 
for 6 days after transfection in suspension culture after harvesting from a 175 cm2 T-
flask at 30 °C to obtain enough protein for in vitro characterization.  In normal 
circumstances, it would be best to express in bacteria because bacteria will produce a 
large amount of protein, but, since these designed sensors are not fluorescent in 
bacteria, it is best to use mammalian cells for the expression.  In addition, the folding in 
bacteria is different so the characterization needed to be performed with the same 
protein that was being tested by microscopy.  Expression in mammalian cells does not 
yield a large amount of protein, but these sensors are bright enough that small amounts 
are measurable.  EGFP can saturate the fluorimeter linear range at 1 µM. 
 After expression, the cells were harvested from the dish by trypsinization and 
sonicated to break the cell membrane and release the protein.  Protein purification was 
276
  
attempted by binding to the nickel chelating column with the protocol utilized for 
bacterial expressed protein (Chapter 4), as shown in figure 6.11.  Elution of the protein 
did not yield pure protein as all of the HeLa proteins had also remained in the column 
and eluted with Site 1, as shown in figure 6.11.  The protein was then bound to the 
Hitrap Q anion exchange column (Chapter 4) with the same results as for the nickel 
chelating column with many contaminant proteins evident in each of the fractions. 
 Another approach was then taken to try to purify the protein by partitioning the 
samples by molecular weight.  Initially, a 10 KDa centricone was utilized to remove salt 
from the sample along with any small molecule proteins or peptides.  The sample was 
exchanged in this manner with buffer (10 mM Tris, 1% glycerol, pH 7.4) numerous 
times, approximately 10-15, until it was certain that all small molecules were removed.  
Then, a 50 KDa centricone was utilized to allow Site 1 to pass through the membrane 
but keep the larger proteins, such as albumin, in the original sample.  After half of the 
sample was exchanged in this way, it was collected and concentrated to 1 mL with the 1 
KDa centricone.  A gel of this process is shown in figure 6.12.  The lack of protein 
observed in the sample after concentration of the 50 KDa exchange indicates that Site 1 
did not pass through the membrane as was expected.  Some precipitation was 
observed during the exchange process, which may have been due to Site 1.  The 
sample was then dialyzed overnight against 2 L of 10 mM Tris, 1 mM DTT, 1% glycerol, 
pH 7.4 to try to remove any contaminants that may have been causing the precipitation.  
The protein appeared to have precipitated in the bag during dialysis, which would have 
allowed for separation by centrifugation and refolding with urea.  However, when the 
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Fig 6.11 SDS-PAGE gels of the purification of Site 1-His/pcDNA 
expressed in suspended HeLa cells.  The top gel is the fractions during 
the binding of Site 1 to the column.  Initially, much of the protein did not 
bind to the column.  The bottom gel is the elution from the nickel chelating 
column, indicating that the protein is not pure.  In addition, distinguishing 
the Site 1 band is difficult since it is not overexpressed as it would be in 
bacteria and there is no distinct band at 30 KDa.
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Fig 6.12 SDS-PAGE gel of the partitioning by molecular weight of Site 1 
expressed in HeLa cells.  Lane 1 is the marker,  lane 2 is the concentrated 
sample after exchange with the 10 and 50 KDa centricones, lane 3 is the 
exchange with the 10 KDa centricone, lane 4 is the cell pellet before 
sonication, lane 5 is the cell pellet after sonication.  The lack of protein 
observed in lane 1 indicates that Site 1 did not pass through the membrane 
as was expected.
1        2       3                              4       5
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protein was transferred to a falcon tube, the protein resolubilized.  Repeated attempts at 
purifying this protein were not successful. 
 6.5.2 Fluorescence profile of Site 1 
 Since the protein could not be purified, a fluorescence profile was obtained with 
the cell lysate after sonication.  Since HeLa cells do not normally express fluorescent 
proteins, any fluorescence observed with the mixture should be due to Site 1.  The 
excitation and emission profiles were obtained as shown in figure 6.13.  Initially, the 
emission was set to 510 nm and the excitation profile was obtained.  A large peak at 
398 nm was observed but no peak at 482 nm, as is normal for EGFP.  The excitation 
was then set to 398 nm and an emission scan was performed from 420 nm to 580 nm.  
It was observed that the emission of Site 1 expressed in HeLa cells occurred at 465 nm, 
between the two peaks (450 nm and 510 nm) normally observed for EGFP.  Excitation 
at several wavelengths did not result in a wavelength shift in the emission indicating that 
the peak was not an artifact or due to some water scattering as occurs for excitation at 
320 nm and 357 nm.  The likely explanation for the emission difference is that the 
mutations made to form the binding site shifted the equilibrium of the neutral and 
anionic states more towards the neutral since excitation occurs at 398 nm, the neutral 
peak.  The emission of the neutral peak at low pH is at 450 nm.  Perhaps the 
chromophore environment was changed by the introduction of the binding site so that 
emission of the neutral peak is red shifted to 465 nm and the chromophore does not 
undergo excited state proton transfer as EGFP does so the primary emission is not 
observed at 510 nm. 
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Fig 6.13 Excitation (top) spectrum with emission at 465 nm and emission 
(bottom) spectra at various excitations for Site 1 cell lysate (in 10 mM Tris, 
1 mM DTT, 1% glycerol, pH 7.4) after expression in HeLa cells.  The 
excitation and emission profiles differ from EGFP.
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 6.5.3 Calcium response of Site 1 in vitro 
 The calcium induced change to Site 1’s spectra was measured by addition of 
calcium in 100 µM increments and the excitation and emission spectra were monitored 
as shown in figure 6.14.  The excitation with emission at 465 nm was observed to 
increase with increasing calcium concentration until the signal saturated at 600 µM 
calcium.  The emission intensity at 465 nm, with excitation at 398 nm, also increased 
with calcium until saturation was reached at 600 µM.  This result suggests that the 
increase in fluorescence signal observed in vivo is due to calcium response.  The data 
could not be fit to a 1:1 binding equation. 
6.6 Creation of Site 1 cycle 3 
 Although Site 1 was bright enough to measure, it consistently photobleached 
during experiments.  Since the ER calcium release could not be measured due to the 
photobleaching, the cycle 3 mutations were added to improve the fold of the protein and 
to allow for a brighter sensor.  Brighter sensors do not demonstrate photobleaching as 
drastically as the more weakly fluorescent sensors, as observed by Dr. Jin Zou’s results 
on our laboratory.  The mutations, F99S, M153T, and V163A, were added as detailed in 
Chapter 5 with M153T/V163A completed in one PCR round by Angela Holder, a M.S. 
student in our laboratory.  The F99S mutation was then included, also performed by 
Angela Holder. 
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Fig 6.14 Excitation (top) spectra with emission at 465 nm and emission 
(bottom) spectra with excitation at 398 nm of Site 1 cell lysate (in 10 mM
Tris, 1 mM DTT, 1% glycerol, pH 7.4)  after expression in HeLa cells.  The
fluorescence signal increases with increasing calcium until saturation is 
reached at 600 µM.
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 6.6.1 Comparison of Site 1 and Site 1-M153T/V163A 
 The original Site 1 was compared to Site 1-M153T/V163A in fluorescence 
intensity and chromophore formation by expression in HeLa cells for 48 and 72 hrs after 
transfection at 30 °C and 37 °C.  As shown in figure 6.15, Site 1 produces fluorescence 
when expressed in HeLa cells at 30 °C and 37 °C, but the intensity with expression at 
30 °C is on average 8 times brighter than that of expression at 37 °C when the data is 
normalized for exposure time.  Expression of Site 1-M153T/V163A at 30 °C and 37 °C 
in HeLa cells both yield brighter fluorescence than expression of Site 1 in HeLa cells as 
shown in figure 6.16.  At 30 °C, Site 1-M153T/V163A is twice as bright as Site 1 and 1.5 
times as bright as Site 1-M153T/V163A expressed at 37 °C.  At 37 °C, Site 1-
M153T/V163A is 10 times brighter than Site 1.  The addition of these two mutations to 
the designed calcium binding sensor allows for expression of the protein at 
physiological temperatures, an advancement in the design of our sensors.  Interestingly, 
EGFP does not produce fluorescence when expressed at 37 °C, but Site 1 does.  This 
may be due to the S2D mutation since the L194N/S86D mutations of site 194b (Chapter 
4) did not produce fluorescence at 37 °C. 
 Figures 6.17 and 6.18 are examples of Site 1 and Site 1-M153T/V163A 
expressed in HeLa cells for 72 hrs at both 30 °C and 37 °C.  Site 1-M153T/V163A is 6 
times brighter than Site 1 when expressed at 37 °C, but they begin to display the same 
average intensity with expression at 30 °C.  However, there are a greater number of 
very bright cells for Site 1-M153T/V163A at 30 °C than for Site 1.  The saturated cells 
are not normally included in calculating the average intensity of a region of interest; 
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Fig 6.15 Images at 20x magnification of Site 1 expressed in HeLa cells 
at 30 °C (top) and 37 °C (bottom) for 48 hr after transfection.  The left 
images are fluorescence with the FITC filter (top is 500 ms, bottom is 
2000 ms), and the right images are transmitted light.
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Fig 6.16 Images at 20x magnification of Site 1-M153T/V163A expressed 
in HeLa cells at 30 °C (top) and 37 °C (bottom) for 48 hr after 
transfection.  The left images are fluorescence with the FITC filter and 
500 ms exposure, and the right images are transmitted light.
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Fig 6.17 Images at 20x magnification of Site 1 expressed in HeLa cells 
at 30 °C (top) and 37 °C (bottom) for 72 hr after transfection.  The left 
images are fluorescence with the FITC filter (top is 500 ms, bottom is 
1000 ms), and the right images are transmitted light.
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Fig 6.18 Images at 20x magnification of Site 1-M153T/V163A expressed 
in HeLa cells at 30 °C (top) and 37 °C (bottom) for 72 hr after 
transfection.  The left images are fluorescence with the FITC filter with 
500 ms exposure, and the right images are transmitted light.
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therefore, the average intensity is the same but the number of saturated cells for Site 1-
M153T/V163A is greater than Site 1.  From this data, there is no doubt that the 
mutations M153T and V163A are quite useful in engineering brighter sensors so that 
less excitation light may be used with shorter exposure times. 
 6.6.2 Bacterial expression and purification of Site 1-M153T/V163A 
 Since Site 1-M153T/V163A indicated very bright fluorescence in mammalian 
cells even when expressed at 37 °C, it was expressed in bacteria by Angela Holder to 
produce enough protein to obtain a Kd by both chromophore fluorescence change and 
by the dye competition assay with Rhodamin-5N (Chapter 4).  The temperature was 
reduced to 30 °C after induction and the cells were incubated overnight with agitation to 
allow the protein enough time to produce a mature chromophore.  Fluostar results of the 
expression indicated that the protein was fluorescent, as shown in figure 6.19.  The high 
expression yield of the protein is indicated by SDS-PAGE with a large band observed at 
33 KDa, as shown in figure 6.20. 
 After expression, the protein was then purified in conjunction with Angela Holder 
with the nickel chelating column and the Hitrap Q anion exchange column on the FPLC.  
The expression yield was so high that the purification had to be repeated twice to 
produce >95% pure protein.  The protein was dialyzed in 10 mM Tris, 1 mM DTT, 1% 
glycerol, p 7.4 after the anion exchange column to remove the excess salt. 
6.6.3 Fluorescence of Site 1-M153T/V163A 
 The fluorescence of Site 1-M153T/V163A was examined on a PTI lifetime 
fluorimeter, as detailed in chapter 2.  The excitation spectrum was obtained with 
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Fig 6.19 Fluostar microarray results of the expression of Site 1-M153T/V163A 
indicating that the protein is fluorescent when expressed in bacteria overnight at 
30 °C.
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Fig 6.20 SDS-PAGE gel of the expression of Site 1-M153T/V163A in 
E. coli indicating the high expression yield of the protein. 
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emission at 510 nm as shown in figure 6.21.  The emission spectra were obtained with 
excitation at 398 nm (Fig 6.21) and 482 nm (Fig 6.22).  The fluorescence of the protein 
is highly similar to EGFP, suggesting that the two mutations allow for proper 
chromophore formation of the designed protein when expressed in bacteria. 
 6.6.4 Calcium response of Site 1-M153T/V163A 
 Site 1-M153T/V163A was tested for calcium response by addition of calcium and 
measurement of the excitation and emission spectra after each calcium addition (Figs 
6.21 and 6.22).  The 510 nm emission with excitation at 482 nm was observed to 
decrease with increasing calcium while the 510 emission with excitation at 398 nm did 
not change with calcium.  A fit of the decrease at 510 nm with excitation at 482 nm with 
the 1:1 binding equation (Eq 2.3) supplied an average Kd of 107 ±13 µM.  This binding 
affinity is similar to the first generation of designed sites, which displayed binding 
affinities of 50-100 µM by dye competition.  However, measurement of 177c3 calcium 
induced changes in vitro did not yield as strong an effect on the chromophore as Site 1-
M153T/V163A exhibits.  This finding represents great progress towards our goal of 
designing intrinsically fluorescent calcium sensors with calcium induced changes in the 
chromophore at low concentrations of calcium.   
6.6.5 Competition assay with Rhodamine-5N and Site 1-M153TV163A 
 To measure the intrinsic binding affinity of the designed site rather than the 
binding affinity obtained by the binding event’s effect on the chromophore, a dye 
competition assay was utilized as detailed in Chapter 4.  Site 1-M153T/V163A and 
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Fig 6.21 Excitation with emission at 510 nm (top) and emission with excitation 
at 398 nm (bottom) spectra of Site 1-M153T/V163A with calcium after 
expression in E. coli.  The excitation and emission are highly similar to EGFP.  
The experiments were performed in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 
7.4. The excitation spectrum changes with increasing calcium, but the 
emission at 510 nm with excitation at 398 nm does not.
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Fig 6.22 Calcium induced chromophore emission change for Site 1-
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Rhodamine-5N were titrated with calcium and the Rhodamine-5N fluorescence at 578 
nm was measured with excitation at 552 nm as shown in figure 6.23.  The buffer for this 
experiment was 10 mM Tris, 1 mM DTT, 20% glycerol, pH 7.4.  The higher glycerol was 
utilized because the stock protein was stored in 20% glycerol and the concentration was 
only 31 µM, which was the concentration needed for the competition.  A control of 
Rhodamine-5N in the same conditions as the competition samples was performed to 
ensure that the binding affinity was not affected by the addition of 20% glycerol and to 
measure the binding affinity in these conditions.  Rhodamine-5N exhibited a Kd of 61.3 
µM.  After the titration, the data was fit as shown in figure 6.24 using Specfit/32 to obtain 
the protein’s Kd, which was 107 µM for one sample and 21 µM for the second sample.  
The data fit of the second sample is not good, but the fit for the first sample is flawless 
so the Kd is likely ~100 µM.  In addition, the binding affinity obtained by calcium’s effect 
on the chromophore is in agreement with the 100 µM binding affinity.  Repetition of this 
result will be completed by Angela Holder to be included in her Master’s thesis. 
6.7 Major Findings 
 The major findings of the second generation endeavor are several fold.  First, 
there are several mutations that disrupt chromophore formation so that GFP is not 
fluorescent as detailed in table 6.2.  Second, changing one residue in a non-fluorescent 
design site, such as 194b, can yield fluorescent protein, Site 1, that responds to calcium 
both in vivo and in vitro.  This particular residue change, from using K79D to using S2D, 
seems to have yielded some ability for the protein to be fluorescent when expressed at 
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Fig 6.23 Rhodamine-5N competition with Site 1-M153T/V163A for 
calcium binding fluorescence emission with excitation at 552 nm. The 
experiment was performed in 10 mM Tris, 1 mM DTT, 20% glycerol, 
pH 7.4.
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Fig 6.24 The two Specfit results of the competition between Site 1-
M153T/V163A and Rhodamine-5N is shown.  The top is the one sample 
that yields a very good fit with a Kd of 107 µM while the bottom graph is the 
sample with a poor fit and a Kd of 21 µM.
297
  
physiological temperatures.  Site 1 responds to calcium with a fluorescence signal 
enhancement both in vivo and in vitro, although the emission maximum seems to be 
shifted from that of EGFP.  Since the filters in use on the microscopes have a wide 
bandwidth, the fluorescence can still be observed but efficient use of this protein would 
require special filters.  The partial cycle 3 mutations, M153T and V163A, confer much 
more brightness to Site 1 and allow for protein expression at 37 °C in HeLa cells.  
These mutations also allow for fluorescent protein to be formed when expressed in 
bacteria.  The spectral profile of Site 1 with these mutations is highly similar to EGFP, 
suggesting that the chromophore is the same and that the mutations do allow for the 
correct distances for chromophore formation as suggested by Zimmer (141).  Site 1-
M153T/V163A indicates chromophore fluorescence response to calcium with an 
average binding affinity of 107 µM and an intrinsic calcium binding affinity of 100 µM by 
dye competition.  The brightness of this protein and the calcium response indicated by 
this protein will allow Site 1-M153T/V163A to be a useful and productive designed 
calcium sensor for future studies. 
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Chapter 7 Conclusions and Major Findings 
7.1 Major Findings of the Designed Calcium-binding Proteins 
Calcium binding green fluorescent proteins were rationally designed based on 
the ideal geometry of pentagonal bipyramid using the computer algorithm Dezymer to 
identify possible sites.  Six sites, detailed in chapter 4, were selected for protein 
engineering based on the criteria discussed in chapter 4, such as flexibility of the site 
and the surrounding environment.  A method of bacterial expression of the proteins with 
an attached 6x histidine tag, and purification using a nickel chelating column has been 
developed.  The attached histidine tag does not interfere with calcium binding 
measurements with no change observed in the fluorescence on a non-calcium binding 
GFP with or without calcium.  The histidine tag does, however, exhibit binding to nickel, 
zinc, copper, cadmium, and cobalt with a range of binding affinities from 6 µM to 50 µM. 
The design sites 120, 177, 194a, and 194b all exhibit metal binding capability for 
calcium and terbium, which demonstrates the generality of our design approach when 
coupled with the CD2 work performed by others in our laboratory.   The terbium binding 
affinities for bacterially expressed protein with the titrations performed in 20 mM PIPES, 
10 mM KCl, 1 mM DTT, 1% glycerol, pH 6.8 are 4.9 ± 0.2 µM for 120, 1.9 ± 0.4 µM for 
177, and 31.6 ± 12.9 µM for 194a.  Site 194b exhibits a terbium binding affinity of 2.9 ± 
0.3 µM when titrated in 10 mM Tris, 1 mM DTT, 1% glycerol, pH 7.4.  The calcium 
binding affinities measured by Rhodamine-5N competition in 10 mM Tris, 1 mM DTT, 
1% glycerol, pH 7.4 are 57.2 ± 1.6 µM for 120, 59.7 ± 4.8 µM for 177, 95.5 ± 6.6 µM for 
194a, and 37.7 ± 4.5 µM for 194b.  The difference in affinities for the calcium analog, 
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terbium, and for calcium likely result from the location of the binding sites, the ligand 
types involved in binding, and the local environment of the sites.  Further modification of 
the binding sites could allow for tuning of the affinities to suit various needs, such as 
calcium measurement in cellular subcompartments. 
Examination of the secondary structure of these proteins revealed native-like 
secondary β-sheet formation with negative maxima observed at 216 nm in the Far-UV 
CD.  This data suggests that the proteins contain the backbone conformation necessary 
for β-sheet indication by CD.  On the other hand, upon assessment of the optical 
properties of these proteins, it was observed that the chromophore native to GFP did 
not form during the designed protein expression in E. coli.  Absorbance measurements 
of the designed proteins produced only a peak at 280 nm, corresponding to the 
aromatic absorbance, with no peak observed for the chromophore.  Fluorescence 
measurements of these proteins with excitation at 482 nm and emission at 510 nm did 
not produce fluorescence signal.  This result is likely due to decreased tertiary packing 
so that the initial cyclization step of the chromophore formation could not occur.  The 
necessary distance between the amide nitrogen of G67 and the S65 carbonyl carbon 
has been shown to be ~3 Ǻ, with increasing distances observed concurrent with less 
fluorescent protein (141).  Small rearrangements of the sidechains induced by repulsion 
of the negative charges of the binding site could lengthen the distance between the 
amide nitrogen and the carbonyl carbon, resulting in no chromophore formation.  
Examination of the partial sites of the designed calcium binding variants suggests that 
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the mutations V120N and K79D are fatal to chromophore formation.  These two 
mutations made alone in EGFP cause complete fluorescence loss. 
Measurement of the pKa of EGFP and the variants L15N and L194N by 
absorbance and fluorescence were performed.  EGFP exhibits an average pKa of 5.99 
by absorbance and of 5.69 by fluorescence at 510 nm for excitation at both 398 nm and 
582 nm.  The pKa at 450 nm was 6.11 for EGFP, which differs from the other pKa 
values, likely due to excited state proton transfer of the neutral form of the 
chromophore.  L15N exhibits an average pKa by absorbance of 5.87 and of 5.65 by 
fluorescence with emission at 510 nm for both 398 nm excitation and 482 nm excitation.  
L15N exhibits a pKa of 6.10 for the 450 nm emission, again not the same as emission at 
510 nm for likely the same reason as EGFP.  L194N exhibits a pKa of 5.83 for emission 
at 510 nm with excitation at 482 nm.  These pKa values are very close and little 
difference is observed for the two mutants when compared to EGFP. 
The quantum yields of EGFP, L15N, and L194N were also measured in this 
laboratory by examination of several concentrations of protein with both absorbance 
and fluorescence.  EGFP exhibits a quantum yield of 0.603.  L15N and L194N exhibit 
slightly lowered quantum yields of 0.44 and 0.43, respectively.  The two mutations 
cause some reduction in the quantum yield of the chromophore but not so much as to 
be detrimental to measurements of the proteins. 
7.2 Expression of Designed Proteins in Mammalian Cells 
 The designed proteins that were not fluorescent when expressed in bacteria 
were tested in mammalian cells to observe if the folding machinery of the mammalian 
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cells could allow for chromophore formation.  Sites 120 and 194a were not fluorescent 
when expressed in HeLa or CHO cells.  Site 177 exhibited fluorescence when 
expressed in HeLa, CHO, Vero, and HEK293 cells.  This outcome suggests that 
chromophore formation of GFP variants is dependent upon the cellular protein synthesis 
machinery, but, also, that particular mutations lead to fluorescence loss.  The mutations 
V120N and K79D disrupt chromophore formation, even in mammalian cells. 
 Further modification of Site 177 by addition of the cycle 3 mutations (F99S, 
M153T, V163A) increased the brightness of the protein when expressed at 30 °C and 
indicated weak fluorescence when expressed at 37 °C.  These mutations were also 
added to site 120 and 194a, but fluorescence was not observed.  Coupled with 
Zimmer’s observations on the distance changes caused by the cycle 3 mutations, it is 
apparent that chromophore formation is dependent upon several factors, i.e. the 
distance between Gly67 and Ser65 and the folding trajectory of the protein.  The 
increased fluorescence of 177c3 allows for shorter exposure times during imaging 
experiments and measurements of quick calcium response. 
7.3 Major Findings from In Vivo Imaging of Calcium Response 
 Site 177 and 177c3 indicate calcium response when expressed in the cytosol of 
HeLa cells.  Induced calcium concentration changes by addition of ionomycin and 
calcium to the bathing medium indicated an increase in fluorescence of 177 and 177c3 
with decreases observed concomitant with reduction of calcium in the bathing medium.  
These results indicate that the designed proteins 177 and 177c3 are able to sense 
calcium changes in the cytosolic environment. 
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 When the designed proteins 177 and 177c3 were targeted to the ER through the 
use of signal peptides, they were observed to colocalize in the ER with a purchased 
DsRed-ER construct.  When calcium release was stimulated with addition of histamine 
and ATP, no release was apparent by measuring the fluorescence.  This result could be 
due to three factors.  The binding affinity measured by bacterially expressed protein 
may not be the same as the binding affinity for the protein expressed in HeLa cells.  
Since the tertiary structure of the protein is apparently better packed in HeLa cells, as 
observed by the chromophore formation, the binding site could be in a different 
conformation, which may change the binding affinity.  In addition, the effect of calcium 
binding on the chromophore is related to the binding affinity but will not necessarily be in 
accordance with the Kd since it is a secondary process caused by a change in the 
chromophore environment.  Considering the fluorescence increase observed when the 
cytosolic calcium concentration is raised, likely up to 10 µM, and the lack of 
fluorescence change in the ER observed when calcium is released, it is likely that the 
binding affinity for calcium is stronger than that measured from bacterially expressed 
protein.  Modification of the binding site to weaken the affinity would likely result in an 
observable fluorescence change upon calcium release from the ER.  The binding affinity 
of the protein expressed in HeLa cells will be measured before publication of this work.  
Also, the fluorescence of 177 is quite weak when expressed in the ER due to the 
reduced volume and possibly the environment.  For this reason, the sensing ability of 
the protein may be reduced since this protein decreases in fluorescence when calcium 
is removed and measuring a decrease in an already weak signal is difficult. 
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7.4 Major Findings of the Second Generation of Designed Proteins 
 In the second generation, one full site was observed to maintain fluorescence 
after all mutations were made, Site 1 with mutations L194E, S86D, and S2D.  The other 
5 sites in the design included aggressive mutations that likely disrupted the tertiary 
structure of the protein.  For Site 2, the combination of the mutations results in 
fluorescence loss although each of the individual mutations does not.  The introduction 
of the clustered negative charges likely is the cause.  For sites 3 and 4, the mutations of 
Ile and Phe to Asp or Glu possibly cause the fluorescence loss.  For sites 5 and 6, the 
L7D and V12N mutations were fluorescent, but the addition of F114D and L119E 
resulted in no fluorescence.  This could be due to the incorporation of clustered 
negative charges and/or the mutation of Phe to Asp.  Since Sites 2-6 were not 
fluorescent, they were not pursued as calcium sensors. 
 Inclusion of the mutations M153T and V163A in the Site 1 construct allowed for 
expression of the protein at 37 °C in HeLa cells with bright fluorescence observed.  In 
addition, Site 1-M153T/V163A was expressed in bacteria with fluorescence observed.  
Measurement of the calcium affinity of this construct through in vitro fluorescence 
changes of the chromophore upon calcium addition produced a Kd of 107 µM.  Dye 
competition measurements of the intrinsic binding affinity of Site 1-M153T/V163A 
yielded a Kd of 100 µM, which is in good agreement with the chromophore fluorescence 
binding affinity.  This protein will likely prove to be a useful sensor. 
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7.5 Major Findings of the in Vivo Calcium Measurements of Site 1 
 Site 1 exhibits calcium response when expressed in the cytosol of HeLa cells 
with an increase in fluorescence that is removed when calcium is removed from the 
bathing medium.  When Site 1 was targeted to the ER, it was observed to colocalize 
with the purchased DsRed-ER.  Calcium release caused by addition of larger 
concentrations of ionomycin to permeate the ER membrane resulted in a 20% 
fluorescence decrease, indicating that this designed protein responds to calcium 
release from the ER.  Addition of calcium to the bathing medium to force the ER to 
reuptake calcium resulted in fluorescence increase 25% greater than the resting 
fluorescence for a total of approximately 56% from calcium free to calcium loaded.  This 
large change in fluorescence from calcium free to calcium loaded suggests that the 
binding affinity for Site 1 is quite different than that for 177.  When calcium is released 
from the ER, the equilibrium of the protein-calcium binding shifts to free protein if the Kd 
is weak enough.  A stronger binding affinity shifts the equilibrium more to the metal-
protein complex so that removal of free metal would not greatly affect the fluorescence.  
Possibly Site 177 has a stronger binding affinity than Site 1 so that ER calcium changes 
can not be observed because 177 does not release calcium as readily as Site 1.  The 
cytosolic fluorescence response observed by these two sensors, with calcium 
concentration of 10-20 µM, is still in the observable range of these sensors if the binding 
affinities are low micromolar to 100 µM.  The binding affinity of Site 1 will be measured 
from bacterially expressed and HeLa expressed protein before this work is published in 
a journal. 
305
  
References 
 
1. Clapham, D. E. (1995) Cell 80, 259-268. 
2. Carafoli, E., and Penniston, J. T. (1985) Sci Am 253, 70-8. 
3. Murakami, K., Yumoto, F., Ohki, S. Y., Yasunaga, T., Tanokura, M., and 
Wakabayashi, T. (2005) J Mol Biol 352, 178-201. 
4. Barnes, S., and Kelly, M. E. (2002) Adv Exp Med Biol 514, 465-76. 
5. Palczewski, K., Verlinde, C. L., and Haeseleer, F. (1999) Novartis Found Symp 
224, 191-204; discussion 204-7. 
6. Konur, S., and Ghosh, A. (2005) Neuron 46, 401-5. 
7. Rakhilin, S. V., Olson, P. A., Nishi, A., Starkova, N. N., Fienberg, A. A., Nairn, A. 
C., Surmeier, D. J., and Greengard, P. (2004) Science 306, 698-701. 
8. Bootman, M. D., and Berridge, M. J. (1995) Cell 83, 675-8. 
9. Berridge, M. J. (1994) Mol Cell Endocrinol 98, 119-24. 
10. Gunter, T. E., Yule, D. I., Gunter, K. K., Eliseev, R. A., and Salter, J. D. (2004) 
FEBS Lett 567, 96-102. 
11. Malviya, A. N., and Rogue, P. J. (1998) Cell 92, 17-23. 
12. Duchen, M. R. (2000) J Physiol 529 Pt 1, 57-68. 
13. Kohlmeier, L., Gasner, C., and Marcus, R. (1993) American Journal of Medicine 
95, 568-572. 
14. Sigel, H. (1984) in Calcium and Its Biological Role (Sigel, H., Ed.), Marcel 
Dekker, Inc., New York. 
306
  
15. Louis, C. F., Balog, E. M., and Fruen, B. R. (2001) Biosci Rep 21, 155-68. 
16. Balog, E. M., Fruen, B. R., Shomer, N. H., and Louis, C. F. (2001) Biophys J 81, 
2050-8. 
17. Zhao, F., Li, P., Chen, S. R., Louis, C. F., and Fruen, B. R. (2001) J Biol Chem 
276, 13810-6. 
18. Mickelson, J. R., and Louis, C. F. (1996) Physiol Rev 76, 537-92. 
19. Shomer, N. H., Mickelson, J. R., and Louis, C. F. (1995) Muscle Nerve 18, 1167-
76. 
20. Kretsinger, R. H., Rudnick, S. E., and Weissman, L. J. (1986) J Inorg Biochem 
28, 289-302. 
21. Vinogradova, M. V., Reddy, V. S., Reddy, A. S., Sablin, E. P., and Fletterick, R. 
J. (2004) J Biol Chem 279, 23504-9. 
22. Chou, J. J., Li, S., Klee, C. B., and Bax, A. (2001) Nat Struct Biol 8, 990-7. 
23. Fajmut, A., Brumen, M., and Schuster, S. (2005) FEBS Lett 579, 4361-6. 
24. Taylor, C. W., and Laude, A. J. (2002) Cell Calcium 32, 321-34. 
25. Kahl, C. R., and Means, A. R. (2003) Endocr Rev 24, 719-36. 
26. Herzberg, O., Moult, J., and James, M. N. (1986) Ciba Found Symp 122, 120-44. 
27. Heim, N., and Griesbeck, O. (2004) J Biol Chem 279, 14280-6. 
28. Menaldino, D. S., Bushnev, A., Sun, A., Liotta, D. C., Symolon, H., Desai, K., 
Dillehay, D. L., Peng, Q., Wang, E., Allegood, J., Trotman-Pruett, S., Sullards, M. 
C., and Merrill, A. H., Jr. (2003) Pharmacol Res 47, 373-81. 
307
  
29. Merrill, A. H., Jr., Schmelz, E. M., Dillehay, D. L., Spiegel, S., Shayman, J. A., 
Schroeder, J. J., Riley, R. T., Voss, K. A., and Wang, E. (1997) Toxicol Appl 
Pharmacol 142, 208-25. 
30. Hofer, A. M. (2001) in Calcium Signalling (Tepikin, A. V., Ed.) pp 111-123, Oxford 
University Press, Oxford. 
31. Probes, M. (2005), Molecular Probes. 
32. Richard P. Haugland, P. D. (1996), Molecular Probes, Inc., Eugene. 
33. Richard P. Haugland, P. D. (2001), Molecular Probes, Inc., Eugene. 
34. Takita, M., Puka-Sundvall, M., Miyakawa, A., and Hagberg, H. (2004) Neurosci 
Res 48, 169-73. 
35. Rusakov, D. A., and Fine, A. (2003) Neuron 37, 287-97. 
36. Landolfi, B., Curci, S., Debellis, L., Pozzan, T., and Hofer, A. M. (1998) J Cell Biol 
142, 1235-43. 
37. Wang, Z., Tymianski, M., Jones, O. T., and Nedergaard, M. (1997) J Neurosci 
17, 7359-71. 
38. Inouye, S. (2001) Tanpakushitsu Kakusan Koso 46, 220-7. 
39. Robert, V., Pinton, P., Tosello, V., Rizzuto, R., and Pozzan, T. (2000) Methods 
Enzymol 327, 440-56. 
40. Missiaen, L., Van Acker, K., Van Baelen, K., Raeymaekers, L., Wuytack, F., 
Parys, J. B., De Smedt, H., Vanoevelen, J., Dode, L., Rizzuto, R., and 
Callewaert, G. (2004) Cell Calcium 36, 479-87. 
308
  
41. George, S. E., Schaeffer, M. T., Cully, D., Beer, M. S., and McAllister, G. (2000) 
Anal Biochem 286, 231-7. 
42. Torrecilla, I., Leganes, F., Bonilla, I., and Fernandez-Pinas, F. (2000) Plant 
Physiol 123, 161-76. 
43. Tepikin, A. (2001), Oxford University Press, New York. 
44. Magalhaes, P. J., Pinton, P., Filippin, L., and Pozzan, T. (2001) in Calcium 
Signalling (Tepikin, A., Ed.), Oxford University Press, Oxford. 
45. Stables, J., Mattheakis, L. C., Chang, R., and Rees, S. (2000) Methods Enzymol 
327, 456-71. 
46. Persechini, A. (2002) Methods Mol Biol 173, 365-82. 
47. Romoser, V. A., Hinkle, P. M., and Persechini, A. (1997) J Biol Chem 272, 
13270-4. 
48. Persechini, A., Lynch, J. A., and Romoser, V. A. (1997) Cell Calcium 22, 209-16. 
49. Delano, W. L. (2002), Delano Scientific, San Carlos, CA. 
50. Miyawaki, A., Llopis, J., Heim, R., McCaffery, J. M., Adams, J. A., Ikura, M., and 
Tsien, R. Y. (1997) Nature 388, 882-7. 
51. Baird, G. S., Zacharias, D. A., and Tsien, R. Y. (1999) Proc Natl Acad Sci U S A 
96, 11241-6. 
52. Miyawaki, A., Griesbeck, O., Heim, R., and Tsien, R. Y. (1999) Proc Natl Acad 
Sci U S A 96, 2135-40. 
53. Allen, G. J., Kwak, J. M., Chu, S. P., Llopis, J., Tsien, R. Y., Harper, J. F., and 
Schroeder, J. I. (1999) Plant J 19, 735-47. 
309
  
54. Nagai, T., Sawano, A., Park, E. S., and Miyawaki, A. (2001) Proc Natl Acad Sci U 
S A 98, 3197-202. 
55. Kaprielian, R., del Monte, F., and Hajjar, R. J. (2002) Basic Res Cardiol 97 Suppl 
1, I136-45. 
56. Pogwizd, S. M., and Bers, D. M. (2002) Ann N Y Acad Sci 976, 454-65. 
57. Pieske, B., Maier, L. S., and Schmidt-Schweda, S. (2002) Basic Res Cardiol 97 
Suppl 1, I63-71. 
58. Hempel, P., Hoch, B., Bartel, S., and Karczewski, P. (2002) Basic Res Cardiol 97 
Suppl 1, I96-101. 
59. Schuhmeier, R. P., Dietze, B., Ursu, D., Lehmann-Horn, F., and Melzer, W. 
(2003) Biophys J 84, 1065-78. 
60. Linse, S., and Forsen, S. (1995) Adv Second Messenger Phosphoprotein Res 
30, 89-151. 
61. Forsen, S., Linse, S., Thulin, E., Lindegard, B., Martin, S. R., Bayley, P. M., 
Brodin, P., and Grundstrom, T. (1988) Eur J Biochem 177, 47-52. 
62. Palmer, A. E., Jin, C., Reed, J. C., and Tsien, R. Y. (2004) Proc Natl Acad Sci U 
S A 101, 17404-9. 
63. Tsien, R. Y. (1998) Annual Review of Biochemistry 67, 509-544. 
64. Yang, F., Moss, L. G., and G. N. Phillips, J. (1996) Nat. Biotechnol. 14, 1246-
1251. 
65. Remington, S. J. (2000) Methods Enzymol 305, 196-211. 
310
  
66. Baird, G. S., Zacharias, D. A., and Tsien, R. Y. (1999) Proceedings of the 
National Academy of Science 96, 11241-11246. 
67. Angelis, D. A. D., Miesenbock, G., Zemelman, B. V., and Rothman, J. E. (1998) 
Proceeding of the National Academy of Science 95, 12312-12316. 
68. Richmond, T. A., Takahashi, T. T., Shimkhada, R., and Bernsdorf, J. (2000) 
Biochemical and Biophysical Research Communications 268, 462-465. 
69. Jensen, K. K., Martini, L., and Schwartz, T. W. (2001) Biochemistry 40, 938-945. 
70. Miyawaki, A., Griesbeck, O., Heim, R., and Tsien, R. Y. (1999) Proc. Natl. Aca. 
Sci. 96, 2135-2140. 
71. Liao, B., Paschal, B. M., and Luby-Phelps, K. (1999) Proc. Natl. Acad. Sci. 96, 
6217-6222. 
72. Nagai, T., Sawano, A., Park, E. S., and Miyawaki, A. (2001) Proc. Natl. Acad. 
Sci. 98, 3197-3202. 
73. Bajorath, J., Hinrichs, W., and Saenger, W. (1988) Eur J Biochem 176, 441-7. 
74. McPhalen, C. A., Strynadka, N. C., and James, M. N. (1991) Adv Protein Chem 
42, 77-144. 
75. Kretsinger, R. H. (1976) Int Rev Cytol 46, 323-93. 
76. Kretsinger, R. H. (1976) Annu Rev Biochem 45, 239-66. 
77. Kawasaki, H., and Kretsinger, R. H. (1995) Protein Profile 2, 297-490. 
78. Kawasaki, H., and Kretsinger, R. H. (1994) Protein Profile 1, 343-517. 
79. Babu, Y. S., Sack, J. S., Greenhough, T. J., Bugg, C. E., Means, A. R., and 
Cook, W. J. (1985) Nature 315, 37-40. 
311
  
80. Swain, A. L., Kretsinger, R. H., and Amma, E. L. (1989) J Biol Chem 264, 16620-
8. 
81. Nagar, B., Overduin, M., Ikura, M., and Rini, J. M. (1996) Nature 380, 360-4. 
82. Linse, S., Johansson, C., Brodin, P., Grundstrom, T., Drakenberg, T., and 
Forsen, S. (1991) Biochemistry 30, 154-62. 
83. Linse, S., Brodin, P., Johansson, C., Thulin, E., Grundstrom, T., and Forsen, S. 
(1988) Nature 335, 651-2. 
84. Ye, Y., Lee, H. W., Yang, W., and Yang, J. J. (2005) J Inorg Biochem 99, 1376-
83. 
85. Ye, Y., Lee, H. W., Yang, W., Shealy, S., and Yang, J. J. (2005) J Am Chem Soc 
127, 3743-50. 
86. Yang, W., Wilkins, A. L., Ye, Y., Liu, Z. R., Li, S. Y., Urbauer, J. L., Hellinga, H. 
W., Kearney, A., van der Merwe, P. A., and Yang, J. J. (2005) J Am Chem Soc 
127, 2085-93. 
87. Yang, W., Jones, L. M., Isley, L., Ye, Y., Lee, H. W., Wilkins, A., Liu, Z. R., 
Hellinga, H. W., Malchow, R., Ghazi, M., and Yang, J. J. (2003) J Am Chem Soc 
125, 6165-71. 
88. Wilkins, A. L., Ye, Y., Yang, W., Lee, H. W., Liu, Z. R., and Yang, J. J. (2002) 
Protein Eng 15, 571-4. 
89. Yang, W., Lee, H. W., Hellinga, H., and Yang, J. J. (2002) Proteins 47, 344-56. 
90. Minta, A., and Tsien, R. Y. (1989) The Journal of Biological Chemistry 264, 
19449-19457. 
312
  
91. Harootunian, A. T., Kao, J. P. Y., Eckert, B. K., and Tsien, R. Y. (1989) The 
Journal of Biological Chemistry 264, 19458-19467. 
92. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) Journal of Biological 
Chemistry 260, 3440-3450. 
93. Kawanishi, T., Blank, L. M., Harootunian, A. T., Smith, M. T., and Tsien, R. Y. 
(1989) Journal of Biological Chemistry 264, 12859-12866. 
94. Ozmen, B., and Akkaya, E. U. (2000) Tetrahedron Letters 41, 9185-9188. 
95. Akkaya, E. U., and Turkyilmaz, S. (1997) Tetrahedron Letters 38, 4513-4516. 
96. Liu, Y., Zhang, H.-Y., Bai, Z.-P., Wada, T., and Inoue, Y. (2000) Journal of 
Organic Chemistry 65, 7105-7109. 
97. Nakatsuji, Y., Nakamura, T., Yonetani, M., Yuya, H., and Okahara, M. (1988) 
Journal of the American Chemical Society 110, 531-538. 
98. Barbour, L. J., Wall, S. L. D., Meadows, E. S., and Gokel, G. W. (2000) Industrial 
and Engineering Chemistry Research 39, 3436-3441. 
99. Wong, A., and Wu, G. (2000) The Journal of Physical Chemistry A Web, A-I. 
100. Pederson, C. J. (1967) Journal of the American Chemical Society 89, 7017-7036. 
101. Erk, C. (2000) Industrial and Engineering Chemistry Research 39, 3582-3588. 
102. Hay, B. P., and Rustad, J. R. (1994) Journal of the American Chemical Society 
116, 6316-6326. 
103. Boulatov, R., Du, B., Meyers, E. A., and Shore, S. G. (1999) Inorganic Chemistry 
1999, 4554-4558. 
313
  
104. Feller, D., Thompson, M. A., and Kendall, R. A. (1997) Journal of Physical 
Chemistry 101, 7292-7298. 
105. Erk, C., and Gocmen, A. (2000) Talanta 53, 137-140. 
106. Atwood, J. L., and Junk, P. C. (2000) Polyhedron 19, 85-91. 
107. Bradshaw, J. S., and Izatt, R. M. (1997) Accounts of Chemical Research 30, 338-
345. 
108. Prodi, L., Bolletta, F., Montalti, M., Zaccheroni, M., Savage, P. B., Bradshaw, J. 
S., and Izatt, R. M. (1998) Tetrahedron Letters 39, 5451-5454. 
109. Bordunov, A. B., Bradshw, J. S., Zhang, X. X., Dalley, N. K., Kou, X., and Izatt, 
R. M. (1996) Inorganic Chemistry 35, 7229-7240. 
110. Strekowski, L., Lipowska, M., and Patonay, G. (1992) Journal of Organic 
Chemistry 57, 4578-4580. 
111. Gorecki, T., Patonay, G., Strekowski, L., Chin, R., and Salazar, N. (1996) Journal 
of Heterocyclic Chemistry 33, 1871-1876. 
112. Yang, W., Tsai, T., Kats, M., and Yang, J. J. (2000) Journal of Peptide Research 
55, 203-215. 
113. Bagshaw, C. R., and Harris, D. A. (1987)  (Bagshaw, C. R., and Harris, D. A., 
Eds.) pp 91-113, IRL Press, Washington. 
114. Lipowska, M., Patterson, S. E., Patonay, G., and Strekowski, L. (1993) Journal of 
Heterocyclic Chemistry 30, 1177-1180. 
115. Valet, G., Raffael, A., and Russmann, L. (1985) Naturwissenschaften 72, 600-
602. 
314
  
116. Murphy, E., Freudenrich, C. C., Levy, L. A., London, R. E., and Lieberman, M. 
(1989) Proceedings of the National Academy of Science 86, 2981-2984. 
117. Scheenen, W. J. J. M., Makings, L. T., Gross, L. R., Pozzan, T., and Tsien, R. Y. 
(1996) Chemistry & Biology 3, 765-774. 
118. Strekowski, L., Lipowska, M., Gorecki, T., Mason, J. C., and Patonay, G. (1996) 
Journal of Heterocyclic Chemistry 33, 1685-1688. 
119. Linse, S., and Forsen, S. (1995) Adv Second Messenger Phosphoprotein Res 
30, 89-151. 
120. Falke, J. J., Drake, S. K., Hazard, A. L., and Peersen, O. B. (1994) Q. Rev. 
Biophys. 27, 219-90. 
121. Battistutta, R., Negro, A., and Zanotti, G. (2000) Proteins 41, 429-37. 
122. Palm, G. J., Zdanov, A., Gaitanaris, G. A., Stauber, R., Pavlakis, G. N., and 
Wlodawer, A. (1997) Nat Struct Biol 4, 361-5. 
123. Yang, F., Moss, L. G., and Phillips, G. N., Jr. (1996) Nat Biotechnol 14, 1246-51. 
124. Zhu, H., Oezguen, N., Soman, K., Fraczkiewicz, R., and Braun, W. (1996). 
125. King, J., and Betts, S. (1999) Nat Biotechnol 17, 637-8. 
126. Waldo, G. S., Standish, B. M., Berendzen, J., and Terwilliger, T. C. (1999) Nat 
Biotechnol 17, 691-5. 
127. Suzuki, M., Ito, Y., Savage, H. E., Husimi, Y., and Douglas, K. T. (2004) Biochim 
Biophys Acta 1679, 222-9. 
128. Mohanty, A. K., and Wiener, M. C. (2004) Protein. Expr. Purif. 33, 311-25. 
315
  
129. Spiga, O., Scarselli, M., Bernini, A., Ciutti, A., Giovannoni, L., Laschi, F., Bracci, 
L., and Niccolai, N. (2002) Biophys. Chem. 97, 79-86. 
130. Ghanem, M., and Gadda, G. (2005) Biochemistry 44, 893-904. 
131. Hanson, G. T., McAnaney, T. B., Park, E. S., Rendell, M. E., Yarbrough, D. K., 
Chu, S., Xi, L., Boxer, S. G., Montrose, M. H., and Remington, S. J. (2002) 
Biochemistry 41, 15477-88. 
132. McAnaney, T. B., Park, E. S., Hanson, G. T., Remington, S. J., and Boxer, S. G. 
(2002) Biochemistry 41, 15489-94. 
133. McAnaney, T. B., Shi, X., Abbyad, P., Jung, H., Remington, S. J., and Boxer, S. 
G. (2005) Biochemistry 44, 8701-11. 
134. Jain, R. K., Joyce, P. B., Molinete, M., Halban, P. A., and Gorr, S. U. (2001) 
Biochem J 360, 645-9. 
135. Ostergaard, H., Henriksen, A., Hansen, F. G., and Winther, J. R. (2001) Embo J 
20, 5853-62. 
136. Sacchetti, A., Cappetti, V., Marra, P., Dell'Arciprete, R., El Sewedy, T., 
Crescenzi, C., and Alberti, S. (2001) J Cell Biochem 81, 117-128. 
137. Sakikawa, C., Taguchi, H., Makino, Y., and Yoshida, M. (1999) J Biol Chem 274, 
21251-6. 
138. Foecking, M. K., and Hofstetter, H. (1986) Gene 45, 101-5. 
139. Vessoni Penna, T. C., and Ishii, M. (2002) BMC Biotechnol 2, 7. 
140. Vessoni Penna, T. C., Ishii, M., Cholewa, O., and de Souza, L. C. (2004) Lett 
Appl Microbiol 38, 135-9. 
316
  
141. Baffour-Awuah, N. Y., Fedeles, F., and Zimmer, M. (2005) Chemical Physics 
310, 25-31. 
142. Churchill, G. C., Lurtz, M. M., and Louis, C. F. (2001) Am J Physiol Cell Physiol 
281, C972-81. 
143. Lurtz, M. M., and Louis, C. F. (2003) Am J Physiol Cell Physiol 285, C1475-82. 
144. Zou, J., Ye, Y., Welshhans, K., Lurtz, M., Ellis, A. L., Louis, C., Rehder, V., and 
Yang, J. J. (2005) J Biotechnol 119, 368-78. 
 
 
 
317
